Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,42346,-0.482992408665274,0.0113689831423981,-0.505275615624374,-0.460709201706174,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,42611,-0.183200535445049,0.0038785776569089,-0.190802547652591,-0.175598523237508,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42587,-0.310902472073968,0.00834255881261096,-0.327253887346685,-0.29455105680125,2.53518798329176e-289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42754,-0.175000854214824,0.00472687485224108,-0.184265528925217,-0.165736179504432,6.57063556368567e-286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42721,-0.214836496243226,0.00590181646227397,-0.226404056509283,-0.203268935977169,7.19784912656442e-277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.167968626420292,0.00469071317989361,-0.177162424252883,-0.1587748285877,2.58069777223677e-268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.129671885239016,0.00380421957766015,-0.13712815561123,-0.122215614866802,1.59774696935021e-242
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,40532,0.162457029684722,0.00488818552217439,0.15287618606126,0.172037873308183,3.37131834478843e-231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,40116,-0.308075091359585,0.00943812808267266,-0.326573822401624,-0.289576360317547,4.41535264309606e-223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,42569,-0.19844153566644,0.00685243596420968,-0.211872310156291,-0.185010761176589,6.6979287129343e-179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,40511,-0.221679659739803,0.00772040738455539,-0.236811658213531,-0.206547661266074,4.46309704707757e-175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,42568,-0.111122485353951,0.00392564083171974,-0.118816741384121,-0.10342822932378,3.02020989248174e-171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0861200136719273,0.00308982152574739,0.0800639634814624,0.0921760638623922,2.85815822476962e-166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42661,-0.209205479353728,0.00756112509666765,-0.224025284543197,-0.19438567416426,6.13263799707427e-164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0745730681602538,0.0028541774429689,-0.0801672559484729,-0.0689788803720348,8.64622781220139e-147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.167315807514067,0.00641403052126482,-0.179887307335746,-0.154744307692388,2.66263672614459e-146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.142924986303103,0.00549784963465329,-0.153700771587024,-0.132149201019183,1.16841962821247e-144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.0687977331078386,0.00267201765062494,0.0635605785126137,0.0740348877030635,9.4240002543891e-143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.285320674391093,0.0112715125312308,0.263228509829881,0.307412838952305,3.55107682085417e-138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,40532,0.0558169929696697,0.00224051390516348,0.0514255857155493,0.0602084002237901,2.02347702332633e-133
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.127521583640145,0.00516519144846955,-0.137645358879146,-0.117397808401145,4.18433583231219e-131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42636,-0.0787007365848633,0.00321941600190727,-0.0850107919486016,-0.0723906812211251,3.62368246184215e-129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.159775951499065,0.00654510848985789,-0.172604364139186,-0.146947538858943,8.25232451737814e-129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,40182,-0.187988181791838,0.00771080412487542,-0.203101357876594,-0.172875005707082,6.73287216554338e-128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0778634660591129,0.00320311909028951,-0.0841415794760803,-0.0715853526421454,9.5271577874273e-128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,42311,-0.116382415463784,0.00491321397400103,-0.126012314852826,-0.106752516074742,1.68867839836322e-121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42600,-0.229714584066751,0.00976064605240275,-0.248845450329461,-0.210583717804042,4.80602572845485e-120
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.252767590964494,0.0110373563434425,-0.274400809397641,-0.231134372531347,6.63249198836358e-114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.115813642055022,0.00505821850595033,-0.125727750326685,-0.10589953378336,7.66057818195229e-114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.115352128850478,0.00507393064924711,-0.125297032923003,-0.105407224777954,2.93902924699009e-112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,42370,-0.165488858541597,0.00752115448197187,-0.180230321326262,-0.150747395756932,2.10233108924087e-105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.169803196066469,0.0078063503477181,-0.185103642747996,-0.154502749384941,4.21010921100443e-103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42587,-0.0716943226235519,0.00333794171201819,-0.0782366883791076,-0.0651519568679963,1.22019383618516e-100
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,40539,0.140242529826594,0.00652978400999188,0.12744415316701,0.153040906486178,2.4852614535595e-100
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.279168886894208,0.0130546681363776,-0.304756036441508,-0.253581737346907,8.30289076675359e-100
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0701162039140662,0.00332315004998263,-0.0766295780120322,-0.0636028298161003,2.98726855161175e-97
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42636,0.0920934003554799,0.00440337374495457,0.083462787815369,0.100724012895591,1.31320497309219e-95
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,42618,-0.111786005739254,0.00536174313734871,-0.122295022288457,-0.10127698919005,4.97325243835076e-95
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42636,-0.118552466520221,0.00571183830388031,-0.129747669595827,-0.107357263444616,3.25603777755363e-94
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.141841483439569,0.00685981510620865,-0.155286721047738,-0.1283962458314,2.97356963042976e-93
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0379100352776869,0.00186518755951205,0.0342542676610432,0.0415658028943305,1.77793220390758e-90
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0658777837963889,0.00325966582240074,-0.0722667288082943,-0.0594888387844834,1.66758448068923e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0590085268642572,0.00292625335613371,-0.0647439834422793,-0.0532730702862351,4.15423541437267e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,40511,-0.170184039603823,0.00851576508214231,-0.186874939164822,-0.153493140042825,2.38690695306815e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,42754,-0.054626047043739,0.00274768220300088,-0.0600115041616207,-0.0492405899258573,1.02163122756733e-86
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0610660573703591,0.00310356751897322,-0.0671490497075466,-0.0549830650331716,5.3134900336101e-85
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,41747,-0.0783992568849774,0.00399284054804806,-0.0862252243591516,-0.0705732894108032,1.43573718169166e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0569492186991518,0.00290260931694094,-0.062638332960356,-0.0512601044379475,1.5815603385104e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.0615807541777906,0.00314065217499586,0.0554250759147987,0.0677364324407825,2.01367098433971e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,42326,-0.110614605806046,0.00566179730539501,-0.12171172852462,-0.0995174830874719,8.20139773299565e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.274205132683559,0.0142046108650691,-0.302046169979095,-0.246364095388024,6.56268296090718e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,42636,0.0686541221335599,0.00356029484341965,0.0616759442404574,0.0756323000266624,9.40072278281376e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.147841120931669,0.00771820546927234,-0.162968803651443,-0.132713438211895,1.10020021907922e-80
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42636,-0.104784486762166,0.00558538686030515,-0.115731845008364,-0.0938371285159676,1.5501526706929e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0653762005554428,0.00350348793628004,-0.0722430369105517,-0.058509364200334,9.61067747391535e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42794,-0.0906785057834869,0.00495029230253902,-0.100381078696463,-0.0809759328705105,4.62745790748662e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42752,0.0619955615927317,0.00339510015176874,0.055341165295265,0.0686499578901984,1.30354919654285e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.102083689131159,0.00559677164247091,-0.113053361550402,-0.0911140167119165,2.00115276847879e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.0813830739996577,0.00446286644884203,-0.0901302922393881,-0.0726358557599273,2.04051269615868e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0683188574291712,0.00374728451656613,-0.0756635350816408,-0.0609741797767016,2.16477140418419e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,40267,-0.0628881602765366,0.00354960907320959,-0.0698453940600274,-0.0559309264930458,2.79389979389468e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0540872882361874,0.00307552280081317,-0.0601153129257812,-0.0480592635465936,2.7803734672838e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,42587,-0.135421817889788,0.0077109836234652,-0.15053534579178,-0.120308289987796,2.78970645717759e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0606468678040692,0.00345763633106205,-0.0674238350129508,-0.0538699005951875,4.01995124395149e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.124514585222248,0.00715189722434677,-0.138532303781967,-0.110496866662528,5.18122128272118e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.164909841025031,0.00963954741787449,-0.183803353964065,-0.146016328085997,6.6539603619997e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42663,0.0453099240658604,0.00268750917935981,0.0400424060743152,0.0505774420574056,3.96467258346404e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,42679,-0.052175348867226,0.00310145011492071,-0.0582541910924706,-0.0460965066419814,7.24878433557659e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0460815479409701,0.00274963519779474,-0.0514708329286478,-0.0406922629532924,2.0664021519211e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.0871557224120781,0.0052041309823171,-0.0973558191374196,-0.0769556256867366,2.62128154054507e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.126006961766448,0.00753974093957319,-0.140784854008012,-0.111229069524885,4.52505480530592e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.035304271220705,0.00212960764288881,-0.039478302200767,-0.0311302402406429,4.05350874198058e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42611,-0.0646081624794869,0.00389878212068895,-0.0722497754360373,-0.0569665495229366,4.53497992377929e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,40511,-0.0577151315624638,0.00349673158188247,-0.0645687254629535,-0.0508615376619742,1.70332640992898e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42655,-0.0527195873227917,0.00320294771359923,-0.0589973648414462,-0.0464418098041372,2.76995542389534e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0697418108008861,0.00425863470861494,-0.0780887348297714,-0.0613948867720008,1.04711088379046e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.0849143145543001,0.0051851259433748,-0.0950771614033147,-0.0747514677052855,1.06933272782323e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.0533581544931081,0.00327558065118563,-0.0597782925694319,-0.0469380164167842,4.26274660797868e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0484373855697312,0.00297877059231762,0.0425989952087887,0.0542757759306738,8.93292216307535e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0670248548307089,0.00413075231335939,-0.0751211293648933,-0.0589285802965245,1.19405482489347e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42621,0.0692842621941551,0.00427142121066429,0.0609122766212531,0.0776562477670571,1.30342712179242e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,40283,-0.0795423445462844,0.00490019730393559,-0.0891467312619982,-0.0699379578305707,1.4039927254046e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42754,-0.0533013575357253,0.0033082809799296,-0.0597855882563873,-0.0468171268150633,7.29187254603293e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.0986491627346092,0.00612224997283114,-0.110648772681358,-0.0866495527878601,7.36891815963863e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0420370592234398,0.00260964673621446,-0.0471519668264201,-0.0369221516204594,7.77968911212756e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0333537571489728,0.00207355493042503,0.0292895894853398,0.0374179248126059,1.10893540983883e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.123872235611089,0.00771806579959604,-0.138999644578297,-0.10874482664388,2.01608933482388e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0503656102088017,0.00314473123072134,-0.0565292834210155,-0.0442019369965879,3.33970623813705e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.158725874615191,0.00992896705710046,-0.178186650047108,-0.139265099183274,5.3700311859966e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.130959203950855,0.00821988778045198,-0.147070184000541,-0.114848223901169,1.25805959022659e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.0804669260056008,0.00506574595942956,0.0705380639251189,0.0903957880860828,2.68817310301536e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0848798579954178,0.00535189570104553,-0.095369573569467,-0.0743901424213685,4.99773961230247e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42670,-0.0994049602932543,0.00628677198094684,-0.11172703337591,-0.0870828872105985,8.18998471829957e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42674,-0.070057871053471,0.00444678295075145,-0.0787735656369438,-0.0613421764699981,1.98843439526509e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0511372607402485,0.00325591409075466,-0.0575188523581277,-0.0447556691223694,5.225837934452e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0500600144090099,0.00319319292026424,-0.0563186725327278,-0.043801356285292,6.66833235874876e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42721,0.0537859510701403,0.00343192945080783,0.0470593693465569,0.0605125327937236,7.11258765573524e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,42706,-0.0309793869930776,0.00199480337920169,-0.034889201616313,-0.0270695723698423,6.34840645979488e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0463504486938225,0.00298945058902566,-0.0522097718483128,-0.0404911255393322,9.34220344357577e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42611,0.0401846771019975,0.00259262390444621,0.035103134249283,0.0452662199547121,1.01898473232982e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0534093551299037,0.00344725358919467,-0.0601659721647253,-0.0466527380950821,1.12431310873592e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.0841675077255187,0.00545460284804699,-0.0948585293076908,-0.0734764861433466,3.65958622444124e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0584356293785209,0.00381441069472977,-0.0659118743401913,-0.0509593844168505,1.55451573078777e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.124425110477051,0.00814628883956079,-0.14039183660259,-0.108458384351512,3.79798104840254e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0544737985450916,0.00357588876520944,0.0474650565652811,0.0614825405249021,5.71936980567494e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.0825928921845323,0.00542738313929462,-0.0932305631375498,-0.0719552212315149,8.81202775262479e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0524967817476118,0.00348257587822646,-0.0593226304689356,-0.0456709330262879,6.30987633445816e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.0895115949698052,0.00596139848273045,0.0778272539436535,0.101195935995957,1.50607250980891e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.0689620083250867,0.00459801958297811,-0.0779741267077238,-0.0599498899424496,1.95559356329956e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0484661898846023,0.0032494136794208,0.0420973390729375,0.054835040696267,6.49250824611737e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,42587,-0.0603053150928199,0.00406646211207554,-0.068275580832488,-0.0523350493531518,2.31095523114702e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,40283,-0.0401645919115644,0.00271378126641525,-0.0454836031937382,-0.0348455806293905,4.28768911626825e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.104759256648599,0.00708506430916143,-0.118645982694555,-0.0908725306026424,5.16976597165412e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,42754,-0.0622359159343137,0.00422869934316663,-0.0705241666469203,-0.0539476652217071,1.18054657994631e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0726788795469674,0.00495738518284082,-0.0823953545053354,-0.0629624045885994,3.19816931428715e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0421296374931845,0.00287677706940901,0.0364911544371428,0.0477681205492261,3.41489829942329e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.17407266321409,0.0119098597684161,-0.197415988360185,-0.150729338067994,5.16828227537656e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,40539,-0.0278211688709845,0.00190252607497689,-0.0315501199779392,-0.0240922177640298,5.44886617621415e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,40424,-0.0350468488886096,0.00240952342180251,-0.0397695147953426,-0.0303241829818767,1.69322640367557e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.0769369644624723,0.0052994701384205,-0.0873239259337765,-0.0665500029911681,2.16718436018488e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0495380115598623,0.00342043125783322,-0.0562420568252155,-0.0428339662945092,3.55325502527186e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0573061999301956,0.00395945783756268,-0.0650667372918184,-0.0495456625685727,4.01361595111976e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.112104853735896,0.00775360400920963,-0.127301917593947,-0.0969077898778456,5.01197798564626e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,40449,-0.15397793841568,0.0106553165623054,-0.174862358877798,-0.133093517953561,6.50966370704987e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.0856130068712638,0.00596747210418261,-0.0973092521954617,-0.0739167615470659,2.44825912281778e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.0799856780509278,0.00558584542844233,-0.0909339350906748,-0.0690374210111809,3.64960266658619e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,40033,0.0593827169180202,0.004150986651846,0.051246783080402,0.0675186507556383,5.28383894441944e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0529712473273049,0.00370609897759932,-0.0602352013233996,-0.0457072933312102,5.30034775822218e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,40532,0.0688155746530197,0.00483002274945849,0.0593487300640811,0.0782824192419583,1.15106705615503e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,40511,-0.0360373218492114,0.00253589277614774,-0.041007671690461,-0.0310669720079619,1.92699867689362e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42689,-0.0757136791008711,0.00533290762904308,-0.0861661780537956,-0.0652611801479467,2.01671188691315e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,40223,-0.0800364523074682,0.00563657795541151,-0.0910841451000747,-0.0689887595148616,2.31481353700518e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42711,-0.0816867255903127,0.00577149872661081,-0.0929988630944699,-0.0703745880861555,3.73437416896263e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,42671,-0.0417315486988296,0.00295831099692539,-0.0475298382528034,-0.0359332591448559,7.21632076324569e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0616842287709025,0.00439441991956178,-0.0702972918132436,-0.0530711657285614,1.93500133769855e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0466920836714426,0.00333438594045383,-0.0532274801147322,-0.0401566872281531,3.04730062760767e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.088590941186849,0.00632945997030257,-0.100996682728642,-0.0761851996450559,3.3271597578997e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.039240862486986,0.00280496856458622,-0.044738600873575,-0.033743124100397,4.20991017099586e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,42754,-0.0488653214459016,0.00349652643495522,-0.0557185132584138,-0.0420121296333894,4.45299370392598e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.107701819540187,0.00776865298344473,-0.122928379387739,-0.0924752596926356,2.12409792714541e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.108401934193162,0.00784960620327611,-0.123787162351583,-0.0930167060347408,4.3803685831866e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.106091527947472,0.00769074103477334,-0.121165380375627,-0.0910176755193159,5.39544937168139e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42611,-0.0303688260273271,0.00220595792044255,-0.0346925035513945,-0.0260451485032597,7.89730934425591e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42721,-0.0352535891536445,0.0025631823663353,-0.0402774265916617,-0.0302297517156273,9.3653002254583e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42594,-0.065593230353515,0.00477322634700172,-0.0749487539936383,-0.0562377067133916,1.10872451527267e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.0711767346612657,0.00520114222664124,-0.0813709734254825,-0.0609824958970489,2.39543192057526e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0568572348831283,0.00415599423217622,-0.0650029835781936,-0.0487114861880629,2.54582788861338e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,42754,-0.0346957127034587,0.00253640064091749,-0.039667057959657,-0.0297243674472604,2.58323629466017e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0495339960647722,0.00362457081797315,-0.0566381548679996,-0.0424298372615449,3.54836127282039e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42613,-0.0405661935066088,0.0029716951374521,-0.0463907159760149,-0.0347416710372027,3.81363240154628e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0250969156813692,0.00184125862077679,-0.0287057825780917,-0.0214880487846467,5.00124823439376e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0749252687216503,0.00549927100187297,-0.0857038398853213,-0.0641466975579792,6.13495576064971e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0719209378058481,0.00528970553258474,-0.0822887606497141,-0.061553114961982,7.9600196873311e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0534531132064987,0.00393245395702474,-0.0611607229622671,-0.0457455034507302,8.32361953066929e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.163533318445142,0.0120265346869371,-0.187105326431539,-0.139961310458745,8.98041205453594e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0599987219294187,0.00442092672445095,-0.0686637383093426,-0.0513337055494948,1.10346565168236e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42794,-0.0783869385020946,0.00578857370770275,-0.089732542969192,-0.0670413340349972,1.64870910127839e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0590108628642947,0.00436618877920055,-0.0675685928715278,-0.0504531328570617,2.36458459821781e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42538,-0.0925662405774524,0.00685650121121758,-0.106004982951439,-0.0791274982034659,2.89721441787852e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0326400563601901,0.00243460871746274,0.0278682232739631,0.037411889446417,1.00361389822662e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0430510381564152,0.00321142306914209,0.0367566489408967,0.0493454273719337,1.02130896752167e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0394843439234196,0.00294770686499408,-0.045261849378808,-0.0337068384680312,1.17714432408898e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,40482,-0.0562653168648547,0.00421910511199926,-0.0645347628843732,-0.0479958708453361,2.88722306403194e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0386232938842523,0.00290317803286453,-0.0443135228286667,-0.0329330649398378,4.41435478470035e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0343472706540598,0.0025860975809788,-0.0394160219127782,-0.0292785193953413,5.98035667593724e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0586460489463029,0.00442147399232128,-0.0673121379712526,-0.0499799599213532,6.65140345459448e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.0961593488364975,0.00727389423521292,-0.110416181537515,-0.0819025161354801,1.20720140558004e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0652692904450964,0.0049437878856104,-0.0749591147008928,-0.0555794661893,1.50262059405522e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0478627793417204,0.00362562925759487,-0.0549690126866064,-0.0407565459968345,1.51384527898124e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42711,-0.0568812881186042,0.00430963513424143,-0.0653281729817174,-0.048434403255491,1.56861658479113e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.0604760039717926,0.00458206259728561,-0.0694568466624724,-0.0514951612811129,1.59315569272302e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,40223,-0.0788757038337311,0.00600175606803167,-0.0906391457270732,-0.067112261940389,3.71730131857799e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0523885283946359,0.00400919415145988,-0.0602465489314973,-0.0445305078577746,8.73232738624212e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0484130100403072,0.00371523488297913,-0.0556948704109462,-0.0411311496696681,1.39977163365495e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,42663,-0.0224249020539505,0.00172402326563696,-0.025803987654599,-0.0190458164533021,1.89497371151603e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.114723954249836,0.00883324264610203,-0.132037109836196,-0.0974107986634759,2.46931250528801e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0491849497976186,0.00379940454698872,-0.0566317827097165,-0.0417381168855207,4.21969404650705e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.0829153995841085,0.00641125390809042,-0.0954814572439658,-0.0703493419242513,5.46046605452998e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42705,0.0342575875004154,0.00265335314936085,0.0290570153276681,0.0394581596731627,6.53299308866313e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,40283,-0.0479126926318143,0.00371759286553329,-0.0551991746482595,-0.040626210615369,9.79613441873193e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.0938358571955151,0.00729089742579668,-0.108126016150077,-0.0795456982409536,1.09946894113509e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0403860558905566,0.00314589702871014,-0.0465520140668284,-0.0342200977142847,1.66710809494242e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42636,-0.0778180244576262,0.00606512419459687,-0.0897056678790361,-0.0659303810362164,1.83740691106928e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0544379558663623,0.00426376464315526,-0.0627949345669467,-0.046080977165778,4.55597521967677e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,40283,0.0283610876354173,0.00222574078545453,0.0239986356959264,0.0327235395749082,6.24284925282344e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0566686565394404,0.00445739350637784,-0.0654051478119409,-0.0479321652669398,8.99431686676921e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42587,-0.0673635867295473,0.0053261033338357,-0.0778027492638653,-0.0569244241952293,1.85854417782633e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42711,-0.0443494030213883,0.00350933352663254,-0.0512276967335881,-0.0374711093091885,2.10524026998814e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0623071779340263,0.0049411489447317,-0.0719918298657004,-0.0526225260023522,2.98078030677767e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,42475,-0.0408692116399282,0.00324433280653304,-0.047228103940733,-0.0345103193391235,3.52621521725819e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.048717425620508,0.00387211013327433,-0.0563067614817257,-0.0411280897592903,4.23937096972564e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0237315497183185,0.00188977682081987,-0.0274355122871255,-0.0200275871495116,5.81012662591755e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,42594,-0.0457852081731614,0.00366485586829372,-0.0529683256750171,-0.0386020906713057,1.28643076939573e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0669422297632914,0.00535670006785612,-0.0774413618962894,-0.0564430976302935,1.33264438400721e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.0657624311791799,0.00526992354799807,-0.0760914813332561,-0.0554333810251037,1.55337004996314e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.0802718670589981,0.0064853057581391,-0.0929830663449507,-0.0675606677730454,5.93194216858999e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,42611,-0.0368526139638604,0.00297998196173806,-0.042693378608867,-0.0310118493188538,6.13184052516483e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0468024870690988,0.00378575250552192,-0.0542225619799218,-0.0393824121582759,6.4389916114315e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0314798791968039,0.00255202268420968,-0.0364818436578549,-0.0264779147357529,9.84759754552357e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,40482,-0.0532024157325619,0.00431509436981458,-0.0616600006973985,-0.0447448307677253,1.05211829269682e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,40511,0.0413384151234759,0.00335371045928639,0.0347651426232745,0.0479116876236772,1.09275480612022e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,40527,0.0454659637390896,0.0036930991454535,0.0382274894140007,0.0527044380641784,1.31376314069057e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,42613,0.201636358246763,0.0163908127955382,0.169510365167508,0.233762351326018,1.36056477926234e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,42711,-0.0279481420874272,0.00227750552825281,-0.0324120529228027,-0.0234842312520517,1.96741079048747e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.0867242888508878,0.00707279955912253,-0.100586975986768,-0.0728616017150076,2.40231612219857e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.0855235768864676,0.00701709819380601,-0.0992770893463274,-0.0717700644266079,5.47712910963984e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0585156103407239,0.00480362405618113,-0.0679307134908389,-0.0491005071906089,5.89336850705288e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,42594,-0.0858726261765297,0.00705642137732586,-0.0997032120760884,-0.0720420402769711,6.82565737522494e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0411544563026411,0.00339441599265078,-0.0478075116482367,-0.0345014009570456,1.17598164337402e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,42676,0.0489988319385066,0.00404802732333117,0.0410646983847775,0.0569329654922357,1.49467477470815e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,42764,0.0638492232007495,0.00527905515464194,0.0535022750976513,0.0741961713038477,1.67271591083238e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0718702634125981,0.00596708315787946,-0.0835657464020419,-0.0601747804231544,3.06210655519261e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.0767943519550228,0.00638251672194982,-0.0893040847300444,-0.0642846191800011,3.56984860765833e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42749,-0.0316918660495715,0.00264152287320526,-0.0368692508810538,-0.0265144812180892,5.37524475643705e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0531123865700683,0.00443142388478725,-0.0617979773842513,-0.0444267957558853,6.26538704027513e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0277849718129209,0.0023188816137334,-0.0323299797758383,-0.0232399638500034,6.48028634107154e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.0688993333055348,0.00575288767016967,-0.0801749931390674,-0.0576236734720023,6.93449678740718e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0345134558899411,0.00288267940343874,-0.040163507520681,-0.0288634042592012,7.24906414930484e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0291248776074751,0.00243672622278719,-0.033900861004138,-0.0243488942108122,9.25447478663992e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0593977862923575,0.00497638013891114,-0.0691514913646233,-0.0496440812200917,1.12886660812042e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,42794,-0.0577716781368529,0.00484581081835621,-0.0672694673408311,-0.0482738889328747,1.32148531226799e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,40199,-0.0937809686144895,0.00786795377463908,-0.109202158012782,-0.078359779216197,1.48779007333606e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0703565875658859,0.00591980660383094,0.0587537666223773,0.0819594085093946,2.05183733926637e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.0799913523192453,0.00673644349122886,-0.0931947815620538,-0.0667879230764367,2.33756095916651e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.065764906660867,0.00554275144527051,-0.0766286994935972,-0.0549011138281368,2.60983910227111e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0565503959819275,0.00476825926454909,-0.0658961841404437,-0.0472046078234113,2.999473713707e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,42659,-0.0342461780246974,0.00289183822434722,-0.039914180944418,-0.0285781751049769,3.40536482716629e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0687302283706674,0.00581837293651252,0.0573262174151028,0.0801342393262319,5.23652606930161e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0391617738938805,0.00334471066015455,-0.0457174067877834,-0.0326061409999776,1.65320804054373e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0221623111630388,0.00189919387262765,0.0184398911726886,0.025884731153389,2.58755767205678e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0774007464127745,0.00662992535356812,-0.090395400105768,-0.064406092719781,2.6079218718691e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,42676,-0.0405712990485655,0.00348081479489518,-0.0473936960465601,-0.033748902050571,3.03048804621224e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42743,-0.0269155247032064,0.00231007302590318,-0.0314432678339766,-0.0223877815724361,3.18098641736522e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0649928208824315,0.0055853119566829,-0.07594003231753,-0.054045609447333,3.78847962842732e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0469350137052868,0.00403856252601488,-0.054850596256276,-0.0390194311542977,4.49410224012973e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0300315090028198,0.00259329195082035,-0.0351143612264277,-0.024948656779212,7.2530622805023e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0415510430194851,0.00359110895281582,-0.0485896165670041,-0.0345124694719661,8.19383078521189e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0320715759232637,0.00277207070443997,0.0266383173425614,0.0375048345039661,8.19583503218763e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0634528598562016,0.0055006197332579,-0.0742340745333871,-0.0526716451790162,1.21800756246625e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0758059981686185,0.00657132181222125,-0.0886857889205721,-0.0629262074166649,1.30320667247123e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0399671824592342,0.00346557913805992,-0.0467597175698317,-0.0331746473486368,1.3583823073301e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42613,-0.0475686770461895,0.00413120022685122,-0.0556658294908179,-0.0394715246015611,1.55149723096471e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,42754,-0.0390622146759874,0.00339426934176988,-0.0457149825858564,-0.0324094467661184,1.66050702789279e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.0704599619925202,0.00612733662951572,-0.0824695417863711,-0.0584503821986694,1.84839010340787e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,40283,-0.0699127998748655,0.00607754688138237,-0.0818247917623749,-0.058000807987356,1.88610637328586e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,40342,-0.0265414102392273,0.00231039819618142,-0.0310697907037429,-0.0220130297747117,2.25138230473196e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,42311,-0.056094356015969,0.00488531082264881,-0.0656695652283607,-0.0465191468035774,2.26271036536632e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0167404640686868,0.00145792413019027,0.0138829327735138,0.0195979953638597,2.38191058328246e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0851863783366787,0.00742356612065462,-0.0997365679331617,-0.0706361887401956,2.43299300707057e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0218661223900417,0.00190651923020749,-0.0256029000812484,-0.0181293446988351,2.61059288139906e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0395730886782876,0.00345082114938171,-0.0463366981310758,-0.0328094792254995,2.64608792180327e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.0741206630210386,0.00647795887370872,-0.0868174624135077,-0.0614238636285695,3.58276253840482e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0178097302727733,0.00155989216950423,0.014752341620545,0.0208671189250016,4.69762418072765e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,42476,-0.0688361356438941,0.00603899312107154,-0.0806725621611943,-0.0569997091265939,5.85377737414112e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,42754,-0.0332177851094344,0.00293512790054149,-0.0389706357944957,-0.0274649344243731,1.4616195461418e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,42721,-0.0606217197535062,0.00537240717722452,-0.0711516378208663,-0.0500918016861461,2.13248395757816e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0428289224859355,0.00380205546471033,-0.0502809511967677,-0.0353768937751032,2.66917498203162e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,40483,-0.157225151987578,0.0139578206461458,-0.184582480454023,-0.129867823521132,2.82066645814879e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.074383332028514,0.00663050602121988,-0.0873791238301049,-0.061387540226923,4.46588307370818e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0774005549386057,0.00694758777572251,-0.0910178269790218,-0.0637832828981896,1.06562480485349e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0403544980298289,0.00362502520138403,-0.0474595474245416,-0.0332494486351162,1.16797928219678e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.116553846305329,0.0104794296213768,-0.137093528363227,-0.0960141642474305,1.312952856387e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0426443945070701,0.00384585165984691,-0.05018226376037,-0.0351065252537702,1.89767125804791e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0630714422524468,0.00569135642708082,-0.0742265008495252,-0.0519163836553684,2.0488572628911e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0363330005324413,0.00328235877874564,-0.0427664237387827,-0.0298995773260998,2.48440154634251e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.040651688959869,0.00367979817499489,0.033439284536879,0.047864093382859,2.99145004494842e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0463707263887374,0.00420558107862432,-0.0546136653028411,-0.0381277874746337,3.78366531431616e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42754,-0.0434128740046976,0.00394294659111851,-0.0511410493232898,-0.0356846986861053,4.483991511502e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42495,-0.0916980373512704,0.00835903687884331,-0.108081749633803,-0.0753143250687375,7.01932892723093e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0333556230984837,0.00304983620224147,-0.039333302054877,-0.0273779441420905,1.00517091751755e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42587,-0.0735249179620118,0.00673525453815732,-0.0867260168568001,-0.0603238190672235,1.25766194370272e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0496361337606231,0.00455300493850693,-0.0585600234400967,-0.0407122440811495,1.54901132984802e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.039908247005005,0.00366096966965536,-0.0470837475575296,-0.0327327464524805,1.56455484925092e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.0784144204336022,0.00720789548851197,-0.0925418955910856,-0.0642869452761187,1.88956905336351e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0579676928782756,0.00535067460650836,-0.068455015107032,-0.0474803706495192,3.08992671486826e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0546731557806659,0.00505012824990961,-0.0645714071504887,-0.0447749044108431,3.3529583550456e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0610831237556841,0.00566185177191355,-0.0721803532286347,-0.0499858942827335,5.03555658571806e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.12702288317039,0.0117744837283574,-0.150100871277971,-0.10394489506281,5.06620917196399e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0386757407078578,0.00358581747708224,-0.045703942962939,-0.0316475384527766,5.18451090938553e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0360659545012769,0.00335920375652555,0.0294819151384868,0.042649993864067,8.81840688226608e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.111677167893657,0.0104057038964339,-0.132072347530667,-0.0912819882566465,9.66647740904894e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,40283,-0.0468484893030257,0.00436637309811257,-0.0554065805753263,-0.038290398030725,1.00196920067624e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0683646660628708,0.00638040642477024,-0.0808702626554204,-0.0558590694703211,1.11279594724828e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.115903314656585,0.0108173157780093,-0.137105253581483,-0.0947013757316864,1.11485833776838e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,42370,-0.0481566500728209,0.00449629616992247,-0.0569693905658689,-0.0393439095797729,1.17237894502978e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42495,-0.0704462621243546,0.00658068067077372,-0.0833443962390711,-0.0575481280096381,1.23766540955905e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0565255768501526,0.00528519862938615,-0.0668845661637495,-0.0461665875365558,1.37404090697945e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0398781671123261,0.00373397971451948,-0.0471967673527843,-0.0325595668718679,1.69120671398331e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.0980488650765692,0.00918456420375223,-0.116050610915924,-0.0800471192372149,1.69554677292505e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.0861717513073958,0.00808837970166106,-0.102024975522651,-0.0703185270921401,2.25067215865777e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.081166085099972,0.0076265918704215,-0.0961142051659982,-0.0662179650339459,2.53690568865278e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,40527,-0.116457914663791,0.0109537077867972,-0.137927181925914,-0.0949886474016687,2.81788183474784e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.0855390724258153,0.00805225470632417,-0.101321491650211,-0.0697566532014199,3.09597429032398e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42495,-0.0542807604060134,0.0051153858946196,-0.0643069167594678,-0.0442546040525589,3.36156948326508e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.0982120889869428,0.00925649732013042,-0.116354823734398,-0.0800693542394872,3.39917524993212e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.106695341125395,0.0100679556620869,-0.126428534223086,-0.0869621480277049,3.8828087403242e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0425616622819808,0.00401761377300124,-0.0504361852770632,-0.0346871392868983,4.2228290281707e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0287003272142151,0.00271168242666767,-0.0340152247704837,-0.0233854296579465,4.68130943650582e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_E,,42594,-0.0311453892399105,0.00294543327145862,-0.0369184384519694,-0.0253723400278516,4.9741676538215e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0250427568713148,0.00237820938767538,0.020381466471471,0.0297040472711585,7.8916446069024e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0695847910472095,0.0066125035561791,-0.0825452980173206,-0.0566242840770985,8.54657770109114e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.0556154373540381,0.00531441445965347,-0.0660316896949589,-0.0451991850131172,1.57497842239406e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42613,-0.0314719851617973,0.00302101327209821,-0.0373931711751098,-0.0255507991484848,2.57136672673951e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,40223,-0.0597881531569649,0.00574588784733163,-0.0710500933377349,-0.0485262129761949,3.06597810293049e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0213397257874131,0.00205714472304303,0.0173077221302488,0.0253717294445775,4.09130944874755e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.0811677763256825,0.00784962151086737,-0.0965530344869825,-0.0657825181643824,5.74614614534256e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,40527,0.0597976668437017,0.00578171261842828,0.0484655101115822,0.0711298235758211,5.8400650652567e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0529988277150085,0.00512668346024303,-0.0630471272970849,-0.0429505281329322,5.89475348933746e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0302029710987424,0.00292549942050921,0.0244689922345443,0.0359369499629404,6.79304069011344e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,42636,-0.0654908612821394,0.00634593812393214,-0.0779289000050464,-0.0530528225592324,7.07722677225728e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,40451,-0.097479499601617,0.00944966225688953,-0.116000837625121,-0.0789581615781136,7.7226750741314e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0380267932691503,0.00368633848622724,-0.0452520167021557,-0.0308015698361449,7.75710070491883e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0437976197150695,0.00425655612586162,0.0354547697083807,0.0521404697217582,9.70421779369332e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0582656845742158,0.00570187323041879,-0.0694413561058366,-0.047090013042595,2.08998113053819e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.027018929804064,0.00265751668446719,-0.0322276625056197,-0.0218101971025083,3.40800480657611e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0466193906978451,0.004587016880633,-0.0556099437838857,-0.0376288376118044,3.52827064524099e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,42488,0.0270212625797538,0.00266291738384453,0.0218019445074185,0.0322405806520891,4.17249366677869e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0544305710369467,0.00536904483028688,-0.064953898904309,-0.0439072431695844,4.7941962698794e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.031700607385364,0.00314178688309967,-0.0378585096762394,-0.0255427050944887,7.76183732957885e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,42188,-0.038555349149964,0.003833187695489,-0.0460683970331224,-0.0310423012668055,1.03116602134797e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0347322350775668,0.00345359060126593,-0.041501272656048,-0.0279631974990856,1.03942412695282e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42648,-0.0310521245585635,0.00308829075019235,-0.0371051744289405,-0.0249990746881865,1.06101988988786e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0453146057980583,0.0045137581543553,0.0364676398155219,0.0541615717805947,1.24006202606529e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0698381470397947,0.00695656330288238,-0.0834730111134441,-0.0562032829661452,1.24268214753931e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,40449,-0.0827770168830517,0.00825339697833661,-0.0989536749605914,-0.0666003588055119,1.42101197447509e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0568516131514708,0.00567708845509597,-0.0679787065234589,-0.0457245197794827,1.59700964350483e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0866240679409266,0.00866333765199158,-0.10360420973883,-0.0696439261430231,1.86159336222532e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0302561885391876,0.00302539300630861,-0.0361859588315525,-0.0243264182468227,1.89706194772393e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.035434703172953,0.00354717767137288,-0.0423871714088438,-0.0284822349370621,2.04823711319125e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,42636,-0.0339544861353008,0.00339922414543015,-0.0406169654603439,-0.0272920068102577,2.05720158708147e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0650022163900974,0.00651958786418867,-0.0777806086039072,-0.0522238241762876,2.58616686297555e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,42679,-0.0378636612496166,0.00380026764237377,-0.0453121858286692,-0.030415136670564,2.65249353912031e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0296128065482829,0.00297546395546094,-0.0354447159009863,-0.0237808971955794,3.07269091253545e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0596474468325436,0.00600033340302094,-0.0714081003024647,-0.0478867933626226,3.34318304144423e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.101831609484561,0.0102690842346337,-0.121959014584443,-0.0817042043846785,4.39578357944586e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0425769201651097,0.00429936331069795,-0.0510036722540777,-0.0341501680761417,5.03811804944613e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.03973499786091,0.00402123878348087,-0.0476166258765326,-0.0318533698452875,6.01209828073539e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0748737529772927,0.00757960657264796,-0.0897297818596827,-0.0600177240949027,6.40646818446872e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0251783504765649,0.00255023391058312,-0.0301768089413078,-0.0201798920118219,6.52149197652855e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0708079314594844,0.00717084759162245,0.0567530701799044,0.0848627927390644,6.65117398205279e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,42587,-0.0303074876632849,0.00307409463403422,-0.036332713145992,-0.0242822621805778,7.4965889804497e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0601239563259857,0.0061090835505297,-0.0720977600850239,-0.0481501525669475,8.91954354798593e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,40284,0.0292121207728244,0.00298020010408056,0.0233709285688265,0.0350533129768223,1.36244544524788e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.027498990064956,0.00280787962914385,-0.033002434138078,-0.0219955459918341,1.4310016457619e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0378531666761251,0.00386581736044031,0.0302761646496621,0.0454301687025881,1.45238242646434e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,42136,-0.0857210012594311,0.00875374304430779,-0.102878337626274,-0.0685636648925878,1.45241323168258e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42636,0.0483802685514406,0.00494517555285899,0.038687724467837,0.0580728126350443,1.57866375666827e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0493403986564114,0.00504400080082342,-0.0592266402260253,-0.0394541570867975,1.59717158408649e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,40483,-0.0354291333056898,0.00362271010986808,-0.0425296451210312,-0.0283286214903484,1.68984193998171e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0530340939378699,0.00543042881958028,-0.0636777344242472,-0.0423904534514925,1.86644186315154e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0802085577609038,0.00821788133990703,-0.0963156051871216,-0.0641015103346861,1.99100559622871e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.0698275760370992,0.00715469913173901,-0.0838507863353076,-0.0558043657388907,2.06378688178749e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0377369232854947,0.00387033515604228,-0.0453227801913376,-0.0301510663796518,2.1807578083025e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0203020693042966,0.00208145801077141,-0.0243817270054086,-0.0162224116031846,2.18643919160999e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,42594,-0.0878659849931369,0.00901643215547165,-0.105538192017861,-0.0701937779684124,2.29698601903193e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0249846232480698,0.00256677159122436,0.01995375092927,0.0300154955668695,2.64302900149081e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.0824374125818648,0.0084877000105198,-0.0990733046024836,-0.065801520561246,3.15985481865728e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42711,0.0353091030144047,0.00364234962806285,0.0281700977434016,0.0424481082854079,3.77336471114565e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42683,-0.0342211028784497,0.00353172323072198,-0.0411432804106648,-0.0272989253462346,3.94015489047004e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0751715326037895,0.00776141708453841,-0.0903839100894848,-0.0599591551180942,4.11383167384139e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0467551569692573,0.00483017309995621,-0.0562222962451715,-0.0372880176933431,4.33080140721834e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,42495,0.032004198601608,0.00331876671827361,0.0254994158337917,0.0385089813694243,6.18418269716358e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0312873945246107,0.00324868567188975,-0.0376548184415146,-0.0249199706077068,6.97991981296614e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,42721,-0.0369227123210697,0.00383788694789714,-0.0444449707389481,-0.0294004539031914,7.68931138595842e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0188597943618988,0.00196197200112375,-0.0227052594841014,-0.0150143292396963,8.31345674718498e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0677810109502432,0.00705980111498106,-0.0816182211356061,-0.0539438007648803,9.64867742549978e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,42476,-0.0347929663287454,0.00362528301299949,-0.0418985210342244,-0.0276874116232664,9.65262816028072e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,42659,0.0494414871620422,0.00515411840707759,0.0393394150841701,0.0595435592399142,1.00767399736383e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42594,0.031143071585334,0.00324655296341664,0.0247798277770374,0.0375063153936306,1.00806248998295e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0454680534597277,0.00474946364133599,0.0361591047227092,0.0547770021967463,1.25045377382324e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0257923435852388,0.00269423485270002,-0.0310730438965309,-0.0205116432739468,1.25190934728971e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.025871873312348,0.0027055044471663,-0.031174662028794,-0.020569084595902,1.3434532487556e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0580636165646338,0.00608673273759006,-0.0699936127303104,-0.0461336203989573,1.74223910843743e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0250504437557849,0.00262751234921928,-0.0302003679602547,-0.0199005195513151,1.77148867068304e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0315693912658058,0.00331027775032585,-0.0380575356564445,-0.0250812468751671,1.78340058060681e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,40539,0.0278267477064846,0.00292001640419361,0.0221035155542652,0.0335499798587041,1.89827341682046e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,40511,-0.0619133604990202,0.00651838780088277,-0.0746894005887505,-0.04913732040929,2.56227040488336e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.046577616369285,0.00490568875682168,-0.0561927663326555,-0.0369624664059145,2.57319294574748e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42611,-0.0353649919227848,0.00372545848945069,-0.0426668905621082,-0.0280630932834615,2.62373355402359e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,42563,-0.0331839608728337,0.00349572880690372,-0.0400355893343649,-0.0263323324113024,2.62700816738887e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.0831739640801817,0.00876701990892666,-0.100357323101678,-0.0659906050586854,2.84841485647923e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42590,-0.0831813415536959,0.00878008918465558,-0.100390316355621,-0.065972366751771,3.14271502744368e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0410147769921592,0.00432959632799559,-0.0495007857950306,-0.0325287681892878,3.27135127956814e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0462515334616082,0.004884926523941,-0.0558259894485326,-0.0366770774746838,3.32544140669131e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,40511,-0.0491657799934617,0.00519210178472814,-0.0593422994915289,-0.0389892604953945,3.37361642634845e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0625346188371289,0.00662166420363033,-0.0755130806762443,-0.0495561569980134,4.29446567660095e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,40468,-0.0309351030643277,0.00327925176219203,-0.0373624365182241,-0.0245077696104313,4.73802816666806e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0326516320559097,0.0034695917933278,-0.0394520319708322,-0.0258512321409873,5.87020327236362e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0259185924964762,0.00275608873189189,-0.0313205264109843,-0.0205166585819681,6.10639759864698e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0209528467441021,0.00223199244060534,-0.0253275519276886,-0.0165781415605157,7.11889410418587e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0617965367831122,0.00658276501322966,-0.0746987562090423,-0.0488943173571821,7.34309394073626e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0353408245298856,0.00376877414321666,0.0279540272091809,0.0427276218505902,7.84125497825133e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42556,-0.0746323037008675,0.007960486275326,-0.0902348568005065,-0.0590297506012286,7.98829279090854e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0244331065049361,0.00260813553537997,0.0193211608555913,0.0295450521542808,8.5522011794167e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42654,-0.0523215180859467,0.00559506622094816,-0.0632878478790051,-0.0413551882928883,9.99873005396967e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0275722889813537,0.00295458823044495,-0.0333632819130258,-0.0217812960496816,1.19997730144011e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.0885190382934296,0.00948606722868035,-0.107111730061643,-0.0699263465252161,1.23922288031848e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.0870030691900621,0.00932834889773694,-0.105286633029626,-0.0687195053504977,1.29481547732901e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0209059062465751,0.00224490578799488,-0.0253059215910451,-0.0165058909021052,1.47689712135478e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0592170987614336,0.00637107554655478,-0.071704406832681,-0.0467297906901863,1.74786673434503e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.063844126577448,0.00688031987367623,-0.0773295535298534,-0.0503586996250426,1.97046134659439e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,40449,-0.0913252862102359,0.00986442696880898,-0.110659563069101,-0.0719910093513703,2.45843843479899e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0373253894417871,0.0040536259768527,-0.0452704963564183,-0.0293802825271558,3.80957361404131e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42611,0.0252603221204453,0.00275573961857087,0.0198590724680464,0.0306615717728442,5.59061785248078e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0374420344332293,0.00409926462472375,-0.0454765930976879,-0.0294074757687708,7.53997003896574e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0395764421014574,0.00434542418237725,-0.0480934734989168,-0.031059410703998,9.84031768779052e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0431319838394374,0.00473713784348065,-0.0524167740126595,-0.0338471936662153,9.84936271039509e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,40169,-0.0256588460511911,0.00281731288820958,-0.0311807793120819,-0.0201369127903003,9.88437038379442e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0448034352617652,0.00492315203741834,-0.0544528132551051,-0.0351540572684252,1.02683982459315e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,40379,0.0950917563501184,0.010480939724862,0.0745491144893889,0.115634398210848,1.35324131686324e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0235191954606486,0.00259584992684098,0.0184313296040403,0.0286070613172569,1.47825606034357e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.0789998797481548,0.00872669272477957,-0.0961041974887228,-0.0618955620075869,1.58408182763433e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.0972489829002679,0.0107416776307227,-0.118302671056484,-0.0761952947440514,1.61638110662197e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0734664301327279,0.00813066092618124,-0.0894025255480431,-0.0575303347174126,1.84955612119797e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0710266628475249,0.00787651647431933,-0.0864646351371908,-0.055588690557859,2.18026110002842e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,40346,-0.0241322363506555,0.00267709621555098,-0.0293793449331354,-0.0188851277681756,2.30337887648791e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0387076782669779,0.00430541277433218,0.0302690692292869,0.047146287304669,2.7874330802537e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0708635000539484,0.007882479492159,-0.08631315985858,-0.0554138402493168,2.8652381044402e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0231453547585997,0.00258060759518333,-0.0282033456451591,-0.0180873638720404,3.46898734534897e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0342853783571149,0.0038292028807741,-0.0417906160034321,-0.0267801407107976,3.97618410305114e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,42668,0.0333278642595848,0.0037272921403273,0.0260223716645432,0.0406333568546263,4.33042886695923e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0386783781158596,0.00432686808635386,-0.0471590395651132,-0.030197716666606,4.43220867582117e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42594,-0.0490990879475878,0.00549276412072122,-0.0598649056242014,-0.0383332702709742,4.44019382273365e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,42475,-0.0434081534603158,0.00487743267284252,-0.0529679214990871,-0.0338483854215445,6.3119858509473e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0495059175900297,0.0055628036999347,-0.0604090128419017,-0.0386028223381577,6.32359893993704e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0719168305776381,0.00808682751069577,-0.0877670124986018,-0.0560666486566744,6.69579772047291e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0235495050729743,0.00264853736932905,-0.0287406383168593,-0.0183583718290894,6.78802674984792e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.117909702324297,0.0132690846965196,-0.143917108329475,-0.0919022963191183,7.29340748821294e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.044098379046516,0.00496678559227672,-0.0538332788073784,-0.0343634792856536,7.61393964673115e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0279243095032615,0.00315742478084577,0.0217357569328038,0.0341128620737192,1.03581406718641e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0400917668266451,0.00453604231442056,-0.0489824097629094,-0.0312011238903808,1.08986613945503e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,42613,-0.0312341695919212,0.00353524997647424,-0.0381632595458107,-0.0243050796380317,1.12338477384506e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.0713618988713196,0.00807544088741232,-0.0871897630106478,-0.0555340347319915,1.13318666673906e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,42594,-0.0748019911760911,0.00847850740722959,-0.0914198656942611,-0.0581841166579211,1.25586149708655e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,42346,-0.0400149571403483,0.00454325132312605,-0.0489197297336753,-0.0311101845470212,1.43754552937574e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,42370,-0.0380968870414945,0.00433629703586207,-0.0465960292317842,-0.0295977448512049,1.74605713052719e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.091613236702144,0.0104494320203484,-0.112094123462027,-0.0711323499422612,2.09362512006156e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,42311,-0.0292809864380186,0.00334313185936283,-0.0358335248823697,-0.0227284479936675,2.21798677710752e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0158614932219179,0.00182003749019525,-0.0194287667027005,-0.0122942197411352,3.24806618802493e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0425022921687035,0.00489845549883873,-0.0521032649464274,-0.0329013193909796,4.55110855822934e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0240887480089037,0.00277647775634913,-0.029530644411348,-0.0186468516064594,4.5625770311541e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0258470246937049,0.0029793674538672,-0.0316865849032846,-0.0200074644841252,4.68708296298108e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.0855997064565762,0.00987549507487859,-0.104955676803338,-0.0662437361098141,4.90258654343341e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.0711610261175696,0.00821607001299719,-0.0872645233430441,-0.0550575288920951,5.30232638462564e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.062255218393984,0.00719218856400767,-0.076351907979439,-0.048158528808529,5.43411214799056e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0240798906321891,0.00278141007008071,-0.0295314543695473,-0.0186283268948309,5.48091066445313e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0561025377024241,0.00648540791296326,-0.0688139372118321,-0.0433911381930161,5.69799778433325e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,42587,-0.0443506758571983,0.00512852475673704,-0.0544025843804029,-0.0342987673339936,5.83961522787593e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,42594,-0.0273620170728165,0.00317734276550361,-0.0335896088932035,-0.0211344252524294,8.00193606062522e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.0779110790341295,0.00906215350207854,-0.0956728998982034,-0.0601492581700555,9.04785338287978e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0327932166449047,0.00381478800571257,-0.0402702011361013,-0.025316232153708,9.15192893438828e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,40527,-0.0612935092229659,0.00712939090790531,-0.0752671154024603,-0.0473199030434715,9.23164704430645e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0198240294947041,0.00230657657509397,0.0153031394075199,0.0243449195818883,9.26925446897215e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0531139297562321,0.00618196625211077,-0.0652305836103692,-0.040997275902095,9.49491070632789e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0498995804249062,0.00580857217636467,-0.0612843818905809,-0.0385147789592314,9.61441058400682e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,40283,-0.095085884422106,0.0110819185264096,-0.116806444733869,-0.0733653241103431,1.07244731841298e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0659609743259629,0.00771732960822784,-0.0810869403580895,-0.0508350082938364,1.42435810957694e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,42746,-0.0177993068414104,0.00208339482863551,-0.021882760705536,-0.0137158529772848,1.44103337943326e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,40449,-0.0854209942827896,0.00999814452681166,-0.10501735755534,-0.0658246310102387,1.46738868680574e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,40199,-0.0383977956557409,0.00449740744361804,-0.0472127142452322,-0.0295828770662495,1.54827586462042e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0489970420088514,0.00575675823734044,-0.0602802881540387,-0.0377137958636642,1.90614976921445e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0423401511474814,0.00497747412352517,-0.0520960004295907,-0.032584301865372,2.02169302991226e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0308492873987834,0.00363172501707426,-0.0379674684322489,-0.0237311063653178,2.1979341171534e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0371986356204162,0.00437830912933004,-0.0457801215139031,-0.0286171497269293,2.20537794045804e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,40257,-0.040894845318801,0.00481494482566821,-0.0503321371771107,-0.0314575534604913,2.26499397764678e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0428640168126305,0.00505267935623319,0.0329607652744135,0.0527672683508476,2.41376679940259e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0427788396183642,0.00505063269668975,0.0328795995328522,0.0526780797038761,2.70758433235844e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,40488,0.0158546347112826,0.00187140165625471,0.0121866874650234,0.0195225819575418,2.7092548244898e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,42679,-0.0359441621296742,0.00425663614328876,-0.0442871689705202,-0.0276011552888282,3.36979788367026e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0398853817413741,0.0047252938952731,-0.0491469577761093,-0.0306238057066388,3.47137579855506e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0586002489061828,0.00695122879964842,-0.0722246573534937,-0.0449758404588719,3.87978635327726e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0569494082492106,0.00676108225822724,-0.070201129475336,-0.0436976870230852,4.03628908927445e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.051029122453624,0.00605952773258335,-0.0629057968094873,-0.0391524480977606,4.17287113761041e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0278741887506977,0.00331109582642629,0.0213844409309022,0.0343639365704933,4.1967290234307e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42721,0.0380917762450985,0.0045283237972793,0.0292162616024311,0.0469672908877659,4.43566463233701e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0668407970077911,0.00794821172973787,-0.0824192919980773,-0.0512623020175049,4.5291762764445e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,39872,-0.0196786740814099,0.0023404974146211,-0.0242660490140673,-0.0150912991487526,4.70517090532848e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0530662321127179,0.00631386483169311,-0.0654414071828364,-0.0406910570425994,4.71168065828127e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0467844993458342,0.00556946799656017,-0.0577006566190922,-0.0358683420725763,4.91173487574521e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.097383497621697,0.0115919796084429,-0.120103777654245,-0.0746632175891488,4.97418150840828e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0729240198865175,0.00868620587528005,-0.0899489834020664,-0.0558990563709686,5.10642124534721e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0583866495025935,0.00695794151537757,-0.0720242148727335,-0.0447490841324535,5.27995360939028e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.0679473256987415,0.00810012130360892,-0.0838235634538149,-0.052071087943668,5.42445282554495e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,40511,-0.0377952500062163,0.00450869924368896,-0.0466323005238467,-0.028958199488586,5.78213406414547e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0241270057526974,0.00288658623913651,-0.029784714781405,-0.0184692967239898,6.98335851216244e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0669325149554328,0.00801160369057272,-0.0826352581889553,-0.0512297717219102,7.35671239431951e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42754,-0.073255714014922,0.00878370512661406,-0.0904717760630855,-0.0560396519667584,8.14335713082682e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42794,-0.0439209540567727,0.00527076164317452,-0.0542516468773947,-0.0335902612361506,8.63581880329072e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0296698464360745,0.00356786133257193,-0.0366628546479155,-0.0226768382242335,1.01785642214494e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0650091353813731,0.0078177306586837,-0.0803318874723932,-0.049686383290353,1.0209847914517e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,42587,-0.0436092789713378,0.0052570124953933,-0.0539130234623087,-0.0333055344803669,1.18438754871214e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42495,-0.031734645799948,0.00383308722727182,-0.0392474967654008,-0.0242217948344952,1.35833750859083e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0464523435673522,0.00561171555757458,-0.0574513060601984,-0.035453381074506,1.37223268051393e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,42317,-0.0392162841132979,0.00474846423845616,-0.048523274020672,-0.0299092942059238,1.61240076520664e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0449327535590614,0.00545394920203804,-0.055622493995056,-0.0342430131230669,1.90657550297498e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0316634777415049,0.00385737640423443,-0.0392239354938044,-0.0241030199892054,2.487848179207e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0359851130421848,0.00439095681266184,-0.0445913883950021,-0.0273788376893676,2.77445748726554e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0457484948679292,0.00558573206319545,-0.0566965297117922,-0.0348004600240661,2.84054769259112e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0241980142707285,0.00295849492296925,-0.0299966643197482,-0.0183993642217087,3.11359938680075e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0242835137732979,0.00296910646522334,0.0184640651014601,0.0301029624451356,3.12468494837702e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0475241917902787,0.00582938331936402,-0.0589497830962322,-0.0360986004843252,3.87826560992139e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0324404876283763,0.00398097695264934,0.0246377728011836,0.040243202455569,3.99708266375327e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0357907711023129,0.00439403152070249,0.027178469321736,0.0444030728828897,4.11571241148504e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0253637885213361,0.00311484914527339,-0.031468892846072,-0.0192586841966003,4.19973689782605e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,40515,-0.0436744205054505,0.00536316662878614,-0.0541862270978713,-0.0331626139130296,4.24589692323622e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.048456077490557,0.00595757742342392,-0.0601329292404679,-0.0367792257406462,4.53462544319774e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0374517489300199,0.00460759932239005,-0.0464826436019044,-0.0284208542581354,4.81056649876295e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42754,-0.0726065137261891,0.00894191500349033,-0.0901326671330301,-0.055080360319348,5.0702666396391e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.0815972758941505,0.0100525503523813,-0.101300274584818,-0.0618942772034831,5.19055500292473e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0494467180057378,0.00609710942506804,-0.0613970524788711,-0.0374963835326044,5.59122501768621e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.025289811263546,0.00312034265168908,0.0191739396662354,0.0314056828608566,5.73490436094212e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0671176896760548,0.00828273143345333,-0.0833518432856234,-0.0508835360664863,5.80660300856564e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0604875338022139,0.00746565126615303,-0.0751202102838738,-0.0458548573205539,5.87665788199765e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0298244405943971,0.00369400686877481,-0.0370646940571958,-0.0225841871315985,7.40646178525804e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0193785338499405,0.00240152489372659,0.0146715450582363,0.0240855226416446,7.67138322448952e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0339079230973217,0.00420474002259844,-0.0421492135416146,-0.0256666326530287,7.99329546023101e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0479368906028632,0.00594503404120037,-0.0595891573236159,-0.0362846238821105,8.19832758414626e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0602132234395368,0.00747327876885717,-0.0748608498264969,-0.0455655970525768,8.59363566068753e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0344432596377396,0.00427550345573113,-0.0428232464109726,-0.0260632728645066,8.6936056764908e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0353725846963962,0.00439229800652541,-0.043981488789186,-0.0267636806036064,8.73155140241088e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,42676,-0.0353081018982001,0.00439374245051612,-0.0439198371012117,-0.0266963666951885,1.00496992214646e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.028514070831937,0.00355357144950029,0.0215490707909164,0.0354790708729576,1.1242099662178e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0669557345141958,0.00835532144810061,0.0505793044759186,0.083332164552473,1.20576715330676e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,42346,-0.0309837527864364,0.00386732135084015,-0.038563702634083,-0.0234038029387897,1.22631685775499e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.0646200771506707,0.00808391737338814,-0.0804645552025114,-0.0487755990988299,1.41666192789249e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0247897768650109,0.00310296524975099,-0.0308715887545229,-0.018707964975499,1.47004457424911e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0520175524917061,0.00651198613561318,-0.064781045317508,-0.0392540596659043,1.48247976645066e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.044442858793413,0.00557138050033028,-0.0553627645740603,-0.0335229530127656,1.622763473417e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,42587,-0.022835158042427,0.00286625856840089,-0.0284530248364928,-0.0172172912483613,1.7580049630407e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REN,Renin,42636,-0.065382238044833,0.00821276558424934,-0.0814792585899617,-0.0492852174997043,1.84203926012184e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42581,0.0476966703170547,0.00600185663369085,0.0359330313150207,0.0594603093190888,2.06315402216325e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,40430,-0.0326816961683679,0.00411495655163467,-0.0407470110095718,-0.0246163813271639,2.17592218988802e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,42449,0.0210244121007017,0.00264889315905549,0.0158325815089529,0.0262162426924504,2.23602078176725e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0404191718015641,0.0051045260199578,-0.0504240428006814,-0.0304143008024468,2.59789237082908e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.02139475164078,0.00270301827671386,-0.0266926674631391,-0.0160968358184208,2.66377668153345e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0305662525997582,0.00386151226117197,-0.0381348166316553,-0.0229976885678611,2.69789963870278e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0503396875168155,0.00636227538415031,-0.0628097472697502,-0.0378696277638809,2.72422452611669e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,40482,-0.078719460311429,0.00996172299209838,-0.0982444373759418,-0.0591944832469162,2.99480353209352e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,40539,-0.0238628415383645,0.00302169120226872,-0.0297853562948112,-0.0179403267819178,3.11561690040844e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.0860908944395787,0.0109070097105702,-0.107468633472296,-0.0647131554068612,3.21904721393354e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0495527078626679,0.00628777867603003,-0.0618767540676867,-0.037228661657649,3.55029142805136e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0176242082905108,0.00223823270184255,-0.0220111443861221,-0.0132372721948994,3.75005507771644e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0403138228838545,0.00511973606429104,-0.0503485055698649,-0.030279140197844,3.75149865054909e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,42620,-0.0243668568346843,0.0030969697067347,-0.0304369174598843,-0.0182967962094843,3.87910483781166e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0210495494066774,0.00267570575261742,-0.0262939326818075,-0.0158051661315473,3.91052902636353e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0178017256883096,0.00226293223060862,-0.0222370728603025,-0.0133663785163168,3.9222512934742e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0207087691736131,0.00263565475874333,0.0155428858464762,0.02587465250075,4.28402274905337e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,42255,-0.0519693941463338,0.00662026061581723,-0.0649451049533356,-0.038993683339332,4.48160130169196e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0200069466364596,0.00254893686995556,-0.0250028629015725,-0.0150110303713467,4.56579225983735e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0638713999359778,0.00814619194480995,-0.0798379361478053,-0.0479048637241503,4.81818229602006e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0363411717335218,0.00463673669147652,-0.0454291756488158,-0.0272531678182278,5.00220379979969e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0400335790259297,0.00511018037228184,-0.0500495325556021,-0.0300176254962573,5.15625897627567e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0253905517161041,0.00324252338284756,-0.0317458975464853,-0.0190352058857229,5.23714718793121e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0270067893968587,0.00344911829639278,-0.0337670612577886,-0.0202465175359289,5.23915921555532e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,42346,-0.047735076755051,0.00610113732795408,-0.059693305917841,-0.035776847592261,5.50791653150945e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0297442673265926,0.00380147361116784,-0.0371951556044816,-0.0222933790487036,5.55666846819015e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0438639560546859,0.00562244901666137,-0.0548839561273422,-0.0328439559820296,6.55797977598083e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0379536874219436,0.00486587830822457,-0.0474908089060638,-0.0284165659378235,6.65754348073664e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,42618,-0.0209881643859563,0.00269123404319118,-0.026262983110611,-0.0157133456613016,6.7138121574478e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0586527754831604,0.00752361420670725,-0.0733990593283066,-0.0439064916380142,6.96088758611716e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0283659706130165,0.00364272675415994,-0.03550571505117,-0.021226226174863,7.35556669247922e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42588,0.0288771208056446,0.00370937770465706,0.0216067405045167,0.0361475011067724,7.4873492251852e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0385023708445476,0.00495014699544155,-0.048204658955613,-0.0288000827334822,8.02305367810805e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,42357,-0.0407423199098175,0.00524229060008988,-0.0510172094859937,-0.0304674303336413,8.30657451980061e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,42636,-0.0518798978816218,0.00667695505523201,-0.0649667297898765,-0.038793065973367,8.41653622060028e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0618135248971545,0.00795371133599076,-0.0774027991156964,-0.0462242506786126,8.42016075624522e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0367114343420455,0.00473152016880109,-0.0459852138728957,-0.0274376548111954,9.32599271021647e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0225394774297416,0.00290651134356384,0.0168427151963565,0.0282362396631267,9.4787935784578e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.02668980790024,0.00344833712414067,-0.0334485486635557,-0.0199310671369243,1.06530189277114e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0219531941423944,0.00283939717733075,-0.0275184126099627,-0.0163879756748262,1.15160256149974e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0177074664651362,0.00229064847305255,-0.0221971374723192,-0.0132177954579532,1.16591436422369e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0204965586527833,0.00265817321463356,-0.0257065781534651,-0.0152865391521016,1.33800992970576e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0291015884950522,0.00377823147197642,-0.036506922180126,-0.0216962548099784,1.44983450919899e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0358529066695416,0.00465696586182189,-0.0449805597587125,-0.0267252535803707,1.46889163153461e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0226678496293427,0.00294547673792793,-0.0284409840356814,-0.016894715223004,1.52243466081492e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,42624,-0.0406694529538948,0.00528602259877508,-0.051030057247494,-0.0303088486602957,1.52792233206472e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,42566,-0.0342675703649602,0.00445746161101903,-0.0430041951225575,-0.0255309456073629,1.60248218320508e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0394254884785328,0.0051309036882254,-0.0494820597074546,-0.029368917249611,1.64877434780631e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,40532,0.0363690794392973,0.0047383817195865,0.0270818512689078,0.0456563076096868,1.7839880908407e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0286041359238235,0.00372837437012155,-0.0359117496892617,-0.0212965221583852,1.81187100446159e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0155985882255743,0.00203302913246721,-0.01958332532521,-0.0116138511259386,1.82473212702093e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0473581900606099,0.0061732948548604,-0.0594578479761363,-0.0352585321450835,1.83993953429399e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42495,-0.0303511361680461,0.00395938487374073,-0.0381115305205779,-0.0225907418155143,1.90283643350493e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0279964998881783,0.00366564143343081,-0.0351811570977026,-0.0208118426786539,2.36712914672746e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0618920827174042,0.00810509710305065,-0.0777780730393835,-0.0460060923954249,2.41849063642421e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0258584155836244,0.00338699899842627,-0.0324969336205399,-0.0192198975467089,2.45254776352772e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,42676,0.0471415983819076,0.00617800370390374,0.0350327111222562,0.0592504856415589,2.49398803120955e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0349917607993111,0.00459337301481999,-0.0439947719083583,-0.0259887496902639,2.75347688304615e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0358429273386403,0.00470754001219609,-0.0450697057625446,-0.026616148914736,2.87629115140624e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0692385339737715,0.00910564175252502,-0.0870855918087206,-0.0513914761388225,3.0622116535808e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0253952127828833,0.00334623280072619,-0.0319538290723066,-0.01883659649346,3.42914879478391e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,42336,-0.0288963485991635,0.00381025733228689,-0.0363644529704458,-0.0214282442278812,3.5799700944675e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0721806589117135,0.00953986488762628,-0.090878794091461,-0.053482523731966,4.09099678532684e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0435223506497612,0.0057652412579113,0.032222477784255,0.0548222235152673,4.66574869788193e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.045112245477463,0.00598194678786226,-0.056836861181673,-0.033387629773253,5.00613948486906e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0300484021571384,0.00399054248531084,-0.0378698654283476,-0.0222269388859292,5.47193577915267e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,40302,-0.0932230574700301,0.012403114026296,-0.11753316096157,-0.0689129539784899,6.07744965030791e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,42476,-0.0577615028339436,0.00769134451517491,-0.0728365380836864,-0.0426864675842008,6.29279111928838e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0514811574555646,0.0068623876980173,-0.0649314373436785,-0.0380308775674507,6.76185728127845e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.06978845665074,0.00930747052649818,-0.0880310988826764,-0.0515458144188035,6.88867150652676e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42754,-0.024887589535674,0.00332147028919884,-0.0313976713025037,-0.0183775077688443,7.15106500723024e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.05337916334891,0.00712937985101737,-0.0673527478569041,-0.039405578840916,7.55784394212989e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0412004104202547,0.00550667092849991,-0.0519934854401145,-0.0304073354003948,7.7915975410738e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,42692,-0.0446623182572856,0.00598082354679172,-0.0563847324089973,-0.0329399041055738,8.6684836528362e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,42636,-0.0773502635153011,0.0103765710014485,-0.0976883426781402,-0.057012184352462,9.58538408070896e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0573244629227485,0.00769358516490915,-0.0724038898459705,-0.0422450359995266,9.83466882868987e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0672688614639548,0.00905462372428803,-0.0850159239635594,-0.0495217989643503,1.15961728931733e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,40527,-0.0198854979944726,0.00267859671436368,-0.0251355475546254,-0.0146354484343198,1.21915477289897e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0530928855082454,0.00715490546680761,-0.0671165002231883,-0.0390692707933024,1.25272649621613e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42679,-0.0373637362250831,0.00503884315451809,-0.0472398688079386,-0.0274876036422277,1.2873896171312e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,42663,-0.0228686663476023,0.00308413271721021,-0.0289135664733343,-0.0168237662218703,1.28940839709822e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,40483,-0.02736819950925,0.00369041879103097,-0.0346014203396707,-0.0201349786788293,1.29342304756733e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0717057525356812,0.00968315609392431,-0.0906847384797728,-0.0527267665915895,1.3876878332464e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,42311,-0.0451000853098948,0.00609737740301959,-0.0570509450198132,-0.0331492255999764,1.48159224513711e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0411240187539736,0.00556374725437854,-0.0520289633725555,-0.0302190741353917,1.55553590250668e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0245318419512571,0.00332297276130048,-0.031044868563406,-0.0180188153391082,1.64393442749999e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.0964104429338606,0.0130959533892576,-0.122078511576806,-0.0707423742909156,1.91957228740227e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.033198803164036,0.00451116465253106,-0.0420406858829969,-0.0243569204450751,1.95576629035477e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,40527,0.0288696051224238,0.00392338109995276,0.0211797781665164,0.0365594320783312,1.99068609378107e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,42339,-0.0271669703743729,0.00370147644090259,-0.034421864198542,-0.0199120765502038,2.26990947325851e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,42689,-0.0393478852885185,0.00536237879341925,-0.0498581477236202,-0.0288376228534167,2.29590561948762e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.053701053915347,0.00733514004197776,-0.0680779283976234,-0.0393241794330706,2.60035920133041e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0229931855224242,0.00314275429928485,-0.0291529839490225,-0.0168333870958259,2.69529695788395e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0752330558449563,0.0102900676185979,-0.0954015883774081,-0.0550645233125044,2.79827894853395e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0460144322178105,0.00631163793513944,-0.0583852425706838,-0.0336436218649372,3.26664250931456e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0464163873797315,0.00636931706682836,-0.0589002488307151,-0.0339325259287479,3.37223450008166e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,40199,-0.0656207028285752,0.0090173902042123,-0.0832947876288313,-0.0479466180283191,3.6422494338335e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,42370,-0.0372892972952853,0.00512553560152694,-0.0473353470742781,-0.0272432475162925,3.65465103453675e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0244014516328433,0.00335641989294173,-0.0309800346230091,-0.0178228686426775,3.79326933624487e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0227276063811733,0.00312699145488112,-0.0288565096327403,-0.0165987031296063,3.88934814639941e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0195817491456218,0.00269593287604305,-0.0248657775826662,-0.0142977207085774,3.9807034403791e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0275063156069659,0.00378839965705916,-0.0349315789348019,-0.02008105227913,4.06210179191908e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0225979903589396,0.00311378914231559,-0.0287010170778781,-0.016494963640001,4.16335985841921e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0282708618082558,0.00389618586489236,-0.0359073861034448,-0.0206343375130668,4.24811993658907e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0468641994059901,0.00646789472515337,-0.0595412730672907,-0.0341871257446895,4.53697246536412e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42721,0.0113997581811967,0.0015742368572275,0.00831425394103079,0.0144852624213626,4.6789000366285e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0471008323423011,0.00650562295940621,-0.0598518533427373,-0.0343498113418649,4.73497336543662e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0529858952390724,0.00732770044669396,-0.0673481881145926,-0.0386236023635523,5.05855916640463e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,42587,-0.0704344894691385,0.0097506691049935,-0.0895458009149257,-0.0513231780233512,5.33823563465707e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.036879527918757,0.0051072029313934,-0.0468896456642881,-0.026869410173226,5.43585363774047e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0445910863293127,0.00617635355722965,-0.0566967393014828,-0.0324854333571426,5.54716947042764e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,42346,-0.0516190112753198,0.00715511881865663,-0.0656430441598868,-0.0375949783907528,5.71902670020091e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,40511,-0.0223678260667576,0.00310305254731529,-0.0284498090594955,-0.0162858430740196,6.02490683335861e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0277309228303791,0.00385174546216124,-0.0352803439362151,-0.0201815017245431,6.3608441454852e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.027960169474586,0.00388643073192714,-0.0355775737091632,-0.0203427652400088,6.68296074379104e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0253490793232843,0.00352585114630524,-0.0322597475700425,-0.018438411076526,6.92496588004539e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,40283,-0.0227153221895523,0.00316271321963603,-0.028914240100039,-0.0165164042790657,7.29798843738615e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42711,-0.0158675447061433,0.00221025661725214,-0.0201996476759575,-0.0115354417363291,7.38618195871971e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42679,-0.0391147023993666,0.00545774639276648,-0.0498118853291889,-0.0284175194695443,8.07477843963156e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0579311754774484,0.00809512798341399,-0.0737976263249398,-0.042064724629957,8.72883820445414e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0247656231905043,0.00346031354617084,-0.0315478377409992,-0.0179834086400095,8.7561747089494e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0196149888463114,0.00274136556754208,-0.0249880653586938,-0.0142419123339289,8.89135934061899e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.044643425388875,0.00624266353432409,-0.0568790459161502,-0.0324078048615998,9.13423770537636e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0301397326307885,0.00421959278102147,-0.0384101344815906,-0.0218693307799864,9.72200665476571e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0297585648462719,0.00417216807114193,-0.0379360142657101,-0.0215811154268338,1.03554596667508e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0714122268484362,0.0100156155538479,-0.0910428333339782,-0.0517816203628943,1.05412332239063e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,40539,-0.0134015824414857,0.00188023695933769,-0.0170868468817875,-0.00971631800118382,1.08330238993936e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0392611645454303,0.00551295392939257,-0.0500665542470397,-0.0284557748438208,1.12146925827082e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.0552176126613036,0.00775530562531189,-0.0704180116869149,-0.0400172136356923,1.13390786652218e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0582652849986205,0.00818958401843323,-0.0743168696747497,-0.0422137003224914,1.17938159321044e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0349017656404021,0.00490786195153282,-0.0445211750654065,-0.0252823562153978,1.20645557066643e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0333625561305472,0.00469952256108255,0.0241514919108254,0.0425736203502689,1.31991543238663e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0260418546308813,0.00367109043198523,-0.0332371918775723,-0.0188465173841902,1.37078824572671e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0192821085261626,0.00271821226574836,-0.0246098045670294,-0.0139544124852958,1.37114037624561e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0264599495805622,0.00373538682063932,-0.0337813077490153,-0.0191385914121092,1.47469132238245e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0232768265266117,0.00328869931885089,-0.0297226771915594,-0.0168309758616639,1.53653890300817e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,40451,-0.0220119801585771,0.00312112217931117,-0.028129379630027,-0.0158945806871273,1.859189521005e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0565444163199239,0.00803013644309651,-0.072283483748393,-0.0408053488914547,1.99417179368211e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.058270606154525,0.00827443472521904,-0.0744884982159543,-0.0420527140930957,2.00157811717328e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,40342,-0.0736577103649634,0.0104619489399679,-0.0941631302873005,-0.0531522904426263,2.02764858388964e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0278802752278517,0.00396237464504707,0.0201140209235595,0.035646529532144,2.07059332025259e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0395510268042095,0.00562115528865323,0.0285335624384492,0.0505684911699699,2.07203740938595e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,40532,-0.0192138781924772,0.00273178242590484,-0.0245681717472507,-0.0138595846377037,2.13072513035736e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0343620223200317,0.00489014045215695,-0.0439466976062593,-0.0247773470338041,2.23725480512937e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0357774954365332,0.00509559142087506,-0.0457648546214484,-0.0257901362516181,2.30558254904646e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,42534,-0.047023629300682,0.00670469123193311,-0.0601648241152709,-0.0338824344860931,2.43556105320389e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0744083896245704,0.0106142694344865,-0.095212357716164,-0.0536044215329769,2.49433551056251e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0317508982721713,0.00453341338305664,-0.0406363885029623,-0.0228654080413803,2.61046579233564e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0268930189984551,0.00383969322189891,-0.0344188177133769,-0.0193672202835332,2.63034085002922e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,40463,-0.065854172665159,0.00942698401087119,-0.0843310613264665,-0.0473772840038514,2.99391056819248e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0594147307861734,0.00850887555343722,-0.0760921268709103,-0.0427373347014365,3.05869343145629e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.035262032841159,0.00505286136089457,-0.0451656411085123,-0.0253584245738056,3.12000778582001e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.0826039836727428,0.0118370777047457,-0.105804655974044,-0.0594033113714413,3.12485259064591e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0334330454038913,0.00479188351677988,-0.0428251370967798,-0.0240409537110027,3.1557681145088e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,42640,0.0255098912754588,0.00365655126148325,0.0183430508029516,0.032676731747966,3.16808280875642e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,40483,-0.0713092525376115,0.0102504329344284,-0.0914001010890911,-0.0512184039861319,3.67587383042801e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0527926208932647,0.00759576669176713,0.0379049181774011,0.0676803236091282,3.81399901489767e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0219751400853957,0.00316505615021444,-0.028178650139816,-0.0157716300309754,4.01740614968474e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42760,-0.018966342887929,0.00273391824534152,-0.0243248226487983,-0.0136078631270596,4.17425621521838e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0381924950732769,0.00552043468032967,-0.049012547046723,-0.0273724430998307,4.7801984197401e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0376319304332222,0.0054388316040499,-0.04829204037716,-0.0269718204892844,4.79633536098197e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,42611,0.0170669542830827,0.00248158172888446,0.0122030540944692,0.0219308544716962,6.36318227288717e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0417706046650965,0.00607529305013382,-0.0536781790433588,-0.0298630302868343,6.50294929766061e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0363637669395294,0.00529075039007311,-0.0467336377040727,-0.0259938961749861,6.61398038953098e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0221325404665202,0.00323074231852389,-0.028464795410827,-0.0158002855222133,7.6750088838233e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.01979654705656,0.00289166278363172,-0.0254642061124782,-0.0141288880006418,7.99117923120703e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,42587,0.030479083040848,0.00445424476867527,0.0217487632942445,0.0392094027874515,8.10901586261473e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0220905044920355,0.00323002272096926,-0.0284213490251353,-0.0157596599589358,8.3907178896536e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0359219912999297,0.00525724681176478,-0.0462261950509887,-0.0256177875488708,8.76397438430059e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0231006949150557,0.0033815964642029,-0.0297286239848934,-0.016472765845218,8.77816428800462e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0589108622351103,0.00862544658035713,-0.0758167375326103,-0.0420049869376103,8.93448021134517e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0290019692874806,0.00424946450426768,-0.0373309197158453,-0.020673018859116,9.26041998543024e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0482929798718886,0.00708912629126528,-0.0621876674027686,-0.0343982923410087,1.00949107381266e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,42437,-0.0277590166194276,0.00407639853182329,-0.0357487577418012,-0.0197692754970539,1.02027254916093e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0257530673758257,0.00378326222175602,-0.0331682613304675,-0.0183378734211839,1.03793048677889e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0219547292555491,0.0032295665027612,-0.0282846796009611,-0.0156247789101372,1.10621919710868e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0669384480512942,0.00985070129878035,-0.0862458225969037,-0.0476310735056847,1.12635374633891e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0339065279333532,0.00499216400564417,-0.0436911693844158,-0.0241218864822906,1.15252990455664e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.0698873077415814,0.0102885965340337,-0.0900529569482874,-0.0497216585348754,1.155888647821e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0285497770686724,0.00420792782726427,0.0203022385272344,0.0367973156101103,1.21132805258254e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,42445,-0.0250421462075006,0.00369714776260707,-0.0322885558222104,-0.0177957365927907,1.3112666637672e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.0634436246125882,0.0093686837701039,-0.0818062448019919,-0.0450810044231846,1.3235249176364e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0266924617060464,0.00394421591974612,-0.0344231249087488,-0.018961798503344,1.36397278224606e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0180701581842375,0.00267391042597305,-0.0233110226191447,-0.0128292937493303,1.4703821329309e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,40483,-0.0150601040222786,0.00222912594666109,-0.0194291908777344,-0.0106910171668229,1.48770867467711e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0172494207712756,0.00255438137383206,0.0122428332785647,0.0222560082639864,1.5092022437757e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,40539,0.0179223886822416,0.0026582094664646,0.012712298127971,0.0231324792365122,1.63489815095904e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.0118777491407922,0.00176195346912107,0.00842432034131488,0.0153311779402695,1.64675315297977e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0292660956794323,0.00434905734572992,-0.037790248077063,-0.0207419432818017,1.77467688664743e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,40449,-0.0200912579029099,0.00298933599934297,-0.0259503564616221,-0.0142321593441977,1.89232148246696e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0342539607986163,0.00510328175535851,-0.044256393039119,-0.0242515285581137,2.00976025195594e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0245919575943266,0.00366687926995339,-0.0317790409634352,-0.0174048742252179,2.07329431371609e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0225460964269038,0.00336321385605593,-0.0291379955847734,-0.0159541972690342,2.12819049180485e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0356791075730632,0.00532455579482665,-0.0461152369309235,-0.025242978215203,2.15422837981843e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,42794,0.017901929818956,0.00267342378018878,0.012662019209786,0.0231418404281261,2.22221980579242e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0220021158374199,0.00328759516796915,0.0155584293082003,0.0284458023666394,2.28139482975976e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,40449,-0.0432531465648966,0.00646771914199645,-0.0559298760832097,-0.0305764170465836,2.37698224086792e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.015261818706639,0.00228278282262585,0.0107875643742923,0.0197360730389856,2.39060674057579e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0201339916293181,0.00301134815334038,-0.0260362340098653,-0.014231749248771,2.40307609369744e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.0186332766815662,0.00278920374789,-0.0241001160274306,-0.0131664373357018,2.47641852699171e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0415151759763815,0.00621697076931419,-0.0537004386842373,-0.0293299132685257,2.5440246808446e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0220565030553464,0.00330392881474936,0.0155808025784376,0.0285322035322551,2.55479790016749e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0258218796706645,0.00387573955478374,-0.0334183291980407,-0.0182254301432884,2.7971905432804e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0307876822214261,0.00462203032028976,-0.039846861649194,-0.0217285027936581,2.8446956898781e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0402777375319868,0.0060498800561284,-0.0521355024419985,-0.0284199726219751,2.89122651530906e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.028635075954507,0.00430991546126789,0.020187641650422,0.0370825102585921,3.17023548584265e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,40054,-0.0464675211464152,0.00699364593147422,-0.0601750671721047,-0.0327599751207258,3.19354722532381e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0488016013046103,0.00734574261385605,-0.0631992568277682,-0.0344039457814525,3.20402889858497e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0365702095999597,0.00550837275949869,-0.0473666202085771,-0.0257737989913422,3.27825626762804e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,42311,-0.0393506734671491,0.00593146560846098,-0.0509763460597326,-0.0277250008745656,3.39016405241246e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0257057170712826,0.00387669189905549,-0.0333040331934313,-0.0181074009491338,3.49019791871599e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0458618769369832,0.00691901637716698,-0.0594231490362305,-0.0323006048377359,3.54855287244896e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,40283,-0.0212906505835565,0.00321569132221332,-0.0275934055750946,-0.0149878955920184,3.73605944232011e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.033280602684802,0.00503011533455578,-0.0431396287405313,-0.0234215766290727,3.82344482899368e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00554674938933961,0.000838557736624583,0.00390317622555543,0.00719032255312379,3.86449412462331e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,40511,0.0179281766497412,0.00271254118758564,0.0126115959220734,0.0232447573774091,4.03313655757198e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0563704927163527,0.00855364184961561,-0.0731356307415993,-0.0396053546911061,4.59206125661297e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0273737701131463,0.0041559860062701,-0.0355195026854357,-0.0192280375408569,4.70043175502035e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0175392060099256,0.00266345267025706,0.0123188387762218,0.0227595732436295,4.71340765070391e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,40482,-0.0348433892541439,0.00529141517976197,-0.0452145630064773,-0.0244722155018104,4.75428002217405e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0436547386371416,0.00663160006674329,-0.0566526747679584,-0.0306568025063247,4.78742153467723e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0377517694911362,0.00573615148433798,-0.0489946264004386,-0.0265089125818338,4.83585183306769e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0416243617326245,0.00633419641823923,-0.0540393867123734,-0.0292093367528756,5.20485923132187e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0205707641387097,0.00313303440854161,-0.0267115115794513,-0.0144300166979682,5.40379580024658e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42594,-0.0513307946630984,0.00782413870168189,-0.0666661065183949,-0.0359954828078019,5.55722689560529e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0417800024928219,0.00637605731997065,-0.0542770748399644,-0.0292829301456794,5.86409407599967e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0423638967499204,0.00646849466189283,-0.0550421462872304,-0.0296856472126105,5.99349070098156e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42754,-0.0362176405865256,0.00553130645362557,-0.0470590012356317,-0.0253762799374195,6.05118310597208e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0190716405443883,0.00291533412066883,-0.0247856954208992,-0.0133575856678774,6.29914478385568e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,40511,-0.0188847466921924,0.00288693130968569,-0.0245431320591764,-0.0132263613252084,6.3547866909179e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,42594,-0.0221291874035792,0.0033839449917151,-0.0287617195873408,-0.0154966552198176,6.39786809994098e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0525890840217422,0.00804191410203611,-0.068351235661733,-0.0368269323817514,6.40239999624735e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,42636,-0.0752137736216932,0.0115065081499266,-0.0977665295955494,-0.052661017647837,6.51916915303031e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,40199,-0.026654345275843,0.0040805355313691,-0.0346521949173265,-0.0186564956343596,6.77280414688675e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0334765248252857,0.00513385915748953,-0.0435388887739652,-0.0234141608766063,7.25191239461022e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,42754,-0.0307019244522934,0.00470887320432066,-0.0399313159327619,-0.0214725329718249,7.27896620593253e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0299636269424882,0.00459974912212855,-0.0389791352218601,-0.0209481186631162,7.56630485629273e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0196991001071098,0.00302883649624604,-0.025635619639752,-0.0137625805744676,8.10435469364931e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0678974201029054,0.0104487948304343,-0.0883770579705567,-0.0474177822352541,8.47697262136087e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0606477207302114,0.0093377621123379,-0.0789497344703937,-0.0423457069900291,8.66700856956179e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0435911634585,0.00671796103076264,-0.0567583670787948,-0.0304239598382052,8.95952500750788e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0356773950135951,0.00549859791603865,-0.0464546469290309,-0.0249001430981593,8.97938564362891e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.035317695729227,0.00544321428988997,-0.0459863957374113,-0.0246489957210426,8.98668913848081e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.018501989134699,0.00285304328163755,-0.0240939539667086,-0.0129100243026894,9.18215688730966e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0372545863133629,0.00574512764656523,-0.0485150365006307,-0.025994136126095,9.2170100890444e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0495575997601697,0.00764323144078909,-0.0645383333841163,-0.0345768661362231,9.31398634186634e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0455397811027751,0.00702628417327692,-0.0593112980823978,-0.0317682641231523,9.47026497283371e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.038562189433351,0.00595061799417333,-0.0502254007019308,-0.0268989781647713,9.53101261299255e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.0365722021426157,0.00564738314065805,0.0255033311869259,0.0476410730983055,9.74770957222923e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0348057547587585,0.00538880733002375,-0.045367817125605,-0.0242436923919119,1.09110066096422e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.040673915752169,0.00630088800789897,-0.053023656247651,-0.028324175256687,1.12457841155659e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42494,-0.0431657123698451,0.0066911614560242,-0.0562803888236525,-0.0300510359160376,1.14844684095363e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0327714773831126,0.00507974673955874,-0.0427277809926477,-0.0228151737735775,1.15429890330041e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,42594,0.0273265257138933,0.00423915771373312,0.0190177765949764,0.0356352748328103,1.1860549907737e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,40182,-0.0289495197231894,0.00449076007665256,-0.0377514094734284,-0.0201476299729504,1.19289419945987e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.022410063252036,0.00348348916463497,-0.0292377020147206,-0.0155824244893515,1.29171119696517e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0185004398402661,0.00287774119658487,-0.0241408125855724,-0.0128600670949597,1.3305196355137e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.021251782830724,0.00331068070237328,-0.0277407170073757,-0.0147628486540724,1.42540249729375e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0410647335599938,0.00640295384200931,-0.053614523090332,-0.0285149440296555,1.47990680508618e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.027793736661179,0.00433777144293917,-0.0362957686893397,-0.0192917046330182,1.52989078386598e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0209221749378702,0.00326550449384591,-0.0273225637458082,-0.0145217861299322,1.5334857629518e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0165239544271146,0.00257905017942958,-0.0215788927787966,-0.0114690160754326,1.54309692660275e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0579871685092014,0.00905962018369337,-0.0757440240692404,-0.0402303129491624,1.59941687463584e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,42597,-0.0252050401279276,0.00394099440221209,-0.0329293891562633,-0.0174806910995919,1.65221580593066e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0275386960788289,0.00431058307830591,-0.0359874389123085,-0.0190899532453494,1.74142802033161e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0803249450615686,0.0125772616196297,-0.104976377836043,-0.0556735122870944,1.7525525660692e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42754,-0.0301715695131245,0.00472570760790915,-0.0394339564246265,-0.0209091826016226,1.77489363735521e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0262306816776436,0.00411253623280135,-0.0342912526939343,-0.018170110661353,1.86381366858805e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0205907571719538,0.00322857515986043,-0.0269187644852802,-0.0142627498586274,1.87138143963052e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,40449,-0.042900728114549,0.00673067899375635,-0.0560928589423115,-0.0297085972867866,1.91476690444799e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0268032892420385,0.00420626140267681,-0.0350475615912851,-0.018559016892792,1.93737254739639e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0578521572675733,0.00909216537477009,-0.0756728014021226,-0.0400315131330239,2.04598950599466e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0381438739534231,0.0059962460381518,-0.0498965161882006,-0.0263912317186456,2.06689271605322e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0296163850068828,0.00465560869926403,-0.0387413780574403,-0.0204913919563253,2.07814652509788e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0180046824556607,0.00283381546162531,0.0124504041508751,0.0235589607604463,2.1725027645478e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.02961398347587,0.00466197629440133,-0.0387514570128967,-0.0204765099388434,2.20366225918967e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0347687026373785,0.005492007114179,-0.0455330365811693,-0.0240043686935876,2.51868361511438e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0217043574633325,0.00343186425366863,0.014977903526142,0.028430811400523,2.62317978861161e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0266373098307496,0.00421173924147272,-0.0348923187440361,-0.018382300917463,2.6247055535849e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0329112552341088,0.0052106256153427,-0.0431240814401805,-0.0226984290280371,2.76640182702262e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0260609373290533,0.00413347857314839,-0.0341625553324242,-0.0179593193256825,2.97690061166084e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0330367269266281,0.00526286413832476,-0.0433519406377447,-0.0227215132155116,3.5493231902265e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.0148818016004154,0.00237082887093351,-0.0195286261874451,-0.0102349770133858,3.55635126340908e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,40482,-0.0331532086305636,0.00528136070561006,-0.0435046756135593,-0.0228017416475679,3.56916169479249e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0269211794925216,0.00429333751892317,-0.035336121029611,-0.0185062379554321,3.73184906986226e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,42357,-0.0343182337073165,0.00547564245245243,-0.0450504929141233,-0.0235859745005098,3.78494498250947e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0198114682714999,0.00316885897272614,-0.0260224318580431,-0.0136005046849566,4.17646293901266e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39870,-0.0744876322143238,0.011918396362671,-0.0978476890851589,-0.0511275753434887,4.26651336391961e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,40199,-0.0342834928325162,0.00549064099005525,-0.0450451491730245,-0.0235218364920079,4.42277887182822e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,42618,-0.0201096524284519,0.00322414564161683,-0.0264289778860208,-0.0137903269708829,4.58827780735987e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,40223,-0.054537042496712,0.00875110044154138,-0.0716891993621331,-0.0373848856312908,4.77262459135657e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0579506599742972,0.00930860078023377,-0.0761955175035554,-0.039705802445039,4.97521458804126e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,40283,-0.0425747080295794,0.00685495792292374,-0.0560104255585099,-0.0291389905006489,5.46066546006165e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0280079756565845,0.00451869453420974,-0.0368646169436356,-0.0191513343695334,5.90942521994852e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0360054744341844,0.00581086716623409,-0.0473947740800033,-0.0246161747883656,5.98944768114766e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0466078507875674,0.00752468030753341,-0.0613562241903329,-0.0318594773848019,6.07353535054868e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,40223,-0.0403488048959407,0.0065152655849269,-0.0531187254423975,-0.027578884349484,6.11452622335019e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0417997311032916,0.00675249438181281,-0.0550346200916447,-0.0285648421149385,6.21478122016022e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0566666786206907,0.00915833016111789,-0.0746170057364818,-0.0387163515048997,6.29157977587772e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,40449,-0.0205456888163038,0.00332133417652679,-0.0270555038022963,-0.0140358738303113,6.38628715987322e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0292604506564134,0.00473169039453842,-0.0385345638297087,-0.0199863374831181,6.47215256595781e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0337046372943961,0.00545745986884168,-0.0444012586373257,-0.0230080159514664,6.76826949899243e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0125935225251846,0.00204062893998205,-0.0165931552475495,-0.00859388980281982,6.96431312313393e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.067272210447959,0.0109036361343662,0.0459010836246011,0.0886433372713168,7.09056793478665e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0168098597131808,0.00273085353105039,-0.0221623326340395,-0.011457386792322,7.6941422511137e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0249749691008834,0.00406297475315135,-0.03293839961706,-0.0170115385847067,8.12606891907608e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0546211423129336,0.00888798811243935,-0.0720415990133147,-0.0372006856125524,8.20121794758665e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0284496038202452,0.00463791602674784,-0.0375399192326709,-0.0193592884078194,8.80321305638353e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0403123010268947,0.00657459757221658,-0.0531985122684392,-0.0274260897853502,8.94778195751984e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0259160483672446,0.00423541654154863,-0.0342174647886799,-0.0176146319458093,9.68507576574821e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,40471,-0.0494480467560494,0.00808602708245999,-0.065296659837671,-0.0335994336744278,9.95998414270381e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.042484393636343,0.00695347274229308,-0.0561132002112375,-0.0288555870614486,1.02563841152757e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0216144347779305,0.00354187901062829,-0.0285565176387619,-0.014672351917099,1.07941468292749e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0523621027856698,0.00858221150063925,0.0355409682444169,0.0691832373269227,1.08225368179757e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,40516,0.0216456685443888,0.00355078449398052,0.0146861309361869,0.0286052061525906,1.12280085462693e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0294879693048119,0.00484096868351708,-0.0389762679245053,-0.0199996706851184,1.15033002006754e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0247846380618527,0.00407188630018414,-0.0327655352102136,-0.0168037409134918,1.18358274532861e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0175973184813868,0.00289366774174309,-0.0232689072552033,-0.0119257297075703,1.2241069525837e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0242591984064552,0.00399476440845941,-0.0320889366470356,-0.0164294601658747,1.29768871026049e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,40482,0.0282842955223206,0.00465856307499974,0.0191535118953211,0.0374150791493201,1.30824513869183e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0387684701950674,0.00638896299550059,-0.0512908376662486,-0.0262461027238863,1.3293174334874e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0213861636445089,0.00353289401541955,-0.0283106359147312,-0.0144616913742865,1.45566274846812e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.0145636974805439,0.00241071962185459,-0.0192887079393789,-0.00983868702170895,1.56980774846986e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,40483,-0.0361150512227335,0.00597863175897496,-0.0478331694703244,-0.0243969329751426,1.58292846579052e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,42689,0.0280430952957288,0.00464727506263756,0.0189344361729592,0.0371517544184984,1.63824729636753e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.0340628079534315,0.00564671635016185,-0.0451303719997487,-0.0229952439071143,1.65910270352043e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0306790308501644,0.0050967650788487,-0.0406686904047079,-0.020689371295621,1.79761783918952e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,40116,-0.0380083410046461,0.00632756363008545,-0.0504103657196136,-0.0256063162896786,1.95262487195265e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0199984778048336,0.00332990565529665,-0.026525092889215,-0.0134718627204522,1.95401165285717e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0244626722157552,0.0040753788468783,0.0164749296758738,0.0324504147556367,2.00263228921795e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0476092532663528,0.00793302694875715,-0.0631579860859168,-0.0320605204467888,2.00681375937909e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0133786408306192,0.00223032283140699,-0.0177500735801769,-0.00900720808106152,2.04270997585859e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,40283,0.0301291153328569,0.00502422597442472,0.0202816324229844,0.0399765982427293,2.07557598041626e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,40483,-0.0322260333236333,0.00538198926332557,-0.0427747322797514,-0.0216773343675152,2.19230930437423e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,42613,-0.0223647551187746,0.0037364017202587,-0.0296881024904817,-0.0150414077470676,2.21039245348853e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.0135419023732807,0.0022642868089004,-0.0179799045187255,-0.00910390022783595,2.27874755679807e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0205452250264479,0.00343591152081777,-0.0272796116072507,-0.0138108384456451,2.30538878698805e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.013408035320814,0.00224486331984765,-0.0178079674277154,-0.0090081032139126,2.39231385767319e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.026130396599062,0.00437919487373725,-0.0347136185515871,-0.017547174646537,2.49199661136615e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0171028282013232,0.00286768973557981,-0.0227235000830597,-0.0114821563195868,2.53571648233456e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,40494,-0.0269366236102176,0.00452088795819452,-0.0357975640082788,-0.0180756832121563,2.6253839290422e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0398688968805201,0.00669233248314632,-0.0529858685474869,-0.0267519252135534,2.64138811946432e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0345210478726669,0.00579904504627543,-0.0458871761633668,-0.0231549195819671,2.71270540455664e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0199858959913156,0.00335925408863596,-0.0265700340050421,-0.0134017579775891,2.77143908834756e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0157178678218416,0.00264576061756899,-0.0209035586322768,-0.0105321770114064,2.92284869410924e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0406592334731999,0.00686734787707948,-0.0541192353122757,-0.0271992316341242,3.28381860546327e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0370992771765521,0.0062701736813576,-0.049388817592013,-0.0248097367610912,3.37823722457836e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,42476,-0.0356761269209777,0.00604091703760849,-0.0475163243146903,-0.023835929527265,3.59634775149598e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0269685404492576,0.00457088975145051,-0.0359274843621006,-0.0180095965364146,3.72299199332173e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,42311,-0.0379972781032067,0.00644290187185735,-0.0506253657720471,-0.0253691904343663,3.78043212907014e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0327644674334275,0.00556569639691084,-0.0436732323713728,-0.0218557024954823,4.05009313548904e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0299573409896125,0.00509001909565918,-0.0399337784171045,-0.0199809035621205,4.06485510725115e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0153917774087569,0.00261564511278619,0.010265112987696,0.0205184418298178,4.10544048781421e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0400843719142031,0.00681624685841915,0.0267245280717016,0.0534442157567046,4.20085879382023e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.045110099641758,0.00767581057618875,-0.060154688371088,-0.0300655109124281,4.30089823827937e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,40223,-0.0172483309377354,0.0029390660936576,-0.0230089004813043,-0.0114877613941666,4.52019905817483e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0441469297465153,0.00752457719128507,-0.0588951010414341,-0.0293987584515966,4.54142071089991e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0216134617227388,0.00368403956319162,-0.0288341792665944,-0.0143927441788832,4.54806391909447e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0577639434156315,0.0098497458610352,-0.0770694453032605,-0.0384584415280025,4.63385809592234e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0135212192327741,0.00230600336927275,0.00900145262899951,0.0180409858365487,4.63888755667714e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0150103885707096,0.00256159399141336,-0.0200311127938798,-0.00998966434753941,4.74456491134259e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42611,-0.0140745517251236,0.00240238593743246,-0.0187832281624912,-0.00936587528775596,4.77809653093454e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.0135547654895231,0.00231536511576466,-0.0180928811164219,-0.00901664986262442,4.90334080584415e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0620929782545269,0.0106071313440942,-0.0828829556889516,-0.0413030008201021,4.9144500003008e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0276376789315167,0.00472355083659126,-0.0368958385712356,-0.0183795192917978,5.00130620398884e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0144209835619471,0.00246475620625894,0.00959006139767957,0.0192519057262146,5.02503418352433e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0299915138501918,0.00512969253502827,-0.0400457112188473,-0.0199373164815364,5.16014254619412e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.0242688186594798,0.0041521209394038,-0.0324069757007113,-0.0161306616182484,5.18800763461197e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0325261508617362,0.00556704344482204,-0.0434375560135874,-0.021614745709885,5.2600593947141e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0329262824332814,0.00563912736994513,-0.0439789720783738,-0.0218735927881889,5.37882293433287e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,42654,-0.0174127500847166,0.00298610983603475,-0.0232655253633447,-0.0115599748060885,5.62763106146683e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0575427525724717,0.00987061922413961,-0.0768891662517854,-0.0381963388931581,5.70519707893148e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0495524048609067,0.00851552412053746,-0.0662428321371601,-0.0328619775846532,6.08240684642286e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0180630456440216,0.00310576378733614,-0.0241503426672004,-0.0119757486208428,6.19166068411491e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0402319432991778,0.0069176423176973,-0.0537905222418645,-0.026673364356491,6.20096740830757e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,40539,0.0133766307860388,0.00230023719165024,0.00886816589040432,0.0178850956816732,6.2148273996291e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.0725718426541159,0.0124906771210758,-0.0970535698114244,-0.0480901154968074,6.38528070613206e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,40451,-0.034255849556969,0.00589524701496903,-0.0458105337063083,-0.0227011654076297,6.38768111258208e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0540458162163087,0.0093244777092927,-0.0723217925265224,-0.035769839906095,6.93912046388224e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0287612749302225,0.00497265449741811,-0.038507677745162,-0.019014872115283,7.49367082971809e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0160375927357129,0.00277563127222634,0.0105973554421493,0.0214778300292765,7.72730881430248e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0238321503001617,0.00412495280382413,-0.031917057795657,-0.0157472428046664,7.75096444756324e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,40223,-0.0404094044892574,0.00699801578346838,-0.0541255154248555,-0.0266932935536594,7.93087807437077e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0093075303874306,0.00161196436324268,-0.0124669805393863,-0.00614808023547494,7.94281033893435e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0288835363452145,0.00500438447301707,-0.0386921299123279,-0.019074942778101,8.02764292765906e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0199858830206035,0.00346557702615965,-0.0267784139918764,-0.0131933520493306,8.25105310512269e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0460784103018709,0.00799605495921557,-0.0617506780219334,-0.0304061425818084,8.46292296422916e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0314212103638177,0.00545359929292415,-0.042110264977949,-0.0207321557496864,8.55572611578082e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0128882521943204,0.00224151863168407,-0.0172816287124212,-0.00849487567621962,9.16646311630285e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0178810530806351,0.00311027219820435,-0.0239771865891156,-0.0117849195721546,9.16986539147085e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,42333,-0.0279040557355924,0.00486075260355653,-0.0374311308385632,-0.0183769806326216,9.63783293743417e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0183968894344956,0.00320489388159063,-0.0246784814424133,-0.012115297426578,9.65604452840545e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0289717530709032,0.0050482167069186,-0.0388662578164637,-0.0190772483253428,9.73396587756878e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,42771,0.0260511315712421,0.00453998789851203,0.0171527552901585,0.0349495078523256,9.77600369469946e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0158045483039603,0.00275396507406808,-0.0212023198491338,-0.0104067767587869,9.77781213315355e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0237362088240798,0.00414006981657143,-0.0318507456645598,-0.0156216719835997,1.00624137695757e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0524265015403056,0.00915519769818507,-0.0703706890287483,-0.0344823140518629,1.04790544152676e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,42679,-0.038392100318383,0.00671613753030292,-0.0515557298777768,-0.0252284707589893,1.11111742603408e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0133980260141948,0.00234893382879242,-0.0180019363186279,-0.00879411570976163,1.19591481661403e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0177358930041784,0.00311642579731125,-0.0238440875669084,-0.0116276984414483,1.28827991445455e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0149463376088117,0.00262663852145691,-0.0200945491108673,-0.00979812610675618,1.29446687284808e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0330509042986821,0.00582781295944397,0.021628390898172,0.0444734176991923,1.446723792927e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0167585014238977,0.00296194596926949,-0.0225639155236659,-0.0109530873241295,1.56313293943598e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0276857095255369,0.00489692278104388,-0.0372836781763829,-0.0180877408746909,1.602400798229e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,40449,-0.0197738938162213,0.00349877894564168,-0.026631500549679,-0.0129162870827636,1.62772655129421e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,42495,0.0139650285836266,0.00247284536732634,0.00911825166366696,0.0188118055035862,1.6627425265338e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,40499,-0.0238406350592413,0.00423057467679687,-0.0321325614257632,-0.0155487086927195,1.78916146159349e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0421897795027355,0.00748986113306385,-0.0568699073235406,-0.0275096516819304,1.81567281870669e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,42638,-0.0276076387609842,0.00490352910011124,-0.0372185557972022,-0.0179967217247662,1.83649451709643e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,40451,-0.0257493811823156,0.00457339002670393,-0.0347132256346553,-0.0167855367299759,1.84245414592608e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0343486754530333,0.00610717101942802,-0.0463187306511122,-0.0223786202549544,1.90047714049896e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0204066242375233,0.00363345366931818,-0.027528193429387,-0.0132850550456597,1.98914856805762e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0530089805293212,0.00944091673433679,-0.0715131773286213,-0.0345047837300211,2.01411483901199e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0164489114856913,0.00293287072116362,-0.022197338099172,-0.0107004848722107,2.09040028548086e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.019188807049619,0.00342306782964218,-0.0258980199957177,-0.0124795941035203,2.11543035889965e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0357291825891094,0.00637472114325327,-0.0482236360298858,-0.023234729148333,2.12581912139534e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0354919211795824,0.00633683641766452,-0.0479121205582049,-0.0230717218009599,2.18325018771719e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.0185657843895062,0.00332032669466912,-0.0250736247110577,-0.0120579440679547,2.29541887911604e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0316335563744489,0.00566012700794797,-0.0427274053100269,-0.0205397074388709,2.33048646196941e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42543,-0.0175928242357076,0.00314951625793636,-0.0237658761012629,-0.0114197723701524,2.37062622133595e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,42311,-0.0463535561751821,0.00829864966154866,-0.0626189095118175,-0.0300882028385468,2.37425446449479e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0535421141516517,0.00958972563485908,-0.0723379763959755,-0.0347462519073279,2.4061278928799e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0255055802356393,0.00457108097857158,-0.0344648989536396,-0.016546261517639,2.46519767621072e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42587,0.0413528046180031,0.00742550243156832,0.0267988198521292,0.055906789383877,2.611012414156e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0414466477954991,0.00744357891100777,-0.0560360624610743,-0.0268572331299239,2.63408148948686e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0253848520162958,0.00456552899815047,-0.0343332888526707,-0.0164364151799209,2.74749547024004e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0346485175782361,0.00623251514016609,-0.0468642472529616,-0.0224327879035105,2.75965493602976e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,40449,-0.0300314590555517,0.00540261189279331,-0.0406205783654266,-0.0194423397456768,2.77993757654573e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0373010292478207,0.00671103873949054,-0.0504546651772222,-0.0241473933184193,2.7884041356185e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-0.0198548253613234,0.00358266261530642,-0.0268768440873239,-0.0128328066353228,3.060484498283e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0305919420174882,0.00552121466386275,-0.0414135227586592,-0.0197703612763172,3.07968544571836e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0381077463697319,0.0068814876366455,-0.0515954621375571,-0.0246200306019067,3.1224689912133e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0122581408442101,0.00221716589370654,-0.0166037859958749,-0.00791249569254526,3.28475876063468e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0599518333913987,0.010845382273164,-0.0812087826468002,-0.0386948841359972,3.30200794639882e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0199334972299213,0.00360691601854843,-0.0270030526262762,-0.0128639418335664,3.34244909323565e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0437596331067319,0.00792059680610543,-0.0592840028466986,-0.0282352633667653,3.37175318651187e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,42346,-0.0205624425006562,0.0037265878257014,-0.027866554639031,-0.0132583303622815,3.49827232497705e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42594,-0.0215601052886852,0.00391246317143656,-0.0292285331047009,-0.0138916774726696,3.64170129236834e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,40470,-0.017219233121336,0.00312773907263922,-0.0233496017037088,-0.0110888645389631,3.76545504908415e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,42711,-0.0315194095276044,0.00572814442376626,-0.0427465725981862,-0.0202922464570225,3.81146091737688e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.0686364872969051,0.0124827421989181,-0.0931026620067846,-0.0441703125870256,3.91577687875198e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0320680654695454,0.00586612653432652,-0.0435656734768254,-0.0205704574622654,4.68373920326337e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0399414647706264,0.00731177096118872,-0.0542725358545562,-0.0256103936866965,4.7935335304405e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0167992597544723,0.00307911141994884,0.0107642013713726,0.022834318137572,4.97783915561065e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0235353477308002,0.00432030852467994,0.0150675430224275,0.0320031524391728,5.21229258230248e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,42794,0.0157512542746203,0.00289441747145381,0.0100781960305709,0.0214243125186698,5.36154136395851e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.04157830406387,0.00765467577828135,-0.0565814685893015,-0.0265751395384386,5.67686896979054e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.0126466312635773,0.0023286561287761,-0.0172107972759784,-0.00808246525117613,5.7056472734535e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0431319925251945,0.00794352554545589,-0.058701302594288,-0.027562682456101,5.75798304404195e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0330773633371391,0.0060922304933973,-0.0450181351041978,-0.0211365915700804,5.77073652826616e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,40136,-0.0282901004598889,0.00522342088744287,-0.0385280053992769,-0.0180521955205008,6.22335511534406e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0280941320870552,0.00519064242738028,-0.0382677912447206,-0.0179204729293899,6.34604206913587e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0224607564799145,0.00415494046604351,-0.0306044397933597,-0.0143170731664692,6.56198675227733e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,40527,-0.0145633986772668,0.00269596364184635,-0.0198474874152856,-0.00927930993924795,6.72620192612407e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.039071156722055,0.00723329985780865,-0.0532484244433599,-0.02489388900075,6.74020270104522e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0227189303645572,0.00420701752428394,-0.0309646847121537,-0.0144731760169606,6.79310088564834e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42611,-0.0230654898178544,0.00427445242844882,-0.031443416577614,-0.0146875630580947,6.92513752168799e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,42476,0.0258659667430624,0.00479545813106666,0.0164668688061718,0.0352650646799531,7.01465974510911e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0365127411786086,0.00677247810433376,0.0232386840941145,0.0497867982631028,7.11153719244482e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0344886367972821,0.00640149372955638,-0.0470355645072126,-0.0219417090873516,7.26044986073168e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0169180875366455,0.00314484422827804,-0.0230819822240704,-0.0107541928492205,7.59164818857349e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0221531763466112,0.00411765331383929,0.0140825758514862,0.0302237768417362,7.59889426759791e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42611,-0.0141248195553829,0.00262755120035581,-0.0192748199080803,-0.00897481920268546,7.75801552505839e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0218919355685119,0.0040748321954564,-0.0298786066716064,-0.0139052644654174,7.89615832169794e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,42495,0.0218708890713042,0.00407136403603434,0.0138910155606769,0.0298507625819315,7.92309086087347e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0224668157875081,0.00418775421956489,-0.0306748140578553,-0.014258817517161,8.26069305772018e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.039720040717644,0.00744150785384867,-0.0543053961111874,-0.0251346853241006,9.60537946713087e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0352917783726653,0.00661551276952306,-0.0482581834009305,-0.0223253733444001,9.72429681683999e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0194945009707687,0.00365605691606392,0.0123286294152834,0.026660372526254,9.86723956075527e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,40539,-0.0212969312197578,0.00399444090300922,-0.0291260353896559,-0.0134678270498597,9.91963620950158e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0435840348456902,0.00817875573063342,-0.0596143960777317,-0.0275536736136487,1.00731050603623e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,40199,-0.0137715019400247,0.00258643857304971,-0.0188409215432021,-0.00870208233684727,1.03221926594793e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0222469756933712,0.00417952680726343,-0.0304388482356075,-0.0140551031511349,1.03835085885133e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,40182,-0.0251004353835885,0.00472220511833152,-0.0343559574155183,-0.0158449133516587,1.08504449763917e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0195104549142197,0.0036747694950663,-0.0267130031245497,-0.0123079067038898,1.11842060435945e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.041395766673934,0.0077999287256593,-0.0566836269762262,-0.0261079063716418,1.13482410678989e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,40182,-0.025629153916974,0.00483162375994313,-0.0350991364864625,-0.0161591713474855,1.15202850931623e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.039579849002188,0.00749503425779902,-0.054270116147474,-0.0248895818569019,1.30669448308879e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,42311,-0.023116023510182,0.00438358399237168,-0.0317078481352305,-0.0145241988851335,1.36109041658988e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42754,-0.0308763859321172,0.00585667229545537,-0.0423554636312097,-0.0193973082330247,1.37015138303097e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0358932678809134,0.00680851102562252,-0.0492379494911335,-0.0225485862706932,1.37172918114155e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.024582796652924,0.00467816504887271,-0.0337520001487146,-0.0154135931571335,1.50883937677288e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42580,-0.0146188353177352,0.0027832307617915,-0.0200739676108465,-0.00916370302462382,1.52373256545637e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0428149631879602,0.00815392460503854,-0.0587966554138358,-0.0268332709620847,1.5371420840082e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0325801498983364,0.00620847140594275,-0.0447487538539841,-0.0204115459426886,1.56345203971822e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0519562338639756,0.00991603994170054,-0.0713916721497087,-0.0325207955782426,1.63351997895073e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0197438435222213,0.00377225544043391,-0.0271374641854717,-0.0123502228589708,1.6899245109877e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,40166,-0.0225804787339261,0.00431549902072003,-0.0310388568145374,-0.0141221006533149,1.70396654413762e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,40116,-0.0198864452087584,0.00380332656759523,-0.027340965281245,-0.0124319251362717,1.73863011998807e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0303851163687915,0.00581399710681783,-0.0417805506981545,-0.0189896820394286,1.75609907968937e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.017704281079016,0.00338790483133682,-0.0243445745484362,-0.0110639876095958,1.7664529778611e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0263224556700326,0.00503875027375989,-0.036198406206602,-0.0164465051334632,1.77689271294938e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0467480241832808,0.00895853165097061,-0.0643067462191832,-0.0291893021473785,1.83807158175136e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0125729624327611,0.00241016665187525,0.00784903579508566,0.0172968890704366,1.84877736090347e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0218934459018944,0.00420263540683142,-0.030130611299284,-0.0136562805045048,1.92256365470534e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0381869353358175,0.00734120685575433,-0.052575700773096,-0.023798169898539,2.00989068137175e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42721,-0.0543051638728255,0.0104477210106997,-0.0747826970537969,-0.0338276306918542,2.0459727638023e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0109624829448226,0.00211242497667332,-0.0151028358991023,-0.00682212999054286,2.1388167382499e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0263683855930093,0.00508471777714902,-0.0363344324362214,-0.0164023387497973,2.18938898167139e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0269860126486195,0.00520649797261573,-0.0371907486749464,-0.0167812766222927,2.21409611542724e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0215529123525238,0.00416085660512324,-0.0297081912985653,-0.0133976334064822,2.25215317221745e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0214578996057309,0.00414435945425581,-0.0295808441360723,-0.0133349550753895,2.28049426484187e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0199826067112994,0.00386145654449215,-0.027551061538504,-0.0124141518840948,2.32064517961131e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0189498467305337,0.00366476304131557,-0.0261327822915122,-0.0117669111695552,2.37052717020024e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0191772108801883,0.00371039866074192,-0.0264495922552425,-0.0119048295051341,2.39370102727294e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,40199,-0.0222315076901331,0.00430318910916211,-0.0306657583440908,-0.0137972570361753,2.42970080672903e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0233338543588945,0.00452105172725998,-0.0321951157443241,-0.014472592973465,2.49020379232057e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0187912539685171,0.00364800866777982,-0.0259413509573655,-0.0116411569796686,2.62709408257589e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0218962522502252,0.004251835214453,-0.0302298492705531,-0.0135626552298974,2.65211814903112e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0173370424375132,0.0033692579397133,-0.0239407879993513,-0.0107332968756752,2.70423747184241e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0153779064141185,0.00299177223308069,-0.0212417799909566,-0.00951403283728032,2.79344373687368e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0527270850956754,0.0102605704246818,-0.0728378031280518,-0.032616367063299,2.81097232870445e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,42618,-0.0120499727007798,0.00234527791988347,-0.0166467174237514,-0.0074532279778082,2.81614566314378e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0170730909300044,0.0033229990256728,-0.0235861690203231,-0.0105600128396858,2.82606370051018e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0337091766356388,0.00656492944026451,-0.0465764383385572,-0.0208419149327203,2.87377092027437e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0294246520308749,0.00573830263914003,-0.0406717252035894,-0.0181775788581605,2.98108157655522e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0340068180704925,0.00664294840611004,-0.0470269969464682,-0.0209866391945168,3.11918404353001e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0189884524490791,0.00371329944220641,-0.0262665193558037,-0.0117103855423546,3.20389021092879e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0295736567895615,0.00578577295006757,-0.040913771771694,-0.0182335418074291,3.24191533225543e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0211707180054645,0.00414464520756224,-0.0292942226122865,-0.0130472133986425,3.31102149653289e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0132155224914293,0.00258821083767908,0.00814262924957835,0.0182884157332803,3.34332347140012e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.036786122566933,0.00723104147599664,-0.0509589638598864,-0.0226132812739796,3.68192019062051e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,42711,-0.0183264089020478,0.00360328879471773,-0.0253888549396946,-0.0112639628644011,3.70546480040077e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0321179495261953,0.00631576172435097,-0.0444968425059232,-0.0197390565464674,3.73006476611186e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0200616121767463,0.00394513290641151,-0.0277940726733128,-0.0123291516801797,3.7323586779774e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.0113743014813572,0.00223840297723533,-0.0157615713167384,-0.00698703164597593,3.79590742902128e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0408509943163219,0.0080427108212134,-0.0566147075259002,-0.0250872811067436,3.84965041086089e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,40449,-0.0297790355475012,0.00586967933180807,-0.0412836070378451,-0.0182744640571574,3.97069971974805e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0506254105874584,0.00998839758930192,-0.0702026698624902,-0.0310481513124267,4.06441460080896e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,40116,-0.0237123448448627,0.00467912211522315,-0.0328834241907001,-0.0145412654990253,4.09259065996374e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0364114733043384,0.00718816651000068,-0.0505002796639398,-0.0223226669447371,4.13821271440412e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42636,-0.0181338128969443,0.00358104653411296,-0.0251526641038057,-0.0111149616900829,4.16355065641084e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,42456,-0.0199972189779464,0.00395131610542774,-0.0277417985445848,-0.0122526394113081,4.22867482119502e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0276976648899851,0.00547633498836153,-0.0384312814671737,-0.0169640483127965,4.31178926633027e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,40418,-0.0222072266297996,0.00439707470201481,-0.0308254930457487,-0.0135889602138506,4.47683870501755e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0310866792370453,0.00615672715885325,-0.0431538644683977,-0.019019494005693,4.50557300545824e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0253692664040881,0.00502562990731316,-0.0352195010224219,-0.0155190317857543,4.52378560541273e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.02694145935021,0.00535007394839554,-0.0374276042890653,-0.0164553144113548,4.82362397748926e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0424472320167536,0.00843024550365448,-0.0589705132039164,-0.0259239508295909,4.84961520134856e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42587,-0.0432523487334131,0.00861378687011872,-0.0601353709988458,-0.0263693264679805,5.19847991482833e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0201414211076861,0.00401188683335565,-0.0280047193010632,-0.012278122914309,5.22067367348888e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0191285041068387,0.00381524875317517,-0.026606391663062,-0.0116506165506154,5.40696627605394e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0330920590589205,0.00661806463774803,-0.0460634657489066,-0.0201206523689344,5.81266712093712e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.0129255779457834,0.0025857208386209,0.00785756510208647,0.0179935907894804,5.85606910326807e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0322572483159909,0.00645396292548369,-0.044907015649939,-0.0196074809820429,5.87807831946217e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.03648435913193,0.00730316052164378,-0.0507985537543519,-0.0221701645095082,5.95047493045025e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0106449105282606,0.00213622521179643,-0.0148319119433816,-0.00645790911313961,6.3514620635777e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0135253002101299,0.00271576625585129,0.00820239834866135,0.0188482020715984,6.42891454721044e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0453370462911515,0.00912332942572077,-0.0632187719655642,-0.0274553206167388,6.80059256242519e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0366225117473871,0.00738025165311783,-0.0510878049874981,-0.0221572185072762,7.07287110699747e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,42346,-0.0309961028155502,0.00624754360295505,-0.0432412882773421,-0.0187509173537583,7.08886599141868e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0556847195362973,0.0112254213042895,-0.0776865452927046,-0.0336828937798899,7.13030413794765e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.0103490442693517,0.00208840364659886,-0.0144423154166854,-0.00625577312201788,7.32256727015844e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0152229246473422,0.00307639970016914,-0.0212526680596737,-0.00919318123501067,7.59732460821935e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0338280415892688,0.00684056906165682,-0.0472355569501162,-0.0204205262284215,7.71769576108096e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0328076593454042,0.00664279608142642,-0.045827539665,-0.0197877790258084,7.97551145553396e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0160088539135691,0.00324279131101176,0.00965298294398608,0.0223647248831522,8.03966473308354e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42587,-0.025994256581832,0.00527051697239124,-0.0363244698477188,-0.0156640433159451,8.23629556290071e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0429203995789051,0.0087025593145776,-0.0599774158354772,-0.025863383322333,8.25786185096849e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,40199,-0.0194083653868276,0.00393533551950127,-0.0271216230050501,-0.0116951077686051,8.26574921972928e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0306894768485575,0.00623015698069365,-0.042900584530717,-0.018478369166398,8.49697880016104e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0233907752245625,0.00476140888242363,-0.0327231366341128,-0.0140584138150122,9.12080292622552e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0317571081412762,0.00646764706938279,-0.0444336963972664,-0.0190805198852859,9.2324706124915e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0203329309417211,0.00414266008935555,-0.028452544716858,-0.0122133171665842,9.32095821743769e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0395575575608873,0.00806389879139854,-0.0553627991920284,-0.0237523159297461,9.45192638186832e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0248250749769407,0.0050661683674153,-0.0347547649770747,-0.0148953849768067,9.70817206496966e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.0685866328236198,0.0140063861986675,-0.096039149773008,-0.0411341158742316,9.87578026853809e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0374008354554035,0.00763910138900835,-0.0523734741778599,-0.0224281967329472,9.91788995609546e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0270523783259057,0.00552739694479563,-0.0378860763377051,-0.0162186803141062,1.00053613621537e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0141245938397547,0.00288681637185746,-0.0197827539285953,-0.00846643375091408,1.00569371669712e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,42636,-0.0490602051761928,0.010035012392741,-0.0687288294659651,-0.0293915808864205,1.02570740305418e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0123974469715293,0.00253699301471142,-0.0173699532803637,-0.00742494066269494,1.03724836529506e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0313213417740725,0.0064210879765875,-0.043906674208184,-0.018736009339961,1.08460200379728e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0162529172723303,0.00333429326400536,-0.0227881320697808,-0.00971770247487974,1.10363054591149e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,42711,-0.0350271522089202,0.00719292237331265,-0.049125280060613,-0.0209290243572274,1.13050061294132e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0311895941092379,0.0064092506331346,-0.0437517253501817,-0.0186274628682941,1.15273136369499e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0384419322990603,0.00790324667006273,-0.0539322957723833,-0.0229515688257374,1.16549539869852e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42597,-0.0218313106022342,0.00448921746570563,-0.0306301768350172,-0.0130324443694512,1.16899910434142e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.0192086173818227,0.00395043157210916,0.0114657715004888,0.0269514632631567,1.17281883685001e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0366307523996957,0.00753595381965953,-0.0514012218862284,-0.021860282913163,1.18234152539901e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0357363711070982,0.0073538070604292,-0.0501498329455394,-0.021322909268657,1.19246780797398e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0214969118869308,0.00442473924220919,-0.0301694008016608,-0.0128244229722008,1.19698049894514e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.013288808719447,0.00273697852081517,-0.0186532866202447,-0.00792433081864926,1.21596365023035e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0319532373834238,0.00660614075201076,-0.0449012732573649,-0.0190052015094827,1.33681193005579e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0112703245853931,0.00233095625353741,0.00670165032845974,0.0158389988423264,1.34571332986e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.027587411589876,0.00571336068419036,0.0163892246488629,0.0387855985308891,1.39015617705744e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.137872266853237,0.028572369638452,-0.193874111344603,-0.0818704223618713,1.41280179944468e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42638,0.00992718464636293,0.00205913597785291,0.00589127812977122,0.0139630911629546,1.44371840424786e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.016824317842564,0.00349202930614322,-0.0236686952826047,-0.00997994040252327,1.46950008470537e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,42461,0.0313172556718872,0.00650728810521352,0.0185629709856687,0.0440715403581057,1.50587825545489e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.02038874404004,0.00425676372910072,-0.0287320009490774,-0.0120454871310026,1.68795831483395e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42626,0.0305166975291762,0.0063745074754998,0.0180226628771966,0.0430107321811558,1.70839637053482e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0139831875321327,0.00292107977840419,-0.019708503897805,-0.00825787116646051,1.71498404208938e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42611,0.0232100198949389,0.00485507332101074,0.0136940761857578,0.0327259636041199,1.76653854535598e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,40483,-0.0623504950335419,0.0130438178344602,-0.0879163779890838,-0.0367846120779999,1.77436619983094e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0185433133227732,0.00388156923499176,-0.0261511890233571,-0.0109354376221894,1.79569063067378e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42603,-0.0184932938375989,0.0038766554294676,-0.0260915384793554,-0.0108950491958425,1.85774158361908e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,40182,-0.0192810017433599,0.00404321355675107,-0.027205700314592,-0.0113563031721278,1.87771135711422e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,40483,-0.0320853448977887,0.00672850155922379,-0.0452732079538673,-0.0188974818417101,1.87855991534624e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0417856208662846,0.00876650707185078,-0.0589679747271121,-0.0246032670054571,1.89847228562431e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0174529542223292,0.00366483638486146,-0.0246360335366577,-0.0102698749080008,1.9346446765777e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.015083766143833,0.00317042652581771,0.00886973015323032,0.0212978021344358,1.9835407424489e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.0116676609266383,0.00245362360833968,-0.016476763198984,-0.00685855865429249,2.00213088834035e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0369538124772799,0.00777830678328875,-0.0521992937725258,-0.0217083311820339,2.05096814560936e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,40482,-0.0144514791909226,0.00304574605527126,-0.0204211414592543,-0.00848181692259094,2.1126430907146e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0368266626136992,0.00776770621364589,-0.0520513667924452,-0.0216019584349533,2.15341984822547e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.0192061301855517,0.00405460570975824,-0.0271531573766778,-0.0112591029944255,2.19699152063876e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.03415478232256,0.00721715980542197,-0.048300415541187,-0.0200091491039329,2.24573277847405e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0264940588856644,0.00560001551442983,-0.0374700892939469,-0.015518028477382,2.25613739323636e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0304386396195257,0.00644219753582854,-0.0430653467897496,-0.0178119324493017,2.33024571628556e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0223033815124051,0.00472520134947484,-0.0315647761573758,-0.0130419868674344,2.38639345277791e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0409822206778425,0.00868574025946245,-0.0580062715863889,-0.0239581697692961,2.4023222848262e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0256311559390388,0.00543318640476562,-0.0362802012923794,-0.0149821105856982,2.41676637697286e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,40283,-0.0256202496318093,0.00543932948990012,-0.0362813354320135,-0.014959163831605,2.5049577103563e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0208974967726942,0.00444039862075648,-0.0296006780693769,-0.0121943154760115,2.55358403643623e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,42488,-0.0160453868883201,0.00340986223283243,-0.0227287168646717,-0.00936205691196856,2.55693887627694e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0275829242615645,0.00586343926449642,-0.0390752652199775,-0.0160905833031516,2.57380111054091e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0219012439087906,0.00465565471640078,-0.0310263271529361,-0.0127761606646451,2.57877713354806e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0422718136405893,0.0089899220605401,-0.0598920608792479,-0.0246515664019307,2.60025393525345e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0231601365703871,0.0049311961774887,-0.0328252810782649,-0.0134949920625092,2.67581585574332e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0264539367607789,0.00563381579284796,-0.0374962157147609,-0.0154116578067969,2.69014897901888e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0133094005403508,0.00283448056808988,-0.018864982453807,-0.00775381862689463,2.69030913489387e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0308129604287578,0.006572928418113,-0.0436959001282593,-0.0179300207292563,2.78801375405938e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0162896933936092,0.00347728591404792,-0.0231051737851431,-0.00947421300207525,2.8390372604201e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0158858263217599,0.00339150500704632,-0.0225331761355706,-0.00923847650794906,2.84088096217986e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42654,-0.038528723923314,0.00823169038324099,-0.0546628370744663,-0.0223946107721617,2.88915826468676e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0149480751598586,0.00319394887014116,0.0086879353743819,0.0212082149453353,2.90023814510777e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0189359611129431,0.00404916385778849,-0.0268723222742086,-0.0109995999516777,2.95241452492945e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,40527,0.023791108347062,0.00509186946080662,0.013811044203881,0.033771172490243,3.01168619229107e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0350253594837291,0.00752400966839452,-0.0497724184337823,-0.0202783005336758,3.26910463886422e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0343372512008562,0.00740346885320754,-0.048848050153143,-0.0198264522485694,3.55195213307208e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,42370,-0.0332792428543263,0.00717736011954504,-0.0473468686886346,-0.0192116170200181,3.57422373819653e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,40283,-0.0300944018542871,0.00649137713720497,-0.0428175010432089,-0.0173713026653654,3.59170723574698e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,40283,-0.0242540564389799,0.00523285213837096,-0.034510446630187,-0.0139976662477729,3.61080284705291e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0179369859764219,0.00387137001229909,-0.0255248712005281,-0.0103491007523157,3.64004618290013e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0219335781588828,0.00474240241900703,-0.0312286869001366,-0.012638469417629,3.78786210344326e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0372519801596062,0.00806361613580489,-0.0530566677857838,-0.0214472925334286,3.88415940162235e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0194133819733271,0.00420633312324462,-0.0276577948948865,-0.0111689690517676,3.96916244629053e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,42328,0.053276426595827,0.0115459935156632,0.0306462793051273,0.0759065738865268,3.98195424497493e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0353925968147954,0.00767126163636532,-0.0504282696220715,-0.0203569240075194,3.99332251287012e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,42594,-0.0411536986524217,0.00892584186466602,-0.0586483487071671,-0.0236590485976763,4.05173476816037e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,40302,-0.0242742735734358,0.00526949558712115,-0.0346024849241933,-0.0139460622226784,4.13928047354264e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0347706094582919,0.00755172714610047,-0.0495719946646488,-0.019969224251935,4.17638309135764e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0274445265442413,0.00596283282769114,-0.039131678886516,-0.0157573742019667,4.21802686428774e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0465937304272143,0.0101358100908277,-0.0664599182052366,-0.026727542649192,4.33466903197005e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.00893099058609007,0.00194532126773641,0.00511816090132671,0.0127438202708534,4.45082882270835e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,42638,-0.0130308860133405,0.00284700238868458,-0.0186110106951623,-0.00745076133151876,4.75792125008289e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0299698270056076,0.00655069980791353,-0.0428091986291181,-0.017130455382097,4.80361252277659e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,40539,-0.0090636289594633,0.00198188616990324,-0.0129481258524737,-0.00517913206645296,4.85338407968197e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0401357556694619,0.00880093899065945,-0.0573855960911544,-0.0228859152477694,5.15177576819641e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0302416949801025,0.00663442844984452,-0.0432451747417977,-0.0172382152184072,5.21268647405032e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0296534354522013,0.00650604049996992,-0.0424052748321423,-0.0169015960722602,5.22289175862238e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0236659590156288,0.00519626533550533,-0.0338506390732193,-0.0134812789580384,5.29936783824838e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0214402452216657,0.00470921472844238,-0.0306703060894128,-0.0122101843539187,5.34831098016375e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.0113371420530699,0.00249123558912008,-0.0162199638077452,-0.0064543202983945,5.3907797126919e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,40527,0.0218423779759082,0.00480325639250509,0.0124279954465982,0.0312567605052181,5.48732671100079e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42600,-0.0132694162916909,0.00291881364352121,-0.0189902910329925,-0.00754854155038933,5.51096749784713e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0246815437969952,0.00543161147621422,-0.0353275022903751,-0.0140355853036153,5.56635255487599e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0107155998683664,0.00236015741673387,-0.0153415084051648,-0.00608969133156806,5.66874262518877e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,40408,-0.0408252405003867,0.00899555388457915,-0.0584565261141619,-0.0231939548866116,5.72777126356765e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0228532509615378,0.00503599592491971,-0.0327238029743805,-0.0129826989486952,5.73960258959993e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0183891943884127,0.00405232938022306,-0.0263317599736499,-0.0104466288031755,5.73970205472661e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0366919029901966,0.00809268238285783,-0.052553560460598,-0.0208302455197953,5.83990049600894e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,-0.0224288712962497,0.00495118737196031,-0.0321331985452919,-0.0127245440472075,5.95868577292421e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0304065245365363,0.0067158322306273,-0.0435695557085658,-0.0172434933645068,6.01724310798509e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0187952696054668,0.00415655530784609,-0.0269421180088452,-0.0106484212020885,6.18319815526593e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,42594,-0.0206774055006756,0.00457444064663549,-0.0296433091680812,-0.01171150183327,6.23092283291203e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,42370,-0.0489889434508782,0.0108479310659249,-0.070250888340091,-0.0277269985616654,6.35743690585426e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00920570375744283,0.00204689086135566,0.00519379766918574,0.0132176098456999,6.94705272977373e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0389680447040986,0.00868679793148209,-0.0559941686498035,-0.0219419207583937,7.33288022461357e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0293507619272771,0.00654825284050019,-0.0421853374946575,-0.0165161863598967,7.44914119315706e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0234147318441155,0.00522676857551843,-0.0336591982521316,-0.0131702654360993,7.54762376091899e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,42130,-0.0107731211428713,0.0024057110950276,-0.0154883148891254,-0.00605792739661722,7.59393561291895e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0269642648856055,0.00603497854733284,-0.0387928228383779,-0.0151357069328331,7.961630263018e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0249996431503834,0.00559944625850461,-0.0359745578170525,-0.0140247284837144,8.09728140755139e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,39042,-0.0471474865444147,0.0106054611152559,-0.0679341903303164,-0.0263607827585131,8.86121689772953e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,42611,0.0102829886905701,0.0023143352926193,0.00574689151703632,0.014819085864104,8.93523580665525e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0198554632296389,0.00446881764099195,-0.0286143458059831,-0.0110965806532947,8.95108398245122e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.0142873381384375,0.00322621755505463,-0.0206107245463445,-0.00796395173053039,9.56441286225229e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0199924757414346,0.00452101887088516,-0.0288536727283695,-0.0111312787544997,9.86484481759796e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0152018705109889,0.00344064579110786,-0.0219455362615603,-0.00845820476041752,1.00396033187486e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0164225525350881,0.00371781860285246,-0.023709476996679,-0.00913562807349729,1.00743672634341e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0481479049338112,0.0109011293196485,-0.0695141184003223,-0.0267816914673002,1.01114111521065e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.037343103743067,0.00845912297925235,-0.0539229847824016,-0.0207632227037324,1.02171228934192e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,42611,-0.0188197783712979,0.0042650304482161,-0.0271792380498015,-0.0104603186927944,1.02943795352934e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0456424655611476,0.0103482126145533,-0.065924962285672,-0.0253599688366233,1.04009503521387e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0128115804362068,0.0029088139091951,-0.0185128556982292,-0.0071103051741844,1.07069826886716e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0205860933318343,0.00468058498648858,-0.0297600399053519,-0.0114121467583167,1.10185649307713e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0432630335443405,0.009850460260514,-0.062569935654948,-0.0239561314337331,1.13183950219586e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0128546345191063,0.00292736830902287,-0.0185922764047911,-0.00711699263342146,1.13754973787605e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.0223245566012545,0.00509031494154777,-0.0323015738866881,-0.0123475393158209,1.16515987088831e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0271737029264036,0.00620003337957792,-0.0393257683503763,-0.0150216375024309,1.18038578812273e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0483947195570304,0.0110582615908624,-0.0700689122751207,-0.0267205268389401,1.21602031768064e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0249130712133775,0.00569440109478459,-0.0360740973591553,-0.0137520450675997,1.22361049222593e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,40283,-0.0451869665839551,0.0103298089041147,-0.0654333920360199,-0.0249405411318903,1.2286543007801e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0105642881571783,0.00241915560271438,-0.0153058331384984,-0.00582274317585807,1.26943726335715e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0309227874669084,0.00708387252042105,-0.0448071776069336,-0.0170383973268831,1.28135106039997e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.012000171327725,0.00275127195817802,-0.0173926643657539,-0.00660767828969603,1.30017840800721e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,40482,-0.0108706526008917,0.00249264398427994,-0.0157562348100804,-0.00598507039170305,1.30561860845012e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0347848595022714,0.00798034185675047,-0.0504263295415023,-0.0191433894630405,1.31769565386152e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,42357,-0.0326328194986377,0.00748675041895339,-0.0473068503197864,-0.0179587886774891,1.31803981779331e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0146171036169248,0.00335509290842408,-0.021193085717436,-0.00804112151641362,1.33022202286029e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0315520127906599,0.00724376438179595,-0.04574979097898,-0.0173542346023399,1.33616492924841e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42676,-0.0381972755848903,0.00878654043085257,-0.0554188948293614,-0.0209756563404193,1.38866541270595e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,39956,-0.00962857486566389,0.00221584668049875,-0.0139716343594414,-0.00528551537188634,1.4034523859083e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,40182,-0.0116515800137011,0.00268157236892584,-0.0169074618567958,-0.00639569817060651,1.40491431158071e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0239160156492968,0.00552080023429899,-0.0347367841085228,-0.0130952471900708,1.48838042721588e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,42636,0.0129302899909463,0.00299383817204864,0.00706236717373101,0.0187982128081617,1.57885009330945e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0249562688802334,0.00577979238182824,-0.0362846619486168,-0.0136278758118501,1.58689729947851e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0167931617751077,0.00388995674820275,-0.0244174770015851,-0.0091688465486303,1.59290446568866e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0348344981753986,0.00807082835598602,-0.0506533217531312,-0.019015674597666,1.59939274145983e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0179973262134684,0.00417055674304683,-0.0261716174298402,-0.00982303499709662,1.60767977162588e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0321987659993552,0.00747040200377654,-0.0468407539267573,-0.0175567780719532,1.64295920097911e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0168434787642149,0.00390911716082094,-0.0245053483994239,-0.00918160912900581,1.65359368958607e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42546,-0.0231815794812018,0.00538424265071789,-0.0337346950766089,-0.0126284638857947,1.67836598419552e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0287469584279703,0.00667862579992876,-0.0418370649958307,-0.0156568518601099,1.68679529374151e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0311670318164491,0.00725210482573407,-0.0453811572748878,-0.0169529063580103,1.74063147090683e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,42721,-0.0102782871782564,0.0023945286654165,-0.0149715633624728,-0.00558501099404007,1.7797825637505e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,40483,-0.0292710919004948,0.00682595250008416,-0.0426499588006598,-0.0158922250003299,1.8161920744828e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,40532,-0.0334330004320447,0.00779789328611909,-0.0487168712728381,-0.0181491295912513,1.82238975554629e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.021730592808374,0.0050718088277066,-0.031671338110679,-0.0117898475060691,1.84602787538537e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0120257775227195,0.00280731290148099,-0.0175281108096222,-0.00652344423581672,1.8506513873496e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42721,-0.00892499411787559,0.00208422030706702,-0.0130100659197269,-0.00483992231602422,1.86352590775613e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0304577904541816,0.00712063720436109,-0.0444142393747293,-0.0165013415336338,1.9067390237599e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.0112848029333514,0.00264191663598705,0.00610664632681681,0.0164629595398861,1.95806731884504e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42594,-0.0146826599528366,0.00344294666336766,-0.0214308354130372,-0.007934484492636,2.01667381968098e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0338495728289308,0.00793779152664075,-0.0494076442211467,-0.0182915014367149,2.01852931649581e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0284262481422917,0.0066823308049214,-0.0415236165199376,-0.0153288797646458,2.11456574531864e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,40527,-0.033869065611307,0.00796530461745918,-0.049481062661527,-0.018257068561087,2.13497782876389e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0282058167297375,0.00663814342526313,-0.0412165778432533,-0.0151950556162218,2.16447573102593e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.014083708253214,0.00331664757980425,-0.0205843375096303,-0.00758307899679764,2.19007739957895e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.0165241001657852,0.00389445905991164,-0.024157239923212,-0.00889096040835842,2.22070141125734e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,40483,-0.0116991489539342,0.00276469438362334,-0.0171179499458359,-0.00628034796203241,2.33842619271036e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0117688423295787,0.0027831567363355,0.0063138551263611,0.0172238295327962,2.37041929264036e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0157367315150075,0.00372236152982512,-0.0230325601134648,-0.00844090291655028,2.38097948452977e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,40449,-0.0178809507825763,0.00423313625549468,-0.0261778978433459,-0.00958400372180676,2.41846788215689e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0158071543327972,0.00374422669043696,-0.0231458386460536,-0.00846847001954075,2.44373562510735e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0489692751156201,0.0116069037413955,-0.0717188064487552,-0.026219743782485,2.47076593186916e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0186303627898067,0.00442130480106332,-0.0272961201998908,-0.00996460537972256,2.52772790418609e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,42261,-0.0293282357184852,0.00696563480300932,-0.0429808799323835,-0.0156755915045869,2.56604751344392e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0255224434569548,0.00606626035229746,-0.0374123137474578,-0.0136325731664518,2.60514704565815e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0151891404899506,0.00361537532615558,-0.0222752761292156,-0.00810300485068571,2.67143613663181e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0230716675705134,0.00550302703418781,-0.0338576005575215,-0.0122857345835052,2.77979410795919e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,42446,-0.0228923541105331,0.00546162303584478,-0.0335971352607889,-0.0121875729602774,2.78922926306884e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.0509398268045536,0.0121650719639335,-0.0747833678538633,-0.027096285755244,2.83986481172608e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0339878604021479,0.00813243015934209,-0.0499274235144584,-0.0180482972898374,2.94651795021934e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.0101396865322083,0.00243394732767386,0.00536914976996758,0.0149102232944491,3.11993617214468e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.0196526743453139,0.00471901777976946,0.0104033994969658,0.0289019491936621,3.1389479158846e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,40483,-0.0333608656689683,0.00803044559896086,-0.0491005390429316,-0.017621192295005,3.28690544895725e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.00906328623469988,0.00218945923001354,-0.0133546263255264,-0.00477194614387334,3.50638486554515e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0364233650887435,0.00880501215091706,-0.0536811889045409,-0.0191655412729461,3.54542426318527e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,42370,-0.013662003538724,0.00330885645628084,-0.0201473621930345,-0.00717664488441357,3.66717204675033e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0317315146031977,0.00768637552734568,-0.0467968106367952,-0.0166662185696002,3.68182174485029e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0209000203590488,0.005063127153828,-0.0308237495805516,-0.0109762911375459,3.68742497707189e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0171668644460733,0.0041633710766519,-0.025327071756311,-0.00900665713583554,3.75703859900474e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,42475,0.0129715645072646,0.00314612277072021,0.006805163876653,0.0191379651378762,3.76191481000629e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0112442532500527,0.00272869198886961,-0.0165924895482371,-0.00589601695186821,3.79922944036433e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0215064781768829,0.00522316645725207,-0.031743884433097,-0.0112690719206688,3.85766940797227e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00940434814827895,0.00228431002608035,0.00492710049716147,0.0138815957993964,3.86247817700044e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,40344,0.0128409366795127,0.00311969665572924,0.00672633123428338,0.018955542124742,3.88136485927776e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,42311,-0.0153931441963741,0.00374374059427867,-0.0227308757611603,-0.00805541263158792,3.9514654546539e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0225823102548136,0.00550820884030007,-0.0333783995818018,-0.0117862209278255,4.1648316559501e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0239364314392962,0.00584435558416688,-0.0353913683842633,-0.0124814944943291,4.23430867024162e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0258539512185955,0.00632189100423281,-0.0382448575868918,-0.0134630448502992,4.35195078878292e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0231721760777276,0.0056851834319967,-0.0343151356044411,-0.0120292165510141,4.61537785699675e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0191847836143845,0.00470818078397545,-0.0284128179509763,-0.00995674927779258,4.63746521908558e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.00846733235961314,0.0020794423548217,-0.0125430393750637,-0.00439162534416261,4.69454456079176e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.0127192872009247,0.00312432617254335,-0.0188429664991097,-0.00659560790273972,4.7119311276362e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42611,0.0142638009435963,0.00350529580474872,0.00739342116628884,0.0211341807209038,4.74419519151616e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0160993326483413,0.00395669285179802,-0.0238544506378654,-0.00834421465881715,4.75065935889055e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0155813706984254,0.00382950110729975,-0.0230871928687329,-0.00807554852811792,4.75830038169058e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.017642621040152,0.00433741191991764,-0.0261439484031906,-0.00914129367711347,4.77809175820337e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.011462901283365,0.00282009208177917,0.00593552080307784,0.0169902817636522,4.83617312777784e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0229386831975943,0.00564705236447277,-0.0340069058319609,-0.0118704605632276,4.89199638154698e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0192475366380343,0.00474212274441343,-0.0285420972170847,-0.00995297605898403,4.96012676763182e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0142002222098619,0.00350399328263874,-0.0210680490438338,-0.00733239537588996,5.09433640593625e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0107454940534164,0.00265456809519021,-0.0159484475199892,-0.00554254058684357,5.20184098074295e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42681,-0.0283706522067825,0.00701627200729211,-0.042122545341075,-0.0146187590724899,5.29404797577154e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,42611,-0.0287243893760199,0.00710424947179368,-0.0426487183407355,-0.0148000604113043,5.30057000628503e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.00927000037172835,0.00229444874577295,-0.0137671199134433,-0.00477288083001337,5.37026715475743e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.00885670222484291,0.0021924611371388,-0.0131539260536349,-0.00455947839605087,5.38931389633575e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,42311,-0.0276871954204258,0.00685749409916019,-0.0411278838547797,-0.0142465069860718,5.43288455575375e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0253440930779084,0.00630856999640268,-0.0377088902708576,-0.0129792958849591,5.92377242538189e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42585,-0.0336959242419354,0.00839151063400826,-0.0501432850845916,-0.0172485633992792,5.96490578118316e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0400952194071801,0.00998901564535062,-0.0596736900720673,-0.0205167487422929,6.0108698651649e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0113366691582901,0.00283037662217671,-0.0168842073377564,-0.00578913097882374,6.23208331029226e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0090692256367313,0.00226661453002481,-0.0135117901155799,-0.00462666115788267,6.33503343494121e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.0127436784425788,0.00318594918595834,-0.0189881388470572,-0.00649921803810046,6.36906076311813e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0146084620028356,0.00365620005967268,-0.021774614119794,-0.0074423098858771,6.49601931624729e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0235161957981937,0.00589394666002417,-0.035068331251841,-0.0119640603445463,6.64633474767084e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0104272265594079,0.00262173518646967,-0.0155658275248884,-0.00528862559392734,7.00887555646591e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.013767803497442,0.00346538390211737,0.00697565104929191,0.020559955945592,7.13551373430131e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0121837026685275,0.00306721249183254,-0.0181954391525193,-0.00617196618453576,7.15727232665337e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.0108986806885551,0.00274372147584413,-0.0162763747812096,-0.00552098659590061,7.16454122897566e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.025366187479978,0.00639902295554326,-0.0379082724728428,-0.0128241024871132,7.40727332771491e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.015567348327182,0.00392731573557552,-0.02326488716891,-0.00786980948545399,7.41984987441125e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0228804672092236,0.00578659849855482,-0.0342222002663911,-0.0115387341520562,7.72374538327311e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0161946446181128,0.00409671835415232,-0.0242242125922513,-0.00816507664397422,7.75445471557596e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0163828520041782,0.00415221957196741,-0.0245212023652343,-0.00824450164312202,8.00141891667341e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,40283,-0.029120535027063,0.00738535860849533,-0.0435958378997139,-0.0146452321544122,8.09604458172438e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0244748533404918,0.00621584257097452,-0.0366579047796018,-0.0122918019013817,8.2842773730421e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0140778159784084,0.00357544786831847,-0.0210856938003126,-0.00706993815650424,8.28915685050621e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0213465213232442,0.00542514697440583,-0.0319798093930797,-0.0107132332534088,8.37156460872205e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0173096962649293,0.004404916580451,-0.0259433327626133,-0.00867605976724538,8.55116525557799e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0350748192334945,0.00893503175445792,-0.0525874814722321,-0.017562156994757,8.69716727159343e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,40532,-0.0275051564637018,0.0070203363120801,-0.0412650156353788,-0.0137452972920248,8.98384920891975e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,42587,-0.0223291761840423,0.00570094413022228,-0.033503026679278,-0.0111553256888067,9.01958885993941e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,40516,0.00555115745346757,0.00141749298016379,0.00277287121234654,0.0083294436945886,9.04910983298327e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0107305912499377,0.0027413742478589,-0.0161036847757411,-0.00535749772413422,9.11940709442051e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,40532,-0.0259443605595406,0.00664151350891014,-0.0389617270370045,-0.0129269940820768,9.42280144769398e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0205447060989667,0.00527296668729267,-0.0308797208060603,-0.010209691391873,9.81757330445199e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0332804330202371,0.00854847601690752,-0.0500354460133759,-0.0165254200270984,9.95253765860319e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0128431491691131,0.00330328007344636,-0.0193175781130679,-0.00636872022515822,0.000101561868912274
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0206703891810707,0.00532037871719901,-0.0310983314667808,-0.0102424468953606,0.000102854893891853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0284265761090149,0.0073207651866467,-0.0427752758748425,-0.0140778763431874,0.00010366937782707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0253518072991837,0.0065318334756265,-0.0381542009114116,-0.0125494136869558,0.000104408903063812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0147715775085723,0.00380906661690722,0.00730580693943419,0.0222373480777105,0.000105828391263695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,42249,-0.0385123595501626,0.00993396741420136,-0.0579829356819973,-0.0190417834183279,0.000106342034319863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,40223,-0.0195478287075446,0.0050453426560811,-0.0294367003134636,-0.00965895710162568,0.000107492709553924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42636,-0.0156585270813668,0.00404354264377761,-0.0235838706631709,-0.00773318349956272,0.000108244953261853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,42495,-0.0163134356800053,0.00421407089388298,-0.024573014632016,-0.00805385672799467,0.000108826604259827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.0161773188554969,0.00418764046902571,-0.0243850941747873,-0.00796954353620648,0.00011258168972944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0343701721816654,0.00890446949738855,-0.051822932396547,-0.0169174119667839,0.00011407542879959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0362827891235194,0.00940270624928752,-0.054712093372123,-0.0178534848749159,0.00011450797929161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42721,-0.0110314013063562,0.00286084751205963,-0.0166386624299931,-0.00542414018271935,0.000115795662105983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0228815709836288,0.00593469123161902,-0.034513565797602,-0.0112495761696555,0.000115997168147726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0259871039227028,0.00675203644319346,0.0127531124940436,0.039221095351362,0.000119273627860684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,40223,-0.010791910401843,0.00280647804136592,-0.0162926073629202,-0.00529121344076583,0.000121053851235174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,40449,-0.0279316573345214,0.00728769363916114,-0.0422155368672772,-0.0136477778017656,0.000127426089705359
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0320455750258707,0.0083649738829457,-0.0484409238364442,-0.0156502262152971,0.000128356678023102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0258502592783296,0.00675947438680396,-0.0390988290764653,-0.0126016894801938,0.000131873413729041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0111228349531957,0.00291196116307539,-0.0168302788328234,-0.0054153910735679,0.00013433053205792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0194379053388776,0.00509084208361032,-0.0294159558227538,-0.00945985485500133,0.000135025868937554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,40223,0.0199707503899228,0.00523606280771622,0.00970806728679901,0.0302334334930466,0.000137437729765687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,40482,-0.0279900875415396,0.00734892319110766,-0.0423939769961106,-0.0135861980869686,0.000140420717420958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0180325841502361,0.00473812736309786,0.00874585451856433,0.0273193137819079,0.000141946220789404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0373721009382419,0.00983080069686357,-0.0566404703040945,-0.0181037315723893,0.000144575582351443
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.032990730439716,0.00868633689567217,-0.0500159507552335,-0.0159655101241985,0.000146629531835855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0119285183806954,0.00314323663904567,-0.018089262193225,-0.00576777456816594,0.000148427478930639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.017454020164717,0.00461046025705479,-0.0264905222685444,-0.00841751806088959,0.000154045680551328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0324423509680141,0.00857336251151685,-0.0492461414905872,-0.0156385604454411,0.000154945877462112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0176736676687534,0.00468247661626154,0.00849601350088076,0.026851321836626,0.000161213813204984
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0149380579366503,0.00395777658202004,-0.0226953000374096,-0.00718081583589105,0.000161239698452282
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42587,-0.0070279048026947,0.00186272775041989,-0.0106788511935177,-0.00337695841187172,0.000162049453663964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0108899870203924,0.00288823563899026,-0.0165509288728133,-0.00522904516797147,0.00016364006490766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0319367101049282,0.00847191525501081,-0.0485416640047494,-0.015331756205107,0.000164288213720173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0181676420633581,0.004820385435928,-0.027615597517777,-0.00871968660893926,0.000164812615316927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0202531490116963,0.00537421320091466,-0.0307866068854891,-0.00971969113790361,0.000164880059312293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,42611,-0.0139594659462103,0.00371506643477715,-0.0212409961583735,-0.0066779357340471,0.000172326928266515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0269549542561876,0.0071747949229588,-0.0410175523051869,-0.0128923562071884,0.000172914046598008
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0272969520007974,0.00727377850440985,-0.0415535578694408,-0.0130403461321541,0.000175613155979147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42594,-0.0140040266619569,0.00373572507524482,-0.0213260478094367,-0.00668200551447706,0.000178516996803741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,42370,-0.0172419683047191,0.00460286037081145,-0.0262635746315096,-0.00822036197792868,0.000180496626567246
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0331867912414474,0.008879868909933,-0.0505913343049161,-0.0157822481779787,0.000186788963399078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.0376176801478635,0.0100657642702949,-0.0573465781176415,-0.0178887821780855,0.00018700852345773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0245638161869706,0.00659496769415918,-0.0374899528675226,-0.0116376795064186,0.000196571613063118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0119586935659332,0.00321784762727126,-0.0182656749153849,-0.00565171221648157,0.00020311167056301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0168696355740541,0.00454312680268337,-0.0257741641073135,-0.00796510704079473,0.000205623005367119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0218010927013562,0.00587831203056945,-0.0333225842812723,-0.0102796011214401,0.00020932426583284
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0389908504769493,0.0105298827769823,-0.0596294207198346,-0.018352280234064,0.000214039908723675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,42141,0.0114991317059273,0.00310560430661939,0.00541214726495334,0.0175861161469013,0.000214200031626156
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0138261974666359,0.00373459721059773,-0.0211460079994074,-0.00650638693386431,0.000214762080423986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0123831928506709,0.00334737739538252,-0.0189440525456206,-0.00582233315572113,0.000217012903394295
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0345043587642126,0.00933500590372206,-0.0528009703355078,-0.0162077471929173,0.000219857535779208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0200189979418876,0.00541703474175756,-0.0306363860357324,-0.00940160984804276,0.000220466904857783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0183190368074922,0.00495784671144045,-0.0280364163619155,-0.00860165725306895,0.000220997279506779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42461,-0.020756530203364,0.00562221434458664,-0.0317760703187538,-0.00973699008797422,0.000223496342469027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.00942743761204693,0.00255459168186932,0.00442043791558305,0.0144344373085108,0.000224959971445164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.020012546095344,0.00542516652185106,-0.0306458724781721,-0.00937921971251589,0.000226344263067453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0240255729823048,0.00651882809174546,-0.0368024760421259,-0.0112486699224837,0.000229262919936793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0128104473760273,0.00347616892742569,-0.0196237384737817,-0.00599715627827298,0.000229421106070706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0148905304267564,0.00404211539953507,-0.0228130766098451,-0.00696798424366766,0.000230854517686146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,42357,-0.0175497089450523,0.00476911185644775,-0.0268971681836899,-0.00820224970641472,0.000234284628001927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,42357,-0.0502499570851838,0.0136586201621491,-0.077020852602996,-0.0234790615673716,0.000235091022997225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0152764610300746,0.00416093226938963,-0.0234318882780783,-0.00712103378207091,0.00024215394177611
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42782,0.0160832916577876,0.00438588547873582,0.00748695611946536,0.0246796271961098,0.000246294324312507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,40532,0.0205945578174293,0.00561592997081499,0.0095873350746319,0.0316017805602267,0.000246373634367332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.032254519904954,0.00882019240933188,-0.0495420970272445,-0.0149669427826635,0.000256476532517594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0231126076290529,0.00632284589847142,-0.0355053855900569,-0.0107198296680489,0.000257767479062523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0144820341106747,0.00396279267565853,-0.0222491077549654,-0.006714960466384,0.000258853404170856
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0267430423171597,0.00732369261702557,-0.0410974798465298,-0.0123886047877896,0.000261624099153327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0195907968439813,0.00536542254128702,-0.0301070250249038,-0.0090745686630587,0.000262119306847954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0282331750721305,0.00775406038450422,-0.0434311334257588,-0.0130352167185023,0.000272708276978724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0102834413101159,0.00283251250020507,-0.0158351658105178,-0.00473171680971392,0.000283942853814258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0237194491539193,0.00653399233001786,-0.0365260741207543,-0.0109128241870843,0.000284516697062416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0140992565507639,0.00388822859516663,-0.0217201845972905,-0.00647832850423734,0.000288990505060173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,42642,-0.0326929686037409,0.00903094903099846,-0.0503936287044979,-0.0149923085029839,0.000295567073117582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0110398529099235,0.00305014221371958,0.00506157417103316,0.0170181316488139,0.000296460667164917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0301366174063962,0.00832718057014428,-0.046457891323879,-0.0138153434889134,0.000296756791778851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.0158686894514364,0.00438569502566084,-0.0244646517017317,-0.0072727272011412,0.000297654769762356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,40199,-0.0174299998798636,0.00481760810900236,-0.0268725117735082,-0.00798748798621895,0.000298243811335225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.00976641638210668,0.00270093615335413,0.00447258152153259,0.0150602512426808,0.000300590213230759
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0196092278196315,0.00542375780105345,-0.0302397931096963,-0.00897866252956672,0.00030096581686263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.00720310254531104,0.00199619843389798,0.00329055361487101,0.0111156514757511,0.000309194401377566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.018922300339226,0.00524574182130887,-0.0292039543089914,-0.00864064636946062,0.000310677283509655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0197612604545305,0.00548580324527958,0.00900908609378248,0.0305134348152784,0.000316609932585866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,40449,-0.0353533365494405,0.00981994229806883,-0.0546004234536554,-0.0161062496452256,0.000319392230092071
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0348765081136894,0.00970486478768453,-0.053898043097551,-0.0158549731298277,0.000327176075731993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0283484914676984,0.00790069287890673,-0.0438338495103556,-0.0128631334250412,0.000334508161267271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,42636,-0.0140168137851097,0.00391136878594171,-0.0216830966055555,-0.00635053096466397,0.000340079016444084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,40283,0.018913216120229,0.00528121403653311,0.00856203660862408,0.0292643956318339,0.000343450210902629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.0132605306449186,0.00370424717503315,-0.0205208551079836,-0.0060002061818536,0.000345321227736951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0184399641762638,0.00515219119741285,-0.0285382589231929,-0.00834166942933458,0.000346284333543415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0157695184993909,0.00440758138043449,-0.0244083780050425,-0.00713065899373926,0.000347961523560126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42754,-0.0265398021686411,0.00743208825532096,-0.0411066951490702,-0.0119729091882121,0.000356885597908499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42794,-0.0067463116359052,0.00188974563100814,-0.0104502130726811,-0.00304241019912926,0.00035826985654981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0133827314764005,0.0037492181324834,-0.0207311990160679,-0.00603426393673302,0.000359223992070813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,42292,-0.0125391078973597,0.00351907047482279,-0.0194364860280124,-0.00564172976670707,0.000367680913085795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.026300273086769,0.0073891904735754,-0.0407830864149768,-0.0118174597585612,0.000373390481378857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0182134723576678,0.00512274574669958,-0.028254054021199,-0.00817289069413663,0.000378935228895079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0119283953667887,0.00335662084786091,-0.0185073722285961,-0.00534941850498133,0.000381170045988287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42711,-0.00972071264210588,0.00273782967112915,-0.015086858797519,-0.00435456648669275,0.000385780807362657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0206084022610904,0.00580638213790276,-0.0319889112513798,-0.00922789327080103,0.000387616194334204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.0100086417608376,0.00282647260790223,-0.0155485280723259,-0.0044687554493492,0.000399909099810674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,40116,-0.019876826599345,0.00561789217354471,-0.0308878952594926,-0.00886575793919736,0.000404646422627882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,40511,-0.00916529786586851,0.00259293374702252,-0.0142474480100326,-0.00408314772170438,0.000409835354712022
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0111414433330091,0.00315552862169358,-0.0173262794315285,-0.00495660723448969,0.000416000468979866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0167237975229022,0.00475089471332749,-0.0260355511610241,-0.00741204388478033,0.000432787569529917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0123881220958386,0.00351945766379107,-0.019286259116869,-0.00548998507480807,0.000433462256977063
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42611,-0.0249977284316303,0.00710770574833291,-0.0389288316983628,-0.0110666251648978,0.000437912773781544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0196025417430845,0.00557552126308782,-0.0305305634187367,-0.00867452006743239,0.000439867599643036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0177766161406102,0.00505960827398157,-0.0276934483576141,-0.00785978392360631,0.000444120662975014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0185877029319641,0.00529777426176173,-0.0289713404850171,-0.00820406537891116,0.000452306246550294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,40269,0.00709946407743741,0.00202783982200221,0.00312489802631307,0.0110740301285617,0.000465343040059858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,40532,-0.0305999216789071,0.008747080084055,-0.0477441986436549,-0.0134556447141592,0.000470026907729462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,-0.0327477970726195,0.00938157759139341,-0.0511356891517506,-0.0143599049934884,0.000483388561172273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,40539,-0.00717317010171002,0.00205499676712687,-0.0112009637652787,-0.00314537643814135,0.000483769982196917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0302364334501109,0.0086810515362061,-0.0472512944610749,-0.013221572439147,0.000497684240682779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0208426253791999,0.00598621949324686,-0.0325756155859637,-0.00910963517243604,0.000500063418679335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0189266244591362,0.00544203790158338,-0.0295930187462396,-0.00826023017203278,0.000507043014931571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,42311,-0.0107036612488688,0.00308170915608173,-0.016743811194789,-0.00466351130294862,0.000515783110392821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,40199,-0.0111683661744741,0.00321808349983787,-0.0174758098341564,-0.0048609225147919,0.000521477608656762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.01395182405953,0.00402142499655296,-0.0218338170527738,-0.00606983106628618,0.000523667593615153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0243252173272417,0.00701339707352415,-0.038071475591349,-0.0105789590631344,0.000525528558269277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42677,0.0139624552303696,0.0040259913677853,0.00607151214951042,0.0218533983112288,0.000525829351017657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,42594,-0.0104197242369379,0.00300464818956204,-0.0163088346884795,-0.00453061378539628,0.00052625112072917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0288973946717474,0.00833890716275668,-0.0452416527107505,-0.0125531366327443,0.000531522341118693
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,42154,-0.0124574614133117,0.00359622871381339,-0.0195060696923859,-0.00540885313423742,0.000533857791284835
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,40375,-0.0328580992173843,0.00949500237729029,-0.0514683038768733,-0.0142478945578954,0.000541049996208044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0229706286454247,0.00665353653764264,-0.0360115602592043,-0.00992969703164515,0.000557741084076851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,42311,-0.0346628867856718,0.0100440662087232,-0.0543492565547692,-0.0149765170165743,0.000560104307459394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42679,-0.0187580420786362,0.00544195307157196,-0.0294242700989172,-0.00809181405835513,0.000568720482884686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0201907959218162,0.00586051493022433,-0.0316774051850559,-0.00870418665857647,0.000572653044133874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0307662037680574,0.00893513634623001,-0.0482790710066682,-0.0132533365294465,0.000576440476594529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0150814779903896,0.00438167655416569,-0.0236695640365544,-0.00649339194422489,0.000579317317444462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42794,0.0135250759025662,0.00393104117295813,0.00582023520356829,0.0212299166015641,0.00058220427487181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42495,0.0113678833270554,0.00330863198892175,0.00488296462876881,0.0178528020253421,0.000592555314929644
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0288880435136182,0.00841634198412984,-0.0453840738025127,-0.0123920132247238,0.000600127696733918
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0196015390723229,0.00571188794597401,-0.030796839446432,-0.00840623869821385,0.000601590024116148
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00975574604761979,0.00284836396119498,-0.0153385394115619,-0.00417295268367763,0.000616907860368913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0158986342669809,0.00464513031549435,-0.0250030896853498,-0.00679417884861199,0.000622034397411055
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0179487634745712,0.0052524187996584,-0.0282435043219016,-0.00765402262724068,0.000634910147954468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,42370,-0.0161425020380638,0.00472986773512889,-0.0254130427989164,-0.00687196127721117,0.00064472045477639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0234997632255071,0.00688693863414608,-0.0369981629484334,-0.0100013635025807,0.000646301806774414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0264037592421639,0.00775042871119706,-0.0415945995161101,-0.0112129189682177,0.000659769691326044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0168345020030908,0.00494912314303434,-0.0265347833634381,-0.00713422064274348,0.0006721416406722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00829988145094623,0.00244357571643777,-0.0130892898551642,-0.0035104730467282,0.00068459934518849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0172123274527212,0.00507439938337182,-0.02715815024413,-0.00726650466131246,0.000696250163742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0188900055020064,0.00557130709218836,-0.0298097674026956,-0.00797024360131716,0.000699480371928188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42711,0.0414758130895678,0.0122516204816351,0.0174626369455631,0.0654889892335725,0.000712942534742826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0156945234286867,0.00463962564121581,-0.0247881896854697,-0.00660085717190368,0.00071982779101125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.017991231501424,0.0053199426438734,-0.0284183190834159,-0.00756414391943218,0.000722453309607521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0168208316116932,0.00498338109163074,-0.0265882585512895,-0.00705340467209697,0.000739622237281261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0183513763058673,0.00543723625411967,-0.0290083593639419,-0.00769439324779277,0.000740387574295619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42495,-0.0106141162295748,0.00314958758115736,-0.0167873078886433,-0.00444092457050639,0.000753813505017872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,42598,-0.0139685311287882,0.00416397388889953,-0.0221299199510313,-0.00580714230654514,0.000796958066013598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,42636,-0.01760715481666,0.00525441271427774,-0.0279058037366444,-0.00730850589667568,0.000807632955331289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.00572809922072691,0.00171049225602194,0.0023755343989239,0.00908066404252991,0.000813855119814688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00880805216142119,0.00263310535472724,-0.0139689386566866,-0.00364716566615581,0.000825140100766422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0151317329604479,0.00452633732606625,-0.0240033541195377,-0.00626011180135803,0.000831349916281325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.00927107083971832,0.00277488657520131,-0.0147098485271129,-0.00383229315232375,0.000837290659514632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0177574687522462,0.0053252592213691,-0.0281949768261297,-0.00731996067836281,0.00085706261047312
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.016744588495503,0.00503015659076364,-0.0266036954133998,-0.00688548157760627,0.000874479158903888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,40199,-0.0055836886372966,0.00167846375625867,-0.00887347759956358,-0.00229389967502961,0.000881794711108552
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42636,-0.00792452013581678,0.00238457933914958,-0.01259829564055,-0.00325074463108361,0.000892172227773559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0107622553588659,0.00324207537293857,-0.0171167230898255,-0.00440778762790629,0.000904526004826131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0175407813440351,0.00529605038508394,-0.0279210400987996,-0.00716052258927054,0.000928647231985033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.0151881319170088,0.00458874056916345,-0.0241820634325692,-0.00619420040144847,0.000936320274216412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,0.00638659147335676,0.00193656627308964,0.00259092157810107,0.0101822613686124,0.000977138651249862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.015453361886653,0.00469191639821888,0.00625720574614404,0.024649518027162,0.000991645485646475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,40223,-0.0163743485976519,0.00497573860755294,-0.0261267962684557,-0.00662190092684818,0.00100203119999445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42587,0.00934114460782505,0.00284130049031491,0.00377219564680783,0.0149100935688423,0.00101294786075439
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0144951449142322,0.00441486183516147,-0.0231482741111487,-0.00584201571731573,0.00102936080988085
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,42779,-0.0112018146901418,0.00341220123518449,-0.0178897291111034,-0.00451390026918022,0.00103015402115986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0189939467265984,0.00579289039749935,-0.0303480119056971,-0.00763988154749967,0.00104505993571127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.00913731257053081,0.00278760314078055,-0.0146010147264607,-0.00367361041460094,0.00104922358222414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0129932998676466,0.00397243885651892,-0.0207792800264237,-0.00520731970886949,0.00107541740540042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.00926643841554346,0.00283838308810984,-0.0148296692682387,-0.00370320756284818,0.00109856893865748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0310770512760766,0.00952694849258575,-0.0497498703215446,-0.0124042322306085,0.00110901917980745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0166058934447649,0.00509300450289664,-0.0265881822704423,-0.00662360461908747,0.00111539234251796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0225921785663052,0.00692904217445985,-0.0361731012282465,-0.00901125590436385,0.00111542716693832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0160284588142739,0.00492822316318609,-0.0256877762141187,-0.00636914141442921,0.00114724309213263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0156942670435155,0.004833207578518,-0.0251673538974108,-0.00622118018962022,0.00116898263488619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0189047206765266,0.00582311620704235,-0.0303180284423296,-0.00749141291072357,0.00117127266184486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42611,0.00986199707166407,0.00304456785735157,0.003894644071255,0.0158293500720731,0.00120152677271002
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00774796679642728,0.00239218107012526,0.00305929189898178,0.0124366416938728,0.00120299095937427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.00970493087322612,0.00300252911503549,-0.0155898879386957,-0.00381997380775655,0.00123180284743426
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.00946207616755345,0.00293380918062202,0.00371181017353429,0.0152123421615726,0.00126250968434847
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.00827493245576939,0.00256880293554565,-0.0133097862094389,-0.00324007870209991,0.00127906526937356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,40136,-0.0137916166405242,0.00428399869045593,-0.0221882540738178,-0.00539497920723057,0.00128864258681681
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0173035044194287,0.0053805786269247,-0.0278494385282011,-0.00675757031065626,0.00130402501356607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0166910138409914,0.00524395350374483,-0.0269691627083313,-0.00641286497365155,0.00146213357060564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0143566937852293,0.00451665936759052,-0.0232093461457067,-0.00550404142475186,0.00148384040191329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42689,-0.0146682764629545,0.00461548240016129,-0.0237146219672707,-0.00562193095863841,0.00148598863590395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0211776646606961,0.00667694088138258,-0.034264468788206,-0.00809086053318626,0.00151859535219369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00958156682103234,0.0030297951851348,-0.0155199653838965,-0.00364316825816813,0.00156874837160458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,42357,-0.0255425311975041,0.0080812724366533,-0.0413818251733445,-0.00970323722166361,0.00157743616998157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0245369345335459,0.0077661008338303,-0.0397584921678533,-0.00931537689923848,0.00158401670873309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,40460,-0.0280309385681347,0.00887179598887773,-0.045419658706335,-0.0106422184299344,0.00158427457867476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.028628246385652,0.00906256525619597,-0.0463908742877961,-0.0108656184835079,0.00158754075368445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,40136,-0.0194106021442905,0.00615490123640268,-0.0314742085676398,-0.00734699572094128,0.00161660589382052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0189322598348819,0.0060227943905548,-0.0307369368403693,-0.0071275828293945,0.00167338904659413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42611,-0.0198673323737675,0.0063243374843236,-0.0322630338430418,-0.00747163090449327,0.00168502387905258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.00656575461886357,0.00209046088987154,-0.0106630579630118,-0.00246845127471534,0.00168844034792934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,42017,-0.00848099647108155,0.00270306851935286,-0.0137790107690132,-0.00318298217314996,0.0017075544880638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42587,0.00839417087497331,0.00267786849604172,0.00314554862273154,0.0136427931272151,0.00172433101212445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42636,-0.0122375979700001,0.00390816642868628,-0.0198976041702252,-0.00457759176977499,0.00174414053695823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00872707942214525,0.00278921385423409,-0.0141939385764441,-0.00326022026784642,0.00175860833504256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0297275042788084,0.00952486562667579,-0.0483962409070929,-0.0110587676505239,0.00180667052714114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0266234904122653,0.0085339373692501,-0.0433500076559955,-0.00989697316853509,0.00181416317065298
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0100072167707008,0.00321154700500721,-0.0163018489005149,-0.00371258464088668,0.00183702015680059
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.00939816230846449,0.00302390179167157,-0.0153250098201408,-0.00347131479678822,0.00188772707187154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0113287249525187,0.00364899838059008,-0.0184807617784753,-0.00417668812656215,0.00191008576558837
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.00748280610713567,0.00241065822129605,-0.0122076962208759,-0.00275791599339541,0.00191288227886335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0349031357159171,0.0112452481126487,-0.0569438220167085,-0.0128624494151256,0.0019153284192129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0136784992062472,0.00441119404607673,-0.0223244395365576,-0.00503255887593677,0.0019345021345561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.00922600382358938,0.00297613877695616,-0.0150592358264234,-0.00339277182075531,0.00194002839688654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0266648696326709,0.00860436041169879,-0.0435294160396005,-0.00980032322574124,0.00194654411715938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.00890376689455487,0.00287325864473353,0.00327217995087714,0.0145353538382326,0.00194676611603277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0166894616598415,0.00538819097602471,-0.0272503159728499,-0.00612860734683307,0.00195620251876506
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,40482,-0.0186990511703999,0.00605252073463807,-0.0305619918102905,-0.00683611053050931,0.00201004669419184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0177296469799628,0.00575123283303119,0.00645723062722172,0.029002063332704,0.00205514720540817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0197508986631247,0.00640719124364431,-0.0323089935006676,-0.0071928038255819,0.00205606349828819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,42495,-0.0166435674564534,0.00540164194916527,-0.0272307856768173,-0.00605634923608949,0.00206585543191154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0215150050068244,0.00698622588044473,-0.0352080077324961,-0.00782200228115276,0.00207684904087253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0196304599581678,0.00638876501249776,-0.0321524393826635,-0.00710848053367222,0.00212670272727737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0172955822499526,0.00563362945674674,-0.0283374959851762,-0.006253668514729,0.00214525320699608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.0179737342564523,0.00586260382666046,-0.0294644377567068,-0.00648303075619776,0.00217496222427548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0141295435646764,0.00462092910759061,-0.023186564615554,-0.00507252251379878,0.00223469294508147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,42216,-0.0224019874160725,0.00732706420660865,-0.0367630332610255,-0.00804094157111959,0.00223696296237295
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,40199,-0.0105030227252893,0.00343881071108229,-0.0172430917190106,-0.00376295373156801,0.00226155629665906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0324518484454015,0.0106289113703956,-0.053284514731377,-0.0116191821594261,0.00226880899761078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0208920364776595,0.00686081807691409,0.00744483304690789,0.0343392399084111,0.00233032667268022
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00885423332995492,0.00291530483897904,-0.0145682308143538,-0.003140235845556,0.00239282668118358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.01104154149303,0.00363962142546145,-0.0181751994869344,-0.00390788349912554,0.00242120442277399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,40383,0.00880372937835786,0.00290435391629435,0.00311119570242092,0.0144962630542948,0.00244126470485235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.017005078904234,0.00561248014050318,-0.0280055399796202,-0.00600461782884772,0.00245134713263604
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0265772609483036,0.00877790840165888,-0.043781961415555,-0.0093725604810522,0.00246951770444562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,40116,0.010781075906589,0.00356333711651416,0.00379693515822124,0.0177652166549567,0.00248753930436472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.0193729465445122,0.00641942575649888,-0.03195502102725,-0.00679087206177437,0.00255057905812353
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0111217909727163,0.00368834103039874,-0.0183509393922978,-0.00389264255313477,0.00257218713370463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0166251308489218,0.00552711878045689,-0.0274582836586173,-0.00579197803922629,0.00263623795969995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,42594,-0.0193456892342123,0.00643713393156358,-0.0319624717400769,-0.00672890672834764,0.00265786799928197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0156842175251209,0.00522504783425385,-0.0259253112802584,-0.00544312376998336,0.00268948202610285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.0116117982019174,0.00386849894134082,-0.0191940561269454,-0.00402954027688943,0.00269140410858081
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0173445021592462,0.00579862481761149,-0.0287098068017647,-0.00597919751672769,0.0027853936392659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0179588629433981,0.00600773826363365,-0.0297340299401201,-0.00618369594667616,0.00280144512334016
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,40182,-0.015790519900034,0.00528600274181018,-0.0261510852739819,-0.00542995452608602,0.00282136890492851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.0160273143656773,0.00536779998535648,-0.026548202336976,-0.00550642639437855,0.00283437196297342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0249643779292744,0.00836196153026151,-0.041353822528587,-0.00857493332996183,0.00283765130468318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,42594,0.0123731960892005,0.00415604200077443,0.00422735376768258,0.0205190384107183,0.00291453641363469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00629856381850613,0.00211626045961973,-0.0104464343193608,-0.00215069331765146,0.00292294234458919
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0200495334252951,0.00675585268805274,-0.0332910046938785,-0.00680806215671177,0.00300653912965356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,40483,-0.00875927879525024,0.00295828499728101,-0.014557517389921,-0.00296104020057946,0.00307348411219616
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0306487615497606,0.0103669080221819,-0.0509679012732372,-0.0103296218262841,0.00311895559709267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0125462743404656,0.00424415319368527,-0.0208648146000887,-0.00422773408084244,0.00312076924752607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0147740830713327,0.00499841653914111,-0.0245709794880492,-0.0049771866546161,0.00312460515842459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0154249677676321,0.00521967206461816,-0.0256555250142837,-0.00519441052098054,0.00313152182794773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0146498103921392,0.00496980052745454,-0.0243906194259501,-0.00490900135832832,0.00320630203627868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,42652,-0.0108567448581809,0.00368773453506614,-0.0180847045469106,-0.00362878516945128,0.00324538254441381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0335639223128687,0.0114123803972101,-0.0559321878914005,-0.0111956567343368,0.00327820290835036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0135899417801419,0.00462209215946354,-0.0226492424126905,-0.0045306411475934,0.00328650453018285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0232866311291938,0.00794170923452388,-0.0388523812288606,-0.00772088102952695,0.00337264582427378
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.013439965543333,0.00459049076574718,-0.0224373274441974,-0.00444260364246849,0.00342067801877523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0103478379529215,0.00354254976196603,-0.0172912354863749,-0.00340444041946806,0.00349488551471973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0208871522752038,0.00715387429551191,-0.0349087458944071,-0.00686555865600044,0.00350968422108324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,40539,0.00647811149367105,0.00222144366280111,0.00212408191458087,0.0108321410727612,0.0035504928907605
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,-0.0102448152457681,0.00351335215591441,-0.0171309854713604,-0.00335864502017586,0.0035517005360645
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.0161743065965496,0.00554782014327075,-0.0270480340773603,-0.00530057911573898,0.00355903459362035
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0084897247834452,0.00291201094133726,-0.0141972662284662,-0.00278218333842417,0.00355930678898961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0172424126472434,0.00592717741566051,-0.028859680381938,-0.00562514491254882,0.00363270712709642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.00821262270637873,0.00282345361511044,-0.0137465917919952,-0.00267865362076227,0.00363621854830936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0101362757725312,0.0034899474393624,-0.0169765727536815,-0.0032959787913809,0.00368547492313531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,42636,-0.00842953439068448,0.00290421415996758,-0.0141217941442209,-0.00273727463714803,0.00370777199296956
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0237288491319186,0.00818017705871049,-0.0397619961669911,-0.00769570209684599,0.00372960421397864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00938663575975363,0.00323666089095707,-0.0157304911060295,-0.00304278041347777,0.00373766993588694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0108078503281139,0.00374423039198633,-0.0181465418964071,-0.00346915875982065,0.00390267824404241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0128236340144461,0.00444525477330293,-0.0215363333701199,-0.00411093465877238,0.00392416202097706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0126712782182897,0.0043932771851776,-0.0212821015012378,-0.00406045493534163,0.00393098085921162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.0128472305917454,0.00445443046443784,-0.0215779143020436,-0.00411654688144724,0.00393117038485527
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,40223,-0.032587481041688,0.0113025724902781,-0.0547405231226331,-0.0104344389607429,0.00394429066686895
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0160354317309678,0.00556422169946261,-0.0269413062619145,-0.00512955720002104,0.00395938774713538
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0154697189550026,0.00536920685149827,0.00494607352606599,0.0259933643839392,0.0039680255234021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0202136766795254,0.00702356493293764,-0.0339798639480832,-0.00644748941096765,0.00400861631814182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,40182,-0.0114663123507867,0.00399269730659004,-0.0192919990717032,-0.00364062562987024,0.00408894583174103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0109118096877717,0.00380967648928096,-0.0183787756067624,-0.00344484376878104,0.00418667121714448
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0124883667829969,0.00436186045390371,-0.0210376132726481,-0.00393912029334561,0.00420205985394168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00877946400452725,0.00307077853163264,-0.0147981899265272,-0.00276073808252727,0.00425708101546465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.00643254701825358,0.00225828814170231,-0.0108587917759901,-0.00200630226051706,0.00440042023700138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,40361,-0.014867959301938,0.0052308013116057,-0.0251203298726851,-0.00461558873119078,0.00448583533582869
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00780799905838614,0.00274749063920966,-0.0131930807112371,-0.00242291740553521,0.0044932863319496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,40080,-0.0200783031786478,0.0070718946394081,-0.0339392166718877,-0.00621738968540796,0.00453149976299293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0220897428403208,0.00778738441527105,-0.037353016294252,-0.00682646938638952,0.00456805128010815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.0095661654356823,0.00337441596189334,-0.0161800207209932,-0.00295231015037136,0.00459073885579159
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42500,0.0131848250877706,0.00465127876259707,0.00406831871308032,0.0223013314624608,0.00459426331296096
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0132649875910601,0.00468236732911096,-0.0224424275561176,-0.00408754762600265,0.00461871354317048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0199914357473718,0.00706012527296168,-0.0338292812823767,-0.0061535902123669,0.00463999242792552
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00968875219317948,0.00342285767045873,0.00297995115908037,0.0163975532272786,0.00465293696191151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0101868393013236,0.00359930826700628,-0.0172414835046559,-0.00313219509799131,0.0046599286358741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.01755480578267,0.00620523958343013,-0.0297170753661931,-0.00539253619914696,0.00467738478511851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,40285,-0.00584101277039863,0.00206845731830063,-0.00989518911426787,-0.00178683642652939,0.00475352170004828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,42638,-0.00921034362081539,0.00326606053714183,-0.0156118222736134,-0.0028088649680174,0.00480915065043285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0134881607044023,0.00478509173777739,-0.022866940510446,-0.0041093808983586,0.00482911667789348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42587,-0.0220476891222851,0.00782538111859067,-0.0373854361147229,-0.00670994212984741,0.00484762006230492
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,42669,-0.00808527032822612,0.0028744174954337,-0.0137191286192762,-0.00245141203717607,0.00491774536488885
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,40116,-0.0172178565593358,0.00612200357686145,-0.0292169835699843,-0.00521872954868739,0.00492526997305902
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00885270776720598,0.00315163764744423,-0.0150299175561967,-0.00267549797821529,0.00497944780425425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0190736333253406,0.0068146660625531,-0.0324303788079446,-0.00571688784273651,0.00513640646003732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42679,-0.0155218350137271,0.00554679408994443,-0.0263935514300182,-0.00465011859743604,0.00514383470049919
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,40483,-0.0104777852728901,0.00374570792363644,-0.0178193728032175,-0.00313619774256269,0.00516224557559262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42754,-0.0116948255066165,0.00418439523956166,-0.0198962401761573,-0.00349341083707563,0.00519941134986472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0215433733778208,0.0077167153307834,-0.0366681354261562,-0.0064186113294853,0.00525103148577694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,42611,0.0176781826475329,0.00633774863071235,0.00525619533133666,0.0301001699637291,0.00528888330054125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0138029294521625,0.00495401795934304,-0.0235128046524749,-0.00409305425185018,0.00534048575166631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0191572463316704,0.00688170538807767,-0.0326453888923026,-0.00566910377103814,0.00538163949664102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.00694363399771961,0.00249449875509082,-0.0118328515576976,-0.0020544164377416,0.00538522357021646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.0102146308303488,0.00367222562537716,-0.017412193056088,-0.00301706860460952,0.00541828526517348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00795120913938166,0.00285987947685629,-0.01355657291402,-0.00234584536474334,0.0054405076504307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,42261,-0.0082033993532375,0.00295581999092296,-0.0139968065354465,-0.0024099921710285,0.00552227601944629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.00757639979743769,0.00273123924552359,-0.0129296287186639,-0.00222317087621146,0.00554511805343655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,42381,-0.0122841258035215,0.0044325775574729,-0.0209719778161684,-0.00359627379087463,0.0055906403479523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0136807660333803,0.00493680977985032,0.00400461886487364,0.0233569132018869,0.00559460069537358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0130278543905482,0.00470378797313663,-0.022247278817896,-0.00380842996320045,0.00562081793102729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0182388733151898,0.00659067025347753,-0.0311565870120058,-0.00532115961837384,0.00565868209938946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,42311,-0.0173219064428242,0.00626901026811074,-0.0296091665683213,-0.00503464631732718,0.00573348996926604
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,42357,-0.0117854728918074,0.00427399376353486,-0.0201625006683358,-0.0034084451152791,0.0058328223003548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.00658857675100176,0.00239305550105903,-0.0112789655330774,-0.00189818796892606,0.00591106451496488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.00955422686090842,0.00347109292800016,-0.0163575689997887,-0.00275088472202811,0.00592375119109763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,42587,-0.0120771201812266,0.00439155509112148,-0.0206845681598247,-0.00346967220262845,0.00596609861910115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0201230413451186,0.00732018227300622,-0.0344705986002108,-0.00577548409002638,0.00598789240154797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00737062099447617,0.00268179175177444,0.00211430916099827,0.0126269328279541,0.00599835571605988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0224297240689115,0.0081744397206515,-0.0384516259213884,-0.00640782221643455,0.006081438664554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0123904087843242,0.00452004928417374,-0.0212497053813047,-0.00353111218734367,0.00612940839562563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0160921904859396,0.00587214983608198,-0.0276016041646602,-0.0045827768072189,0.00614583871741932
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.00691039991049892,0.00253007881672477,0.00195144542971838,0.0118693543912795,0.00631858719076584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0222226441204563,0.00814381646043195,-0.038184524382903,-0.00626076385800971,0.00636544331216179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,42587,-0.0504029457073431,0.0184803879550247,-0.0866245060991915,-0.0141813853154948,0.00639236189561225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,42636,-0.00917842504020317,0.00336922536076558,-0.0157821067473037,-0.00257474333310263,0.00645418450151265
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,40384,-0.00829267078566311,0.00304492269011245,-0.0142607192582835,-0.00232462231304271,0.00647057316290259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0220080610155364,0.00809089602845461,-0.0378662172313074,-0.00614990479976535,0.00653475539374798
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0393461225298659,0.0144809766130097,-0.0677288366913649,-0.0109634083683669,0.00659431985765781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0284500290814649,0.0105181685683693,-0.0490656394754688,-0.00783441868746101,0.00684218320938571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,42311,0.0138394251958694,0.00511687987198422,0.0038103406467803,0.0238685097449584,0.00684623801451273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0152865947347151,0.00565391318201753,-0.0263682645714695,-0.00420492489796073,0.00686735168515394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42588,0.0204538778595956,0.0075665912896307,0.00562335893191946,0.0352843967872718,0.00687656405221623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0229281806857635,0.00848306805260631,-0.0395549940688719,-0.00630136730265517,0.00688613974266843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.0123708155234913,0.00457799111750211,-0.0213436781137955,-0.00339795293318718,0.00689803293831539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00703235325855924,0.00260249642272214,-0.0121332462470946,-0.00193146027002384,0.00689980605796874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,40539,-0.0189448522035743,0.00701148399275977,-0.0326873608293834,-0.00520234357776514,0.00690315049218625
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,40283,0.0242192135638628,0.00896485201004056,0.00664810362418326,0.0417903235035423,0.00691169950443465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0154389163061137,0.0057298666102663,-0.0266694548622357,-0.0042083777499918,0.00705887829097763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42636,0.00926610846121506,0.00344710737495074,0.00250977800631162,0.0160224389161185,0.0071952204445516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.0101356146248324,0.00377421455686441,-0.0175330751562866,-0.00273815409337811,0.00725330237608765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00758157151528217,0.00282396764808343,-0.0131165481055257,-0.00204659492503866,0.00726978151414356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0181469136381805,0.00676563100204207,-0.0314075504021829,-0.00488627687417802,0.00732414410284512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00630772944684803,0.00235271305200405,-0.010919047028776,-0.00169641186492009,0.00735020676347967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0137340924727539,0.00512686200106724,-0.0237827419948456,-0.00368544295066206,0.00739855353497223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0250849154299741,0.00936519507272705,-0.0434406977725191,-0.00672913308742904,0.00740539002060081
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0117330692964799,0.00438263090323129,0.0031431127261466,0.0203230258668133,0.007435322445236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.00694401405290983,0.0026047975958927,-0.0120494173408595,-0.00183861076496013,0.00768848904151041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,40527,0.00837432986181009,0.00315082694621482,0.00219870904722905,0.0145499506763911,0.00787583220115489
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,40451,-0.0210689234937686,0.00792881539982435,-0.0366094016774244,-0.0055284453101129,0.00788898824952578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0129763458785706,0.00489586599247302,-0.0225722432238177,-0.00338044853332343,0.0080476017947789
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0167154783563845,0.00632002249102769,-0.0291027224387988,-0.00432823427397022,0.00818417082463486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,40451,0.0294357548481101,0.0111399025551129,0.00760154584008875,0.0512699638561315,0.00824417403969622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0132412512468537,0.00501189868964606,-0.02306457267856,-0.00341792981514742,0.00825245971604921
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0178277963182714,0.00675254186206673,-0.0310627783679222,-0.00459281426862058,0.00829810095289919
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0209409236584114,0.00795388311830021,-0.0365305345702798,-0.00535131274654299,0.00847829279828453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.014856604716082,0.00564828623051225,0.003785963704278,0.025927245727886,0.00854285089420174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00825697949596926,0.00314142892102361,-0.0144141801811755,-0.00209977881076298,0.00858998888469592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0113245093695372,0.00431183515106993,-0.0197757062656342,-0.00287331247344012,0.00864184174186495
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,42676,-0.0089983685808127,0.00343229539340642,-0.0157256675518893,-0.00227106960973612,0.00875966916700413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.017857806406793,0.00681317753252181,0.00450397844305025,0.0312116343705358,0.00877724396033212
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0152024021888038,0.00580086256584664,0.00383271155974438,0.0265720928178632,0.00878439208794067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0147795657673201,0.00564058664917606,-0.0258351155997051,-0.00372401593493499,0.00879940355774507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,40527,-0.0234923570951453,0.00896924195479313,-0.0410720713265398,-0.00591264286375075,0.00882502167310695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,42346,-0.0145343444764465,0.00555557289689218,-0.0254232673543551,-0.00364542159853781,0.00890228935197952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,42347,-0.0108476556185108,0.0041521366732275,-0.0189858434980367,-0.00270946773898492,0.00899723093249109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0154234917194063,0.00590386122775576,0.00385192371300506,0.0269950597258076,0.00899994140602831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0136305247000221,0.00522295339768397,-0.0238675133594827,-0.00339353604056153,0.00907152864383129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.016903511117499,0.0064962355876025,-0.0296361328691999,-0.00417088936579811,0.00927711367017387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.00823559067327524,0.00316886696117799,-0.0144465699171841,-0.00202461142936638,0.00936236316443296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0188030463113544,0.00724158885282486,-0.0329965604628911,-0.00460953215981767,0.0094273799305675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',40116,-0.0108678143266812,0.00418543721258564,-0.019071271263349,-0.00266435739001334,0.00942836727202516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0105007106996046,0.0040449411999488,-0.0184287954515042,-0.00257262594770494,0.00944160896253797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0117844702625908,0.00454069138207921,-0.020684225371466,-0.00288471515371553,0.00946114533169072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0139727854382087,0.0053872647534357,-0.0245318243549427,-0.00341374652147472,0.0095081957941214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,40136,0.0230405533845648,0.00888469359623694,0.0056265539359404,0.0404545528331892,0.00951901876886522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,42357,0.0058575648562548,0.00226187986810396,0.00142428031477104,0.0102908493977386,0.00961685299041849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0150263318110855,0.00582650667889343,-0.0264462849017167,-0.00360637872045442,0.0099227656630968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0127663225385004,0.00496260137405251,-0.0224930212316434,-0.00303962384535752,0.0101095247742619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,42370,-0.00732942889926728,0.00285414244288394,-0.0129235480873198,-0.00173530971121476,0.010239729237671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0154477467216408,0.0060211617737651,-0.0272492237982204,-0.00364626964506122,0.0103135681358019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.00863786801379381,0.00336810912910234,0.00203637412075323,0.0152393619068344,0.010342445961748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0146797245341539,0.00573123856969971,-0.0259129521307654,-0.0034464969375425,0.0104373906069994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0066465428475019,0.00259565841098896,-0.0117340333330403,-0.00155905236196353,0.0104608342576115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0168603960375197,0.00658907471136935,-0.0297749824718036,-0.00394580960323578,0.0105129798906048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,40451,-0.0172930912086271,0.00677105870007662,-0.0305643662607773,-0.00402181615647694,0.0106632505432411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00642263637505502,0.00251739263672226,0.0014885468070794,0.0113567259430306,0.0107430520802449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0270114829604787,0.0106214319252363,-0.0478294895339418,-0.00619347638701548,0.0109984081295186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0147220125346582,0.00578959331322757,-0.0260696154285843,-0.0033744096407322,0.0110090115669942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.018022083535237,0.00709230649442348,-0.031923004264307,-0.00412116280616696,0.011062400021729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0174962918490846,0.00689272071079057,-0.0310060244422341,-0.00398655925593504,0.0111480917166137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,42276,0.0119026448090423,0.00469317007805262,0.00270403145605915,0.0211012581620254,0.0112189830048106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0180453499579256,0.00711653551471395,-0.0319937595667649,-0.00409694034908621,0.0112339813880255
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42636,-0.0162897218610606,0.00642565830009816,-0.028884012129253,-0.0036954315928682,0.0112525851286345
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,40527,0.0240131963087095,0.00947496472830161,0.00544226544123835,0.0425841271761807,0.0112778762408831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.0125800889327799,0.00496936248857171,0.00284013845517931,0.0223200394103804,0.0113704986248025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,40539,-0.00649152454815583,0.00256650860777077,-0.0115218814193865,-0.00146116767692513,0.0114417695548515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0215095870971875,0.00850842480462943,-0.0381860997142612,-0.00483307448011386,0.0114817370766111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0127261707808565,0.00503552353466989,-0.0225957969088095,-0.00285654465290352,0.0115089354624122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,42357,0.00946213707607832,0.00375491290255196,0.00210250778707647,0.0168217663650802,0.011749377594419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.00996631919813824,0.00395926186624473,-0.0177264724559779,-0.00220616594029857,0.0118423468582971
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,42370,-0.0204980157881428,0.00816717236673223,-0.036505673626938,-0.00449035794934764,0.0120916525717486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0239207729773474,0.00953354430945062,-0.0426065198238707,-0.00523502613082423,0.0121176916963405
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42664,-0.0103525281717653,0.00413293182726436,-0.0184530745532034,-0.00225198179032713,0.012260757778603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,40116,-0.00969766986359505,0.00387163514763842,-0.0172860747529664,-0.00210926497422374,0.0122665307821792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0228441796995795,0.00913990174135617,-0.0407583871126376,-0.00492997228652145,0.0124548578027288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,40483,-0.0126267087929235,0.0050541545001176,-0.022532851613154,-0.002720565972693,0.0124937568767483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0143599041299378,0.00575495997487077,-0.0256396256806845,-0.00308018257919108,0.0126019404221658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0161252028610284,0.00646344608101024,-0.0287935571798085,-0.00345684854224836,0.0126159068452669
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0165908163744598,0.00665539811076277,-0.0296353966715548,-0.00354623607736476,0.0126873779847227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0296309443357622,0.0118881196046361,-0.052931658760849,-0.0063302299106755,0.0126999061074704
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,40451,0.013431727672832,0.00539160680737111,0.00286417833038462,0.0239992770152794,0.0127444902735888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.00854396497009034,0.0034316000713012,-0.0152699011098407,-0.00181802883033999,0.0127961648655987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,40199,-0.0063146107902591,0.00253822618319852,-0.0112895341093282,-0.00133968747118999,0.0128681194209477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0133414823277054,0.00536688620550996,-0.0238605792905049,-0.0028223853649059,0.0129377204315953
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00665246064242984,0.00267675171650697,-0.0118988940067835,-0.00140602727807619,0.012957507920121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0649875548510829,0.0262154538866554,-0.116369844468928,-0.0136052652332382,0.013190748127991
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,40199,-0.0119601208351706,0.0048266734163373,-0.0214204007311917,-0.00249984093914949,0.0132298876793243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.0075143546104669,0.00303471857044637,-0.0134624030085418,-0.00156630621239202,0.0132940475391103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0167002292875762,0.00674689940557636,-0.0299241521225059,-0.00347630645264659,0.0133292844323206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,40511,-0.00720679895221043,0.00291811350885123,-0.0129263014295588,-0.00148729647486202,0.0135381385463399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,42292,-0.0144224384540692,0.00584709431571727,-0.0258827433128751,-0.00296213359526338,0.0136529974357775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0114927753324052,0.00466587176528578,0.00234766667244511,0.0206378839923654,0.013784431680394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0154728024023088,0.00629737220750575,-0.02781565192902,-0.00312995287559749,0.0140217692343447
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.011537610245486,0.00469644507811364,-0.0207426425985887,-0.00233257789238326,0.0140384832530979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00763581093963487,0.00310827720347187,0.00154358762083001,0.0137280342584397,0.0140405665153154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0153394590863906,0.00625098461630144,-0.0275913889343414,-0.00308752923843973,0.0141459797036334
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42679,-0.00815829960252921,0.00332755271851967,-0.0146803029308278,-0.00163629627423066,0.0142292606013204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.0111857993608701,0.00456424281409055,-0.0201317152764876,-0.00223988344525264,0.0142715053307381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0173155662874145,0.00707163695426232,-0.0311759747177686,-0.00345515785706031,0.0143568600195801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.00721867292756116,0.00294850804397869,-0.0129977486937594,-0.00143959716136293,0.0143682379509641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0064585613865732,0.00264199974781519,-0.011636880892291,-0.00128024188085542,0.0145175195442249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,42357,-0.0273322280200975,0.0111861109655738,-0.0492570055126221,-0.00540745052757295,0.0145623408431559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.00773838061123304,0.00316910992443,0.00152692515935024,0.0139498360631158,0.0146288103698997
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0113514996618171,0.00465366323957338,-0.020472679611381,-0.00223031971225331,0.0147305121320769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.0080232645185147,0.00329142230140065,0.00157207680776942,0.01447445222926,0.0147997756813065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.00550634767782937,0.0022680816324717,-0.00995178767747391,-0.00106090767818483,0.0152056663870752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0101731237758458,0.00419110401362058,-0.0183876876425421,-0.00195855990914943,0.0152266821961353
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.015465909781739,0.00637262579301695,0.00297556322742577,0.0279562563360522,0.0152403415870936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.00954507134241156,0.00393801286899538,-0.0172635765656425,-0.00182656611918061,0.0153710125384757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.00314709730384315,0.00130253180887676,0.00059413495844471,0.0057000596492416,0.0157020918830917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0168995458304244,0.00701420443448082,-0.0306473865220068,-0.003151705138842,0.0159954478760936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,40283,-0.00811626884102731,0.00337505516053728,-0.0147313769556804,-0.00150116072637424,0.0161984414073704
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.00687180339541178,0.00285900224058913,-0.0124754477869665,-0.00126815900385708,0.0162524275447786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00738004364967675,0.00307343432965269,0.00135611236355748,0.013403974935796,0.0163563679866434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0270204348613068,0.0112812371440288,-0.0491316596636031,-0.00490921005901042,0.0166290881539206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,42594,-0.0152469044572908,0.0063706314232004,-0.0277333420467636,-0.00276046686781805,0.0167107401198325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,40440,-0.00667953601145382,0.00279314952425281,-0.0121541090789893,-0.00120496294391832,0.0168006178153767
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0150888615029135,0.0063149022681931,-0.0274660699485719,-0.00271165305725499,0.0168896455088335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,40199,-0.0143813982246639,0.00603719626071038,-0.0262143028956562,-0.00254849355367153,0.0172296140141886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42611,-0.0205884834220435,0.00866227176117488,-0.0375665360739463,-0.00361043077014076,0.0174775189477092
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0170075222790233,0.00716193786593326,-0.0310449204962525,-0.00297012406179407,0.0175768845803762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0124054460184898,0.00522567302230149,-0.0226477651422008,-0.00216312689477891,0.0176163615065263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.016196571487134,0.00682405446588955,-0.0295717182402775,-0.0028214247339905,0.0176392830057036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.0142794947956663,0.00602204673350284,-0.0260827063933319,-0.00247628319800075,0.0177445900152793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.00422318092982839,0.00178215630178899,-0.00771620728133481,-0.000730154578321972,0.0178190193645941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00646056244139464,0.00273155330078975,-0.0118144069109426,-0.00110671797184673,0.0180390607772297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0106635039944376,0.004511570183472,-0.0195061815540428,-0.00182082643483252,0.0181133265887057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0147358208339771,0.00623973374100667,-0.0269656989663501,-0.00250594270160399,0.0182099265032415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0132525193519056,0.00561784174444892,-0.0242634891710255,-0.00224154953278571,0.0183415505296206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,42570,-0.0150320668947217,0.00637610863374333,-0.0275292398168586,-0.00253489397258472,0.0184097377730098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.020020884639859,0.0085217210942123,-0.0367234579845151,-0.00331831129520292,0.0188217419794668
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00887869110873111,0.00378769492769776,-0.0163025731670187,-0.0014548090504435,0.0190914828053362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.0073457981246803,0.00313673558582128,-0.01349379987289,-0.0011977963764706,0.0192057085587845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,42711,0.00688295804750063,0.00293967416584118,0.00112119668245192,0.0126447194125493,0.0192259331502253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0162689340591146,0.00698994278235951,-0.0299692219125393,-0.00256864620568997,0.0199549644376205
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,42611,0.0100151724392942,0.00430336912710868,0.00158056895016114,0.0184497759284272,0.0199648278353305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.00889108170269986,0.00382051602880577,0.00140287028624055,0.0163792931191592,0.0199724706644256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,40483,0.00835978459568113,0.00360214962831532,0.0012995713241831,0.0154199978671792,0.0203166287960358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.00988882204008261,0.00426194089549903,-0.0182422261952607,-0.00153541788490452,0.0203447010930687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.00607783311400742,0.00261973872823308,-0.0112125210213442,-0.000943145206670587,0.0203577307420969
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.013693106132671,0.00590610957418086,0.00211713136727651,0.0252690808980655,0.0204393789210186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0170381622884418,0.00736685511410763,-0.0314771983120928,-0.00259912626479086,0.0207512721349972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42531,-0.0101263530864214,0.00437858554206906,-0.0187083807488768,-0.00154432542396605,0.0207543042363886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0254937241856869,0.0110254446252915,-0.0471035956512582,-0.00388385272011564,0.0207784638942449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0079278438683211,0.00343018926954671,-0.0146510148366327,-0.00120467290000956,0.0208373350663752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00461662444790872,0.00200236917763368,-0.00854126803607073,-0.0006919808597467,0.021152556436263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,40527,-0.0217347211667927,0.00944436106172681,-0.0402456688477772,-0.00322377348580815,0.0213902645140512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.00598028758204059,0.00260384419782814,-0.0110838222097837,-0.000876752954297438,0.0216531848356411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00813396357312639,0.00354168980012187,-0.0150756755813652,-0.00119225156488753,0.0216579579337648
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00893637856042269,0.00389263441440989,-0.0165659420126661,-0.00130681510817931,0.0217110460758229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,42416,-0.00919099283661783,0.00402347981418965,-0.0170770132724295,-0.00130497240080612,0.0223673749693857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,40009,-0.00865299414544836,0.00379316119653378,-0.0160875900906546,-0.00121839820024215,0.0225554236619237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0135528200603976,0.005942408618756,-0.0251999409531594,-0.00190569916763588,0.0225856900455673
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,40116,0.0076819535364779,0.0033777126565956,0.00106163672955052,0.0143022703434053,0.0229668788478849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,40451,-0.0116597955990851,0.00513108937363646,-0.0217167307714126,-0.00160286042675767,0.0230822159701184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0037217268607391,0.0016379702635597,-0.00693214857731611,-0.000511305144162088,0.0230956153676475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0167587751864495,0.00737906583709899,0.00229580614573547,0.0312217442271635,0.0231586468781384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.00923577249324036,0.00406758095654824,0.00126331381840581,0.0172082311680749,0.0231911051126336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0235094466507405,0.0103600734298893,-0.0438151905733234,-0.00320370272815749,0.0232701835970716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00752122291809351,0.00331733798659899,0.00101924046435949,0.0140232053718275,0.0233910114377973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,40199,-0.0108560608099819,0.00480560209904746,-0.0202750409241149,-0.00143708069584885,0.0239002062698464
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.00909256044110293,0.00403113857213321,-0.016993592042484,-0.00119152883972184,0.0241132776345304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0120153241654628,0.00535563259696863,-0.0225123640555213,-0.00151828427540428,0.0248815862222296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.0105016905332347,0.00468893064510347,-0.0196919945976375,-0.00131138646883186,0.0251285215142298
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.0153467301213857,0.00685532253395749,-0.0287831622879423,-0.00191029795482898,0.0251978310609453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0180845023870541,0.00807998177031459,-0.0339212666568707,-0.00224773811723754,0.0252289965399245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0219227526816386,0.00981651729382494,-0.0411631265775354,-0.00268237878574167,0.0255523376897959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0135144311834979,0.00605161217895128,-0.0253755910542424,-0.0016532713127534,0.0255561299810826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42608,0.0126161733963917,0.00565506455475456,0.00153224686907282,0.0237000999237107,0.0257008230295906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0256504290674864,0.0114993888733227,0.00311162687577395,0.0481892312591989,0.0257248694974425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00949840658436488,0.00425840773701271,-0.0178448857489098,-0.00115192741981996,0.0257340612939309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0107827892840969,0.00483633737870115,-0.0202620105463512,-0.00130356802184265,0.0257979020724966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0253431191433218,0.0114032001907583,-0.0476933915172081,-0.00299284676943543,0.0262689952905499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0116302002545217,0.00523476115607994,-0.0218903321204384,-0.00137006838860505,0.0263219627790752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0130668120499458,0.00589822693622819,-0.0246273368449531,-0.00150628725493854,0.0267544398626262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,40182,-0.00497277732944609,0.00224506757747484,-0.00937310978129677,-0.000572444877595399,0.0267819450065418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0122363188232714,0.00552549189186199,-0.023066282931321,-0.00140635471522195,0.0268100257480025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0172068529330281,0.00779055641386159,-0.0324763435041968,-0.00193736236185937,0.0272137070730149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00338242152368917,0.00153406214916179,0.00037565971133206,0.00638918333604629,0.0274792582903829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0176545337622648,0.00801074141340047,-0.0333555869325297,-0.00195348059199986,0.0275511926084036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,40479,-0.0101441650522523,0.00460493879880495,-0.01916984509791,-0.00111848500659463,0.0276227719199563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0202338170102439,0.00919095173446143,-0.0382480824097883,-0.00221955161069952,0.02771809953422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0196458414972459,0.00892465550406097,-0.0371381662852054,-0.00215351670928641,0.0277356542375897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.013367010512543,0.00607767823368799,0.00145476117451454,0.0252792598505714,0.0278731333998104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.013446214669428,0.00611861343138576,-0.0254386969949441,-0.00145373234391187,0.0279983668198174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,42346,-0.0157407175307653,0.00718032661084483,-0.0298141576880211,-0.0016672773735094,0.0283824753463981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42611,0.00516266915431159,0.00237315007344837,0.000511295010352783,0.00981404329827039,0.0296138141322967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.0136055100637274,0.00626267219098223,-0.0258803475580525,-0.00133067256940221,0.0298409423882481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,42370,-0.0157668236531072,0.00726787875570951,-0.0300118660142979,-0.00152178129191658,0.0300713217739874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.00664781473383577,0.00306485413348338,0.000640700632208346,0.0126549288354632,0.0301004382237878
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0196611539096605,0.00907065022896744,-0.0374396283584367,-0.00188267946088437,0.03021359618355
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0125641381383462,0.00580262066427917,0.00119100163635904,0.0239372746403334,0.0303892422896992
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0138067939219721,0.00637878354289853,-0.0263092096660532,-0.00130437817789097,0.0304449285150523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.00859254123715758,0.00397569861789389,-0.0163849105282296,-0.000800171946085555,0.0306923364252044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0212175541328577,0.00983331292836308,0.00194426079326608,0.0404908474724493,0.0309705540398032
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,42370,-0.0106818231218308,0.00495098588803198,-0.0203857554623734,-0.000977890781288092,0.0309836280967213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0136148457987533,0.00631047062170262,-0.0259833682172905,-0.00124632338021617,0.0309880333469773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00739337380611829,0.00342801094054209,-0.0141122752495808,-0.000674472362655782,0.031046482201033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,42370,-0.00967613696145691,0.00449300526329763,-0.0184824272775203,-0.000869846645393555,0.0312896235900056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.00900905668188739,0.00418476830718883,-0.0172112025639775,-0.000806910799797288,0.0313541459134658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.00929368125437533,0.00432307564759316,-0.0177669095236579,-0.000820452985092731,0.0315941534503563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,42311,-0.0142662022369895,0.00665226848059515,-0.027304648458956,-0.00122775601502301,0.0320061993416912
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00692824657733165,0.00323159216160801,-0.0132621672140833,-0.000594325940579951,0.0320618826369445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0180960812124574,0.00844685766192149,-0.0346519222298236,-0.0015402401950913,0.0321840392596404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.0185458734143727,0.00866255925912658,-0.0355244895622607,-0.00156725726648456,0.0322982272764416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0195725409825238,0.00914465944595395,-0.0374960734965935,-0.00164900846845403,0.032346689570437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00871876205804137,0.00407445450716234,0.000732831224003182,0.0167046928920796,0.0323839827051291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.00578552652949088,0.00270499461716675,0.00048373707984405,0.0110873159791377,0.0324671627540352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,40080,0.00981442194952228,0.00459344814325278,0.00081126358874683,0.0188175803102977,0.0326516950706382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,42209,0.0142225854033688,0.00665910022464139,0.00117074896307172,0.027274421843666,0.0327133569542497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,40482,-0.00999758890611633,0.00468282929635367,-0.0191759343269695,-0.000819243485263138,0.0327868704246367
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.0092281930046562,0.00432349263814315,-0.0177022385754168,-0.00075414743389563,0.0328259888364933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.00984566065174859,0.00461283263966189,0.000804508678011275,0.0188868126254859,0.0328317822174904
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.0094164210928873,0.00441328557503794,-0.0180664608199617,-0.000766381365812953,0.0328892266975009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.0110703762522963,0.00518909589651998,-0.0212410042094755,-0.00089974829511716,0.032914627134566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0125609596522299,0.00588860783375654,-0.0241026310063927,-0.00101928829806705,0.0329348840332048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0255776728760349,0.0119992180412248,-0.0490961402368355,-0.00205920551523427,0.0330607071857931
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42666,0.00569263237162084,0.00267305077475155,0.000453452853107797,0.0109318118901339,0.0332195289001029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.00954302769282152,0.00448211414531643,-0.0183279714176417,-0.000758083968001326,0.0332615868066198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.0090867155235856,0.00426980315727665,-0.0174555297118478,-0.000717901335323358,0.0333480402967057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.00939057588372356,0.00441797513038375,-0.0180498071392757,-0.000731344628171406,0.0335634226847272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,42357,-0.00493113635074457,0.00232135536918692,-0.00948099287435092,-0.000381279827138215,0.0336679330366082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0071005442052706,0.00334515910533539,-0.013657056051728,-0.000544032358813237,0.03380290233754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.0128727976770589,0.00606698356403827,0.000981509891543941,0.0247640854625739,0.0338745858569803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0106968223303176,0.00504257825754374,-0.0205802757151033,-0.000813368945531844,0.0339183387624399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0137525753256909,0.00649420700271032,-0.0264812210510031,-0.00102392960037867,0.0342217496619378
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,42794,-0.0175952846940821,0.00831210905163051,-0.0338870184352779,-0.00130355095288625,0.0342927657662154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,40539,0.00642855529168302,0.00304378568929504,0.000462735340664738,0.0123943752427013,0.0347059960702654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,42488,-0.0105141172217117,0.00497975698007337,-0.0202744409026555,-0.000753793540767914,0.0347590015006098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0206870648810384,0.00982580385322921,-0.0399456404333676,-0.00142848932870912,0.0352807206884945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,40182,-0.00825806906886006,0.00393131824772462,-0.0159634528344003,-0.000552685303319808,0.0357001197787256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.00553513850794165,0.00263531604539349,0.000369919058970403,0.0107003579569129,0.0357149550086998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,42794,0.0145081419541033,0.00691106053616959,0.000962463303210894,0.0280538206049957,0.0358120012704925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.0159831251808994,0.00762759553529736,-0.0309332124300822,-0.00103303793171659,0.0361510645902323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0199913524323481,0.00954090608641428,-0.0386915283617201,-0.00129117650297617,0.0361645652849469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42734,-0.00693924434673981,0.00331722208301966,-0.0134409996294583,-0.000437489064021277,0.0364674590365709
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00991956458511544,0.00474566708384995,-0.0192210720694613,-0.000618057100769539,0.0366153276997575
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0106311275204297,0.00508859845117577,-0.0206047804847342,-0.000657474556125168,0.0367120962820138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42721,0.014672748193996,0.00702578568393955,0.000902208253474524,0.0284432881345176,0.0367791701551103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00921139820302303,0.00441070739566646,-0.0178563846985293,-0.000566411707516767,0.0367825481281761
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.00966769173825711,0.00463382588832722,0.00058539299713576,0.0187499904793785,0.0369718469597468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0173354968639119,0.00831044131095387,-0.0336239618333815,-0.00104703189444232,0.0370023340195783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.0131393716808877,0.00634670833621605,-0.0255789200198712,-0.00069982334190424,0.0384469176742049
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,40451,-0.00716109325792211,0.00346257756105177,-0.0139477452775836,-0.000374441238260649,0.0386496986753952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0120515499665725,0.00583250222278913,-0.0234832543232392,-0.000619845609905807,0.0388260990705998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.00946905313326608,0.0045889365297156,-0.0184633687315087,-0.000474737535023511,0.039089220788564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0122723448196705,0.00596121290846902,0.000588367519071251,0.0239563221202698,0.0395466728234321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,42636,0.00540857511862136,0.00262741837812559,0.000258835097495203,0.0105583151397475,0.0395601351864328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.0117212450977627,0.00571634121543775,-0.0229252738800207,-0.000517216315504696,0.0403414769085733
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42679,-0.0121865390662224,0.00595246177951799,-0.0238533641540777,-0.00051971397836713,0.0406469172888669
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,42562,-0.00704056972705121,0.00344818435724039,-0.0137990110672424,-0.000282128386860051,0.0411890357238084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42594,-0.00994687597310491,0.00487434291797496,-0.0195005880923358,-0.000393163853873987,0.0413042044182184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.00854193958661331,0.00419248442061132,0.000324670122215121,0.0167592090510115,0.0416295614175186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0151208170223681,0.00744305752675486,-0.0297092097748076,-0.000532424269928574,0.0422248809561426
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0155554462148421,0.00767861380585902,-0.0306055292743257,-0.000505363155358386,0.0428039594821315
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00551754395537365,0.00272665611859084,-0.0108617899478117,-0.000173297962935599,0.0430398779187245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0270615247769628,0.0133740363652465,-0.0532746360528459,-0.000848413501079757,0.0430478972038095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,40451,-0.00887630337107634,0.00440239286950326,-0.0175049933953027,-0.000247613346849957,0.0437980512897333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42587,-0.00641228777881854,0.00318763772599789,-0.0126600577217744,-0.000164517835862683,0.0442809289191396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,40451,-0.00846882971790153,0.00421000885273365,-0.0167204470692595,-0.000217212366543571,0.0442865089956413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0128051071120358,0.00640861006080476,-0.0253659828312131,-0.000244231392858441,0.0457287663145276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00787293046953825,0.00394963893321184,0.000131638160443043,0.0156142227786335,0.0462494423211566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,42134,-0.0116400120757204,0.00584864140961441,-0.0231033492385647,-0.000176674912876183,0.0465890481263165
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,40116,-0.00910602792731694,0.00457641198801558,-0.0180757954238275,-0.000136260430806397,0.0466406736562904
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.00774525016829043,0.00389718788182734,-0.015383738416672,-0.000106761919908841,0.0469028768483619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0192887507294197,0.00970587255435302,-0.0383122609359516,-0.000265240522887782,0.0469110134322169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0158973943310745,0.00805228532842806,-0.0316798735747935,-0.000114915087355526,0.0483758881262166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0107199408365335,0.00543482803122654,-0.0213722037777375,-6.76778953295036e-05,0.0485788731951176
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,42587,-0.0145976685084415,0.00740303641324037,-0.0291076198783926,-8.77171384903227e-05,0.0486474149773143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.00853823933479171,0.00433096614306697,-0.017026932975203,-4.9545694380447e-05,0.0486983636125005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00758622385393283,0.00384964522324205,-0.0151315284914873,-4.09192163784078e-05,0.048791502008322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.00742743376594136,0.0037717275812923,3.48477066084586e-05,0.0148200198252743,0.0489508682470129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.00726666740508233,0.00369073196801101,-0.0145005020623839,-3.28327477807505e-05,0.0489898557558364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.0125655861627061,0.0063864988932111,4.80483320123397e-05,0.0250831239933999,0.0491482478154794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0229678402637522,0.0116781353549418,-0.0458569855594381,-7.86949680663222e-05,0.0492385802831304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00715916757375233,0.00365820087773731,-1.09061466127989e-05,0.0143292412941175,0.0503659643873303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42590,-0.00569842209253231,0.00291694556107721,-0.0114156353922436,1.87912071790098e-05,0.0507743064750297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,40199,0.00632965444545338,0.00324935737607964,-3.90860116627105e-05,0.0126983949025695,0.0514438039697348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,42357,0.00990894486324672,0.00509358865727478,-7.4488905011846e-05,0.0198923786315053,0.051751008411885
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0134418165235123,0.00691551397140154,-0.0269962239074593,0.000112590860434709,0.0519507236781069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00512899859346499,0.00264157971041355,-0.0103064948258755,4.84976389455577e-05,0.0522055386546432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.00608524157792677,0.00314932194320138,-0.0122579125866015,8.7429430747933e-05,0.0533558859133952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.00662569297036656,0.00343145586024145,-0.0133513464564398,9.99605157066845e-05,0.0535200316547371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.00684868676724814,0.00356611608288874,-0.0138382742897101,0.000140900755213794,0.0548222537835832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,40532,-0.00443026778326774,0.00230955821790817,-0.00895700189036776,9.64663238322821e-05,0.0551067255336812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,40116,-0.0157073724985425,0.00819355823787678,-0.031766746644781,0.000352001647695992,0.0552590095675967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,40451,-0.00724792432865502,0.00378211735178197,-0.0146608743381477,0.000165025680837642,0.0553437114417825
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00740319515403238,0.00386961106865906,-0.0149876328486041,0.00018124254053938,0.0557532018049648
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,40532,0.00464116960451389,0.00242804303534283,-0.000117794744758051,0.00940013395378583,0.0559673733225668
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42638,0.00628533649805138,0.00329300241530827,-0.000168948235952829,0.0127396212320556,0.0563227501154187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00470584709152217,0.00246708545622616,-0.000129640402681094,0.00954133458572544,0.0564873333177325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42711,0.00429284186580923,0.00225127405148572,-0.000119655275102782,0.00870533900672124,0.0565611971782001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,40199,-0.00756652457070829,0.00396937294554733,-0.0153464955439811,0.000213446402564483,0.0566468263617781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,40283,-0.00744393723848143,0.00391426988523795,-0.0151159062135478,0.000228031736584954,0.0572305885118428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00689027046216022,0.00363208499934513,-0.0140091570608767,0.000228616136556233,0.0578419342187366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.0131067653245998,0.00692242589963389,-0.0266747200878822,0.000461189438682636,0.0583340939238953
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0064981337699244,0.00343322991558053,-0.0132272644044622,0.000230996864613441,0.0584171609582152
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.0129618264725248,0.00686752412521694,-0.02642217375795,0.000498520812900397,0.0591316335782283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00285915690465235,0.0015154344337471,-0.000111094585491964,0.00582940839479667,0.0592273761891979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.0130122108021676,0.00690684695711053,-0.0265496308381042,0.000525209233769076,0.0595970123380196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0104015613332195,0.00553162193448432,-0.0212435403248088,0.000440417658369767,0.0600775988204781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,42346,-0.0119177325238741,0.00635323353767908,-0.0243700702577251,0.00053460520997692,0.0606975925573067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.00738098659358902,0.00394231525017007,-0.0151079244839224,0.000345951296744309,0.0611988161060551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00870673671350745,0.00465832692788014,-0.0178370574921525,0.000423584065137615,0.0616354150920428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.00659928685926065,0.00353569761153107,-0.0135292541778615,0.000330680459340253,0.0620014841244174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00458983826570075,0.00246157969428174,-0.000234857935091455,0.00941453446649296,0.0622605943004795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,40451,-0.00475304772281028,0.00255528874676163,-0.00976141366646307,0.000255318220842513,0.0628999257526266
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,40235,-0.00747442113686039,0.00402295690832761,-0.0153594166771825,0.000410574403461725,0.0632038323030745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.00973848859644565,0.00525893890167384,-0.0200460088437264,0.000569031650835085,0.0640814602765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0117064431968572,0.00632177433558837,-0.0240971208946104,0.000684234500896009,0.0640858698611162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.00146156153883358,0.000789752714581159,-8.63537817454914e-05,0.00300947685941265,0.0642453590160173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0145327757324093,0.00785433688106624,-0.0299272760192991,0.000861724554480534,0.0642984163648437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.00765462946510334,0.00413728466168697,-0.0157637074020098,0.000454448471803115,0.0643133161859244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.00811933407639119,0.00439501170217808,-0.0167335570126602,0.00049488885987784,0.0647161093094653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.00392668154589026,0.00212901145702531,-0.00809954400165987,0.000246180909879342,0.0651563224099175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,42311,-0.00811768602021056,0.00440927235119539,-0.0167598598285535,0.000524487788132397,0.0656369619129353
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0130416994263068,0.0070887874941963,-0.0269357229149315,0.000852324062317989,0.065825344927731
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,42434,-0.013279702496802,0.00722799946217697,-0.0274465814426688,0.000887176449064879,0.0661941608377427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0071001338127496,0.00386489540234334,-0.000475061175843345,0.0146753288013425,0.0662201455528191
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.00925172963828118,0.00503772103150872,-0.0191256628600383,0.000622203583475913,0.0663069612298599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00769029964567468,0.00418874942787863,-0.0159002485243168,0.000519649232967436,0.0663932461227628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,42370,-0.00550698797625162,0.00300080178301519,-0.0113885594709614,0.000374583518458146,0.0665027086585017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,42553,-0.0105263465122307,0.0057415420245527,-0.021779768880354,0.000727075855892562,0.0667704347127676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,40136,0.00905598544811587,0.00494575625092678,-0.000637696803700618,0.0187496676999324,0.0671184938075445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,40421,0.0126965504624401,0.00695295648171611,-0.000931244241723478,0.0263243451666037,0.0678670177229865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0112154939068975,0.00614423256355213,-0.000827201917664642,0.0232581897314597,0.0679724402349993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00588856569963582,0.00323073559755318,-0.0122208074708401,0.000443676071568402,0.0683806742129686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00767121737591019,0.00420896505631333,-0.000578354134463934,0.0159207888862843,0.0683926423925088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.00866699191580108,0.00478436622518284,-0.0180443497171594,0.000710365885557283,0.0700826533770147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00367860213450372,0.00203183447143851,-0.000303793429515768,0.0076609976985232,0.0702480919130261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,42437,0.00595250919916986,0.0032932899474532,-0.000502339097838401,0.0124073574961781,0.0707123524778544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.00722578384254843,0.00399862042579825,-0.015063079877113,0.000611512192016149,0.0707782315201073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00906332520365137,0.00501993298489889,-0.0189023938540532,0.000775743446750455,0.0710289359689838
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.00743814365500963,0.00412076976662843,-0.0155148523976014,0.000638565087582098,0.0710917478004228
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.0107040615924776,0.00593809250530307,-0.0223427229028717,0.00093459971791638,0.0714722009274193
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,40136,0.00733487088161069,0.00407111224384175,-0.000644509116319146,0.0153142508795405,0.071622146183864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,42663,-0.003970859851285,0.00220420616979257,-0.00829110394407844,0.000349384241508439,0.0716477169666666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0160648780218775,0.00893096592926278,-0.0335695712432326,0.00143981519947755,0.0720753716281796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0147399297797341,0.00820540427054397,-0.0308225221500002,0.00134266259053212,0.0724632855098773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.00892136888427793,0.00498423262244438,-0.0186904648242689,0.000847727055713053,0.0734948399635981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00582320367527208,0.00325429409921331,-0.0122016201097302,0.000555212759186001,0.0735796099558884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,42357,-0.00820747737086608,0.00459428309645696,-0.0172122722399217,0.000797317498189551,0.0740487177260663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.00448224602809199,0.0025180402558573,-0.00941760492957229,0.000453112873388319,0.0750939855505422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.00447782450128658,0.00252220679586761,-0.00942134982118711,0.000465700818613945,0.0758611222592804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.0092708628484301,0.00524973509574479,-0.0195603436360899,0.00101861793922969,0.0774282849701402
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0212826129284083,0.0120519527908579,-0.0449044403984899,0.00233921454167322,0.077439592874019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0183832070069087,0.0104397232673667,-0.0388450646109475,0.00207865059712997,0.0782797699447228
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0212951123165937,0.0121038742031624,-0.045018705754792,0.00242848112160446,0.0785429048529663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00365888246835942,0.00208290309227529,-0.000423607592500152,0.007741372529219,0.0790044158817911
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42594,-0.0100090125667945,0.00571109520493433,-0.0212027591684658,0.0011847340348768,0.0797011662743705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,40199,-0.00633599663699511,0.00362120178342011,-0.0134335521324985,0.000761558858508301,0.0801989240204936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00460894873039437,0.00263576564320985,-0.00977504939108568,0.000557151930296932,0.080384154415642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0245537578985267,0.0140504241245174,-0.00298507338552728,0.0520925891825808,0.0805698000289885
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.00367108013216753,0.00211418090719707,-0.00781487471027378,0.00047271444593872,0.0825145990881292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,40384,-0.0074586058345883,0.00429564499174673,-0.0158780700184119,0.000960858349235292,0.0825351400554901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,42311,-0.0101768974759492,0.00586387552731536,-0.0216700935094873,0.00131629855758888,0.0826714958917916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.0105050267456584,0.00605323184669234,-0.0223693611651754,0.00135930767385854,0.0826900885751494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0248810911870009,0.0143727381704277,-0.0530516580010393,0.00328947562703747,0.0834519346873613
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,42370,-0.0096707548014558,0.00560658254238719,-0.0206596565845347,0.00131814698162308,0.0845702137460988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0161354291475633,0.00938507986482622,-0.0345301856826227,0.0022593273874961,0.0855937400248893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,42587,0.0025249966413397,0.00147035269381751,-0.000356894638542617,0.00540688792122202,0.0859524635638322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0196262837540937,0.0114393702831938,-0.0420474495091536,0.00279488200096619,0.0862439843192421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.014192498446251,0.00830445431487134,-0.00208423201089681,0.0304692289033988,0.0874699974846531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00607715950074291,0.00355723778979175,-0.0130493455687347,0.000895026567248916,0.0875919862741677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.00781460058596933,0.00457427892648747,-0.0167801872818848,0.00115098610994612,0.0875935935217713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.0062416287842079,0.00365460415543033,-0.0134046529288514,0.000921395360435552,0.0876864257257579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00558838944308377,0.00328177649213381,-0.012020671367666,0.000843892481498507,0.0886236634511535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00521458524020419,0.00306373971598247,-0.0112195150835298,0.000790344603121451,0.0887774785067193
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0194055713838505,0.0114273489257108,-0.0418031752782436,0.00299203251054271,0.0894990292981718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00507368168244281,0.00299425881598947,-0.0109424289617822,0.000795065596896556,0.0902043049257515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.00419633903595683,0.00248020801948037,-0.000664868682224685,0.00905754675413835,0.0906824774170621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00896264869522199,0.00531953138538009,-0.00146363282012298,0.019388930210567,0.0920439199117077
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00618465820318287,0.00367075453738426,-0.013379337096456,0.00101002069009027,0.0920466940222102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.0041682050968157,0.00248062863503569,-0.00903023722148566,0.000693827027854263,0.0929269040494476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42679,0.00453955101473575,0.00270555776465224,-0.000763342203982634,0.00984244423345414,0.0933973272121169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,40532,-0.00361592189251221,0.00215751552274322,-0.00784465231708893,0.000612808532064506,0.0937724940752684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.012481145621766,0.00746670592394064,-0.0271158892326896,0.00215359798915769,0.0946369848133004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,40302,-0.00719617951061681,0.00431127058280959,-0.0156462698529236,0.00125391083168998,0.0951148151087092
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.00466101650741631,0.00279695324399227,-0.0101430448656412,0.000821011850808549,0.0956447143514925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.0126030940672228,0.00757064071587843,-0.0274415498703445,0.00223536173589894,0.0959947028170745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.015211146122508,0.00913987413208305,-0.0331252994213908,0.00270300717637477,0.0960884699724665
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.00885213846553993,0.00533234347676237,-0.0193035316799942,0.00159925474891431,0.0969260753495843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.023839179886472,0.0143688292447846,-0.00432372543330579,0.0520020852062499,0.097125534670155
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00333280433747565,0.00200893355766424,-0.000604705435546253,0.00727031411049756,0.0971461530250249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.0110102246748723,0.00664530434367969,-0.00201457183873985,0.0240350211884845,0.0975790743460764
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,40116,-0.00955078589286085,0.00579512940102524,-0.0209092395188703,0.00180766773314862,0.0993668238566404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.00470905307738985,0.00286363741284016,-0.0103217824065566,0.000903676251776861,0.100110978294504
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00455092385409841,0.00277019446250899,-0.00998050500061604,0.000878657292419215,0.100449273806178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00449876062094573,0.00275707715494558,-0.00990263184463906,0.000905110602747607,0.102767580436081
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42591,-0.00389783026617503,0.00239434557242385,-0.00859074758812577,0.000795087055775711,0.103562953840825
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0133589687761707,0.00822146357349549,-0.0294730373802219,0.00275509982788047,0.104209577965865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,40080,-0.00963910927836324,0.00593217341406588,-0.0212661691699324,0.00198795061320589,0.104215666436213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,40182,-0.00958239482846856,0.00590090029790389,-0.0211481594123602,0.00198336975542308,0.104428627846835
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.0100067880838737,0.00616474858042059,-0.022089695301498,0.00207611913375068,0.104568828330411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.00921042951741443,0.00567750236836184,-0.0203383341594036,0.00191747512457478,0.104769506364797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.00623430668483917,0.00385890018496217,-0.00132913767768669,0.013797751047365,0.106211762268127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0111469131512128,0.00690305831852511,-0.024676907455522,0.00238308115309644,0.10638198091683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0141523713635831,0.00876439861460615,-0.0313305926482111,0.00302584992104497,0.106391419901065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0414513289426283,0.0257366173461779,-0.0918950989411371,0.00899244105588044,0.107295543459854
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42721,-0.00985612510263823,0.00612156766369439,-0.0218543977234792,0.00214214751820278,0.107406884039663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0144172362180244,0.00895499148678169,-0.0319690195321165,0.00313454709606771,0.107428681088244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,40302,0.0269343438096774,0.0167309845782675,-0.00585838596372686,0.0597270735830816,0.107459435893866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.00406625273977915,0.00253027523870017,-0.00902559220763148,0.000893086728073176,0.108074663467323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0134155624635663,0.00834982396230788,-0.0297812174296897,0.00295009250255718,0.108146382904615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,40116,0.00620999001096716,0.00388130428367666,-0.00139736638503909,0.0138173464069734,0.10963304191886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0131305576919002,0.00821800577933175,-0.0292378490193905,0.00297673363559001,0.110121027651115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,40539,-0.00342799940121626,0.00214887401744593,-0.00763979247541029,0.000783793672977764,0.110683350881771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42538,-0.00898323862309083,0.00563599550110076,-0.0200297898052483,0.00206331255906665,0.11098110889752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.00329314222530774,0.00206651393676831,-0.00734350954137363,0.000757225090758154,0.111055041690066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,40451,-0.00589298561860572,0.00369886937904447,-0.0131427696015329,0.00135679836432144,0.111146625204831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00526105246356628,0.00331306114805635,-0.0117546523137567,0.00123254738662416,0.112320396811623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.00627539543297102,0.00395529230809601,-0.0140277683568392,0.00147697749089715,0.112635394911513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42654,-0.0126091165182829,0.00796796909581102,-0.0282263359460725,0.00300810290950666,0.113564537605798
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.00954199720522284,0.00604050936514126,-0.0213813955608997,0.00229740115045402,0.114211392849396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.00746208359482688,0.00472443031384148,-0.0167219670099562,0.00179779982030242,0.114252421209446
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,40527,-0.00660173005716915,0.00418234398885223,-0.0147991242753195,0.00159566416098122,0.114484182278338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00683917255118984,0.00433982433337782,-0.0153452282446104,0.00166688314223069,0.115070598513932
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.00514824540909903,0.00327035921235417,-0.00126165864711515,0.0115581494653132,0.115461507286743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.0041980221102174,0.00266835497297508,-0.00942799785724855,0.00103195363681375,0.115681552392977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0106363292009256,0.00676538532553445,-0.00262382603712188,0.0238964844389732,0.115939839675356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),40324,0.0276269621747068,0.0175730436333169,-0.00681620334659436,0.062070127696008,0.115950768522156
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0130872008577726,0.00833243468359079,-0.0294187728376105,0.00324437112206537,0.116295969611535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00457484564144218,0.00291475006739703,-0.0102877557735403,0.00113806449065599,0.116548658814418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42611,-0.0180624819526419,0.0115357044076664,-0.040672462591668,0.00454749868638414,0.117421547122672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0131103392840307,0.00837793872866592,-0.0295310991922159,0.00331042062415446,0.117643740338675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,40482,-0.0241209692684606,0.015468817591023,-0.0544398517468657,0.00619791320994454,0.118946666131204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0107264336401005,0.00696904054817232,-0.0243857531145182,0.00293288583431724,0.123790133031651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0044120444049741,0.00286732946067103,-0.0100320101478893,0.00120792133794113,0.123893756528166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,42611,0.00497910583029144,0.00323937704856881,-0.00137007318490342,0.0113282848454863,0.124303033507267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,40482,-0.0032948825706818,0.00214895164149309,-0.00750682778800827,0.000917062646644656,0.125242011138458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,40182,-0.00617641630888273,0.00405418966966339,-0.014122628061423,0.00176979544365751,0.127671173749832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0103956027647946,0.00684784833755942,-0.023817385506411,0.00302617997682191,0.129021912219241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,40516,0.00324258992143006,0.00213828708179443,-0.000948452758887026,0.00743363260174714,0.129435356779151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,42322,0.0125071950284537,0.00826230579728582,-0.0036869243342265,0.0287013143911339,0.130109351003188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.00580348991577667,0.00383679178258397,-0.0017166219780879,0.0133236018096412,0.130407541500141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00597696707985127,0.00395838755814972,-0.00178147253412218,0.0137354066938247,0.131079428370314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0161333379606711,0.0107036896331202,-0.0371125696415868,0.00484589372024448,0.131770245120903
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00549877380340693,0.00364885095241502,-0.0126505216701404,0.0016529740633265,0.131842710317358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00722641583342332,0.00480820364163669,-0.0166504949710312,0.0021976633041846,0.132884961409053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.0058450108468527,0.00389119799982899,-0.0134717589265175,0.00178173723281212,0.133092547855959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.0108841707735679,0.00725134184824607,-0.0250968007961302,0.00332845924899442,0.133387745011691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,42247,0.00963782378679075,0.00642201783516645,-0.0029493311701355,0.022224978743717,0.133445207415546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42679,0.00536828968344199,0.00358445221296613,-0.00165723665397162,0.0123938160208556,0.134245088931716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0112255805350503,0.00750149578868618,-0.0259285122808752,0.00347735121077463,0.134561119749772
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0171471999983053,0.0114607019718286,-0.0396101758630893,0.00531577586647876,0.134631967035049
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0124342426472365,0.00831798383462086,-0.0287374909630934,0.00386900566862035,0.134973718675108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.00620099680707857,0.00416016319084876,-0.0143549166611421,0.001952923046985,0.136099520949519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,40451,-0.0111547959481631,0.00750204071449237,-0.0258587957485681,0.00354920385224197,0.137068822676646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00562230042863108,0.00378713603857094,-0.00180048620696795,0.0130450870642301,0.137684394632965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,40182,0.00565008850223771,0.0038146523111934,-0.00182663002770136,0.0131268070321768,0.138594146541831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.00676941729346557,0.00457461997538366,-0.0157356724452175,0.0021968378582864,0.138961565478469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.00980677205436594,0.00666492661710979,-0.0228700282239011,0.00325648411516926,0.141211023000196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.00525674552920643,0.00357603321921444,-0.00175227958045388,0.0122657706388667,0.141591318239855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0162677380391788,0.0110949767207007,-0.0380138924117522,0.0054784163333946,0.142610249726233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,42474,-0.00405484667817862,0.00276749412565471,-0.00947913516446184,0.00136944180810461,0.14289848114306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0147993318928161,0.0101457012398388,-0.0346849063229002,0.00508624253726792,0.14468101325076
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,40539,0.00211561366745061,0.00145244359938216,-0.00073117578733842,0.00496240312223964,0.145257483718541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,42611,-0.00748864265149062,0.00515410434141943,-0.0175906871606727,0.00261340185769147,0.146261737380899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.0047755556074597,0.00330682249034961,-0.0112569276885449,0.00170581647362553,0.14872489240463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42505,0.0180309773562504,0.0124898688725622,-0.0064491656339716,0.0425111203464724,0.148861478734394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.00889748581294542,0.00617357734643908,-0.020997697411966,0.00320272578607517,0.149550869887296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.00611425856266037,0.00424376682506475,-0.00220352441446653,0.0144320415397873,0.149675499700163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.00389683878142488,0.00270644419527737,-0.00140779184131876,0.00920146940416851,0.14993670359269
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.0121074506943032,0.00840954808120311,-0.0285901649334613,0.00437526354485494,0.149972923793842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.00904491777198299,0.00628623849351082,-0.0213659452192642,0.00327610967529821,0.150217954570122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.00621092912235909,0.00432172475601044,-0.00225965139942136,0.0146815096441395,0.150701050325964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.00550548107946524,0.00383331095150889,-0.00200780838549218,0.0130187705444227,0.150967873196083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.00302167654534651,0.00211076923872481,-0.00715878425324714,0.00111543116255412,0.152295171420199
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0122571769126411,0.00857245430904764,-0.0290591873583745,0.00454483353309226,0.152793381525318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.00550068384932195,0.00385571221177831,-0.0130578797844074,0.00205651208576354,0.153713543670094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0110445015349729,0.00774776081252856,-0.0262301127275288,0.00414110965758312,0.154033898183436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00271858485546509,0.00190873653059161,-0.00645970845542464,0.00102253874449446,0.154391485242402
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00414154520605927,0.00291127994103294,-0.0015645634783653,0.00984765389048383,0.154879406349978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00844508705518679,0.00593866546287196,-0.0200848713624158,0.00319469725204224,0.15503973742684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,42459,-0.00914699676958535,0.0064342220606149,-0.0217580720083906,0.00346407846921986,0.155161098049501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,40451,-0.0151338662679104,0.0106479692537389,-0.0360038860052386,0.00573615346941775,0.155259787129343
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00601320537043536,0.0042360766628775,-0.0143159156296753,0.00228950488880453,0.155770026765254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00521365717711919,0.00367917025006145,-0.0124248308672396,0.00199751651300125,0.156489857318501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.00514941396757998,0.00364482511961238,-0.0122932712020202,0.00199444326686028,0.157741700116658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00453063915213397,0.00321229941944174,-0.00176546770997184,0.0108267460142398,0.158444128301747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42572,-0.00603398476024941,0.00427891999884181,-0.0144206679579794,0.00235269843748053,0.158514110515801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,42370,-0.00637710347721935,0.00453310407321311,-0.015261987460717,0.00250778050627833,0.159514694106944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.0067487801157961,0.00480875226012074,-0.0161739345456327,0.00267637431404055,0.160515040497342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.00427380813952996,0.00305028305155969,-0.00170474664152704,0.010252362920587,0.161201623140871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,40080,0.0107486976529554,0.00767327150463743,-0.00429091449613398,0.0257883098020448,0.161303213861844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.00436720702430783,0.00311974617134427,-0.0104819095201426,0.00174749547152694,0.161578138160895
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00756032138046236,0.00541549445973684,-0.00305404776062184,0.0181746905215466,0.162721934386352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,40136,-0.00616357887340322,0.00442752524871131,-0.0148415283608774,0.00251437061407094,0.1639189762754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.00676664215737447,0.00486147147945279,-0.0162951262571019,0.00276184194235298,0.16397877323776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.00757864417303021,0.00545196689636991,-0.0182644992899152,0.00310721094385482,0.164529121886513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00539622282102891,0.00388273098080199,-0.0130063755434008,0.00221392990134298,0.164616842857535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00641535687069328,0.00461607806313811,-0.015462869874444,0.00263215613305742,0.16462254011609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0116592974482618,0.0083970789857061,-0.0281175722602457,0.00479897736372219,0.165014640217782
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00459922469746945,0.00332609381510354,-0.00191991918013347,0.0111183685750724,0.166757923476552
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,40116,0.0067340294834752,0.00487333337339019,-0.00281770392836958,0.01628576289532,0.167057761557971
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00493577814095421,0.00357475997058436,-0.00207075140139115,0.0119423076832996,0.167389789892823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.00587330664169021,0.00426270502661169,-0.00248159521046871,0.0142282084938491,0.168282074568098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00600542753754415,0.0043767770584245,-0.0145839105720562,0.00257305549696787,0.170056903009869
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.00963902176727878,0.00702827262256263,-0.0234144361075015,0.00413639257294398,0.170258675051461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0038507080234466,0.00280945131384209,-0.00935723259857711,0.0016558165516839,0.170514082230348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.00842702944362728,0.00614848283897221,-0.0204780558080128,0.00362399692075826,0.170530982074553
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.0111049733318174,0.00814495491419417,-0.027069084963638,0.00485913830000316,0.172778930703153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42794,0.0031441459217522,0.00231873923559746,-0.00140058298001882,0.00768887482352322,0.175130529485042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00534740264830664,0.0039584563087041,-0.0131059770133667,0.00241117171675339,0.176756857307214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.0041207782195715,0.00305276243885436,-0.010104192599726,0.00186263616058304,0.177091450748794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,40136,-0.00485397782976548,0.00360058071463813,-0.0119111160304562,0.00220316037092525,0.17765100461826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.00538022744346513,0.00399544638182467,-0.00245084746491122,0.0132113023518415,0.178135380171699
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42594,0.00714142852235426,0.00530537648124021,-0.00325710938087655,0.0175399664255851,0.178301473691221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.00844089410509343,0.00629291962119665,-0.0207750165626389,0.00389322835245201,0.179835101227184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,40182,-0.00888028374277103,0.00662285253225172,-0.0218610747059844,0.00410050722044234,0.179995310981554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00833023113559984,0.00622916835434774,-0.0205394011101214,0.00387893883892174,0.181154240005989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.0047706163072857,0.00356852088062674,-0.0117649172333141,0.00222368461874271,0.181295399116815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00576869552978515,0.00431979884435853,-0.00269811020515758,0.0142355012647279,0.181770090411912
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,40136,-0.0142435374768487,0.0106775729432495,-0.0351715804456177,0.00668450549192039,0.182242204121929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,42346,-0.00708395972326538,0.00532472695171879,-0.0175204245486342,0.00335250510210346,0.183413107578696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,42370,-0.00418077801773616,0.00314874608029935,-0.0103523203351229,0.00199076429965057,0.184280519950517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,40511,-0.0123197648030596,0.0093263587934955,-0.0305994280383108,0.00595989843219158,0.186540770953044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0117871723764022,0.00892913997739927,-0.0292882867321048,0.00571394197930035,0.186831006089136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.00902054559585328,0.00686333328291468,-0.0224726788303661,0.0044315876386595,0.188764878843409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42794,0.00381276848849773,0.00290296968823904,-0.00187705210045078,0.00950258907744624,0.189069415095646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00446695145628114,0.00341028132728208,-0.011151102857754,0.00221719994519173,0.190270012545221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42794,0.00393391206981998,0.00300573570707176,-0.00195732991604067,0.00982515405568063,0.190623638370436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.0042392699064875,0.00324163171883737,-0.0105928680754087,0.00211432826243374,0.190982652259132
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00566750252698234,0.00433810858298059,-0.0141701953496243,0.00283519029565961,0.191428604067315
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_A,,40482,-0.00419132620144481,0.0032088525211434,-0.0104806771428859,0.00209802473999625,0.191519321922057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.00251523163418674,0.00192661037651417,-0.00629138797215452,0.00126092470378104,0.191737692033876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.00989770377036731,0.00758676268267279,-0.024767758628406,0.00497235108767137,0.192055570950637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00522840135624134,0.00401711210750025,-0.0131019410869418,0.00264513837445915,0.193098804070189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,42794,-0.00664423853142298,0.00510703438831613,-0.0166540259325226,0.00336554886967663,0.19328138129864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.0106956956898814,0.00823690235862785,-0.026840024312792,0.00544863293302917,0.1941351535441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00638388310024078,0.00492222794168171,-0.00326368366545536,0.0160314498659369,0.194675818096563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.00654059129652566,0.00505030397684691,-0.0164391870911456,0.00335800449809428,0.195316864157166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.00321261233913671,0.00248068481973878,-0.00807475458582472,0.0016495299075513,0.195329886582771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,42681,-0.00862254211197935,0.00665896039362618,-0.0216741044834867,0.00442902025952795,0.19538444399757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,42332,-0.00628416507859206,0.00486855163600715,-0.0158265262851661,0.00325819612798196,0.196807247839639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00532129834107997,0.00414160861400306,-0.013438851224526,0.00279625454236603,0.198875696675539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.00781929990635627,0.00608825749843854,-0.0197522846032958,0.00411368479058327,0.199054596744542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.00397674852250321,0.00310447185299869,-0.0100615133543807,0.00210801630937423,0.200229701909098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41779,0.00616969833530595,0.00481894215509057,-0.00327542828867156,0.0156148249592835,0.200462756299481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39926,0.0086359559492427,0.00675080158669051,-0.00459561516067071,0.0218675270591561,0.200837055084493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0112828887994522,0.00885160539628981,-0.00606625777727586,0.0286320353761802,0.202451789347341
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.00453906680916551,0.00356753971066128,-0.0115314446420616,0.0024533110237306,0.203284087434157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.00887207030831669,0.00698201884296923,-0.0225568272405364,0.00481268662390299,0.203856684911832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0121468057501801,0.00956018977061238,-0.0308847777005804,0.00659116620022017,0.203910999454774
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.00271087040899759,0.00213529119081417,-0.00147430032499818,0.00689604114299337,0.204269695964303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.010252573945808,0.0080989585229999,-0.0261265326508878,0.00562138475927179,0.205566380891707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.00345677712617056,0.00273379080010681,-0.00881500709437992,0.00190145284203879,0.206090637713371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00594343900320675,0.0047029912639165,-0.0151613018804831,0.00327442387406959,0.206344164821724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,40434,0.00728999722692043,0.0057743225595091,-0.0040276749897174,0.0186076694435583,0.206800412451036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,-0.00683057716118775,0.00541744971350992,-0.0174487785996672,0.0037876242772917,0.207386305649275
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0131019414213604,0.0104096170801255,-0.0335047908984065,0.00730090805568558,0.208187793344309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.00474875658020419,0.00377756667060586,-0.0121527872545917,0.00265527409418329,0.208745591513255
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0207527920609001,0.0165509113616733,-0.0116869942079795,0.0531925783297797,0.20990919942572
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,42346,-0.0127379226310395,0.0101738746825412,-0.0326787170088203,0.00720287174674128,0.210583836612711
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,40267,0.00363989930476722,0.00292729175007494,-0.00209759252537966,0.0093773911349141,0.213733616811781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,42594,-0.0075444362622684,0.00607510228118566,-0.0194516367333923,0.0043627642088555,0.214309363992745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.00406941393208575,0.00328206970048072,-0.010502270545028,0.00236344268085646,0.21503685306551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.00414989846502737,0.0033476639500156,-0.0107113198070579,0.00241152287700321,0.215135265062081
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00311285595381187,0.00251856180531521,-0.00804923709222969,0.00182352518460594,0.216493033513265
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00764453689328796,0.00619518013036406,-0.0197870899488015,0.0044980161622256,0.217248513825867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00333344686710046,0.00270192320502301,-0.00862921634894555,0.00196232261474463,0.217325201824824
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42651,-0.00417234005454614,0.00338396528839702,-0.0108049120198043,0.00246023191071202,0.217607130801225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.00823439141301912,0.00668854197974304,-0.00487515086727724,0.0213439336933155,0.218304595680757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00959396768018577,0.00780480434764506,-0.0248913842015701,0.00570344884119854,0.219008354638658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00370606663909221,0.00302855631426311,-0.00222990373686348,0.0096420370150479,0.221088183802831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.00731693930133692,0.00600789019459931,-0.0190924040827516,0.00445852548007772,0.223292525991157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,40223,-0.00862524551933085,0.0070988521485258,-0.0225389957304414,0.00528850469177972,0.224384571510151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00492828316654929,0.00405643529698271,-0.00302233001553682,0.0128788963486354,0.224419172698728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0113764498167509,0.00936488705996323,-0.0297316284542788,0.00697872882077704,0.224468476017027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,-0.007010132327043,0.00578410933154413,-0.0183469866168695,0.00432672196278351,0.22554791269229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00353948431256,0.00292043990619041,-0.00218457790357319,0.0092635465286932,0.225550197082244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,40136,-0.0056301963646451,0.00465740801719616,-0.0147587160783496,0.00349832334905936,0.226739283102852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.00415420012842641,0.0034503578459771,-0.0109169015065415,0.0026085012496887,0.228614286725396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.00366517741472194,0.00304919942541613,-0.00231125345909368,0.00964160828853755,0.229379412086937
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,40482,-0.00422622785531758,0.00351882791452373,-0.0111231305677841,0.00267067485714893,0.229763666301482
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00326815320135632,0.00272195363786749,-0.00206687592886395,0.00860318233157659,0.229907347525284
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,40199,0.00488308545650937,0.00408633140314713,-0.003126124093659,0.0128922950066777,0.232120485284273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,40036,-0.00404082531688554,0.00338377465152177,-0.0106730236338682,0.00259137300009712,0.232434926563094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,40116,-0.00388187452212999,0.00325988077753767,-0.0102712408461038,0.00250749180184384,0.233756965013544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00294969418957815,0.00248086834128974,-0.00781219613850604,0.00191280775934975,0.234473993653399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,40199,-0.00304507742520687,0.00257196727279555,-0.00808613327988615,0.00199597842947241,0.236458924076956
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,40482,-0.00779261070806281,0.00658963531335421,-0.0207082959222371,0.00512307450611145,0.237010191627113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.00362149525112575,0.00306284191060138,-0.00962466539590446,0.00238167489365296,0.237069567279413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00735031418780163,0.00622739605656641,-0.00485538208306853,0.0195560104586718,0.237899002882137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00489591420355091,0.00415103526142666,-0.00324011490884534,0.0130319433159472,0.238246904526327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,40116,0.00559359346337241,0.00474871806786209,-0.00371389394963729,0.0149010808763821,0.238855552788545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00674315048009884,0.00572995256526209,-0.00448755654781486,0.0179738575080125,0.239291027296706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,42332,-0.00844495875399691,0.0071859298966583,-0.0225293813514472,0.00563946384345335,0.239933005549537
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.0087369572368656,0.00744022536308939,-0.0233197989485208,0.0058458844747896,0.240301551758708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.00418670702952659,0.00356545221111686,-0.00280157930426247,0.0111749933633156,0.240318960186628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.00840155441018751,0.00719667374124321,-0.0225070349430242,0.00570392612264919,0.243065476954515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00384998374350212,0.00330089385486084,-0.0103197356990294,0.00261976821202514,0.243499364341039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,40080,0.00461393905134874,0.0039625675813057,-0.00315269340801043,0.0123805715107079,0.244295094495166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42587,-0.00317745298363721,0.00273626690361907,-0.00854053611473059,0.00218563014745618,0.245566433643727
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.00389797577284479,0.00335691550262543,-0.0104775301579906,0.00268157861230104,0.245594976014293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,40080,-0.00503365200466882,0.0043412067519919,-0.0135424172385729,0.00347511322923531,0.246275730706598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00352458637067301,0.00305557839581582,-0.002464347285126,0.00951352002647201,0.248729291062249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,-0.0122933587128476,0.0106597130388863,-0.0331863962690646,0.00859967884336952,0.248831304747842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00373896403322421,0.00326528725062274,-0.00266099897799637,0.0101389270444448,0.252202962123639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00374409580472973,0.00327045907903512,-0.0101541955996386,0.0026660039901791,0.252306879315487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00780769204958264,0.00682949423982318,-0.00557811666047079,0.0211935007596361,0.252967179303019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00457999308765378,0.00404872458727853,-0.0125154932787197,0.00335550710341214,0.257983628997501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.00718721868601294,0.00636689437609351,-0.0196663316631562,0.00529189429113034,0.258984983745264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,40449,0.0123752345429811,0.0109866859476191,-0.00915866991435245,0.0339091390003146,0.26002675148137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.00661961036427247,0.00590120138449225,-0.0181859650778773,0.00494674434933235,0.261997714687237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.00545141202665402,0.0048610165794921,-0.0040761804691505,0.0149790045224585,0.262118451877859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00242664573608413,0.00217277356913972,-0.00668528193159797,0.00183199045942972,0.264085453531612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00354797605688717,0.00318293336743848,-0.00269057334329225,0.0097865254570666,0.265004285965039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42711,-0.00317244793921802,0.00284683954688222,-0.00875225345110718,0.00240735757267114,0.265137988916582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,40080,-0.00805368113662767,0.0072290193742462,-0.0222225591101502,0.00611519683689488,0.265270934147946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,40302,-0.00441799256292766,0.00396765894900326,-0.012194604102974,0.00335861897711872,0.265517374822649
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00919739075222855,0.00828315001106338,-0.0254323647739128,0.00703758326945569,0.26686248745749
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00375190587923423,0.00339028376303214,-0.0103968620547772,0.00289305029630876,0.26845933595747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00568124887836101,0.00513460504272883,-0.0157450747621095,0.0043825770053875,0.268550756792508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00293237852121846,0.00265416377734879,-0.00226978248238518,0.00813453952482209,0.269256439724614
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00444119623308431,0.00403352083290476,-0.0123468970655776,0.00346450459940902,0.270889733939924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,42357,0.00759649293028824,0.0069070064182965,-0.00594123964957291,0.0211342255101494,0.271428832128601
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,40116,0.00461646825563711,0.00420065896767255,-0.00361682332100109,0.0128497598322753,0.271798099818197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.00347976136176566,0.00317768737563031,-0.00970802861800107,0.00274850589446976,0.27350995084437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0103406031977552,0.00947029790951808,-0.0289023871004106,0.00822118070490025,0.274897389282832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,42311,-0.00758553447672169,0.00694970677380315,-0.0212069597533759,0.00603589079993248,0.275077439040021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.00300694143963128,0.00278338429826393,-0.00846237466422859,0.00244849178496603,0.280019774284021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.00916209414747156,0.00850643936482528,-0.007510527007586,0.0258347153025291,0.281464963075881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.00797419946100801,0.00741381057520029,-0.0225052681884006,0.00655686926638455,0.282134984239856
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,40116,-0.00741671776667522,0.00691861289403597,-0.0209771990389857,0.00614376350563527,0.28374600695896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,40198,0.00719626956006174,0.00673834897960779,-0.00601089443996953,0.020403433560093,0.285563162638248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.0077915928787779,0.00729926006587428,-0.0220981426078915,0.00651495685033568,0.285791649681358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,42201,-0.00279854048447649,0.00263009021458274,-0.00795351730505866,0.00235643633610569,0.287327009492882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,40283,-0.0037154024272813,0.00349361945982969,-0.0105628965685475,0.00313209171398489,0.287586449689907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,40080,-0.00634944265481303,0.00598060034381253,-0.0180714193286856,0.00537253401905953,0.288407656391453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00929314696116561,0.00876141658995742,-0.00787922955515093,0.0264655234774822,0.288854083581827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.00223021585129547,0.00210415161601677,-0.00635435301868834,0.00189392131609739,0.289203884665154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.011957846663631,0.0113195741198707,-0.0341442119385776,0.0102285186113155,0.290810544259338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00534808121475444,0.00506958142759946,-0.0152844608128494,0.00458829838334051,0.291477787601666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,40199,-0.00744504838782764,0.00710000698419746,-0.0213610620768547,0.00647096530119937,0.294386511563317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.002855861116443,0.00272689775614479,-0.00248885848560079,0.00820058071848679,0.29498320297712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERVV_1,,40116,0.00441392896373039,0.00422026337784962,-0.00385778725685486,0.0126856451843156,0.295635219339629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,42311,-0.00585908095404947,0.00560938306456479,-0.0168534717605965,0.00513530985249752,0.296266744553449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00609124508832123,0.00584020185730596,-0.00535555055199845,0.0175380407286409,0.296973896120728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0035009853689877,0.00337225394949088,-0.0101106031099898,0.00310863237201442,0.299211791123136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.00766903064024011,0.00739637927001414,-0.0221659340094678,0.00682787272898761,0.29982200582922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,42587,-0.00417754326124728,0.00403156307770641,-0.0120794068935518,0.00372432037105728,0.300123205043848
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.00984047543227017,0.00952202461768901,-0.0285036436829406,0.0088226928184003,0.30141496994488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,42636,0.00467554522090878,0.00452849325389893,-0.00420030155673314,0.0135513919985507,0.301869350659287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00973545653026427,0.00943468287425848,-0.00875652190328236,0.0282274349638109,0.302151343256079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.00581115421291061,0.00563606432007551,-0.0168578402802586,0.00523553185443739,0.302528451724108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,40250,-0.00846602234253079,0.00826446054170432,-0.0246643650042713,0.00773232031920968,0.30567399522776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.00844720277498565,0.00828959774874998,-0.00780040881256431,0.0246948143625356,0.308216080556703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00284904950982186,0.00279938871145746,-0.00833585138427849,0.00263775236463476,0.308824211197758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.00499860784317747,0.0049148689613781,-0.00463453532112361,0.0146317510074786,0.309157213690621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.0038714647309919,0.00381215806834108,-0.0113432945449404,0.00360036508295662,0.309862771117305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42794,-0.00266547207979783,0.00262612876046212,-0.00781268445030359,0.00248174029070793,0.310132707571947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00247452634369958,0.00243957449753294,-0.00725609235886414,0.00230703967146498,0.310448386625451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00568169188947062,0.00561594515884681,-0.0166889444008104,0.00532556062186912,0.311700465062652
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00617693779774447,0.00611065996287338,-0.0181538313249763,0.00579995572948735,0.312112483024415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.00726058075931026,0.00718520501017101,-0.0213435825792454,0.00682242106062492,0.3122786045244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,42370,0.00475395329602113,0.00472916800422017,-0.00451521599225041,0.0140231225842927,0.314799305586282
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00388580647077096,0.00386818031513602,-0.00369582694689563,0.0114674398884376,0.315132235720707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.00534917641806932,0.00533008244651711,-0.0157961380132429,0.00509778517710421,0.315598500745796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00588563729958226,0.00589550159335257,-0.0174408204225533,0.00566954582338877,0.318139262735082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.00383480702915427,0.00384185535004241,-0.0113648435152374,0.00369522945692886,0.3182173261291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,42611,-0.00194065568491305,0.00194569284876129,-0.00575421366848518,0.00187290229865909,0.318582983150069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,42346,0.00808150633432905,0.00810898604740458,-0.00781210631858392,0.023975118987242,0.318971601512549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,40482,-0.0037016401775421,0.00371471889933359,-0.0109824892202359,0.00357920886515174,0.319038720503149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,40539,-0.00201703619400919,0.00202423845752547,-0.00598454357075912,0.00195047118274074,0.319056692180173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,40199,0.00280171701984491,0.00281467770666897,-0.00271505128522627,0.00831848532491609,0.319565918679659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.00840950708383869,0.00846746162046957,-0.00818671769228166,0.0250057318599591,0.320652065414067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00506036741442083,0.00509577821912628,-0.0150480927239083,0.00492735789506668,0.32070344258486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,40302,-0.00538903511370746,0.00544845441901477,-0.0160680057749764,0.0052899355475615,0.3226385589267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.00313379290874538,0.00317488717134269,-0.00935657176457704,0.00308898594708629,0.323632780276685
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00523109040890883,0.0053031088442859,-0.0156251837437092,0.00516300292589153,0.32394894609105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00481846043991888,0.00489139366344984,-0.0144055920202806,0.0047686711404428,0.324598290071311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,40182,0.00565645265405094,0.00574635352783527,-0.00560640026050619,0.0169193055686081,0.324962598585554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00464742640828955,0.00472401005570956,-0.0139064861174803,0.00461163330090119,0.325240583508994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00354401913436262,0.00360664729225797,-0.00352500955846301,0.0106130478271882,0.325808403678564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,-0.00484250520791643,0.00493710860797085,-0.0145192380795393,0.00483422766370643,0.326694083415566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,40199,-0.00925395416257049,0.0094618978173719,-0.0277992738846194,0.00929136555947844,0.32808442246729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00828300120861675,0.00847724306208732,-0.0248983976103079,0.00833239519307441,0.328547723086462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,42346,-0.0156654680894875,0.0160598477065373,-0.0471427695943005,0.0158118334153256,0.329358439652288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,40199,-0.00308365443854032,0.00316332791796436,-0.00928377715775046,0.00311646828066982,0.329674256012558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00164093402862431,0.00168400388598345,-0.00494158164515188,0.00165971358790326,0.329863525839348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00505324002634185,0.00519416752141296,-0.0152338083683112,0.00512732831562755,0.330639751798776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,42495,-0.00841801584021373,0.00866284838570093,-0.0253971986761876,0.0085611669957601,0.331198757005998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00779482329843317,0.00804107296952,-0.00796567972182603,0.0235553263186924,0.332378755487079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00468167653197643,0.00483250740186822,-0.0141533910396382,0.00479003797568528,0.332672248462907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.00429953355703114,0.00443971070606414,-0.00440229942685457,0.0130013665409169,0.332848759077265
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,40302,-0.00218782507154608,0.00226829749803786,-0.00663368816770028,0.00225803802460812,0.334804788036465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.0044490875691022,0.00461285887943267,-0.00459211583458584,0.0134902909727902,0.334818272489175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.00447766347239657,0.00464959293751452,-0.00463553868513189,0.013590865629925,0.335553844862979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0058215878950687,0.00605349986386539,-0.0176864476282449,0.00604327183810747,0.336222843986077
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.00536036610835504,0.00558083192428473,-0.0162987966799531,0.00557806446324304,0.336826329768532
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.00481233047565139,0.00501891372393558,-0.0146494013745651,0.00502474042326235,0.337660316209791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,40483,-0.00239627632291262,0.00252215430974879,-0.00733969877002025,0.002547146124195,0.342086312140138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,40136,-0.00501195942207756,0.0052877495010363,-0.0153759484441087,0.00535202959995359,0.343230022586347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.00348928617472743,0.00369270570502195,-0.0107269893565704,0.0037484170071156,0.344723770588043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.00377629587991129,0.00401204325783175,-0.0116399006652615,0.00408730890543895,0.346602506272631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00279884996882986,0.00297589886537075,-0.00303391180729681,0.00863161174495652,0.346979074637182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.00366909228330171,0.0039047225110571,-0.0113223484049736,0.00398416383837021,0.347415301425346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.0041808027723422,0.00445042537167569,-0.0129036365008265,0.00454203095614214,0.347534226095898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,42370,-0.00844502990292316,0.00900865814016644,-0.0261019998576494,0.00921194005180307,0.348552114614226
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.00310707347041477,0.00332534822670113,-0.00962475599474899,0.00341060905391944,0.350138720627609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,40182,0.00632493900341287,0.00677242951253247,-0.00694902284115077,0.0195989008479765,0.35036327376744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,42370,-0.00347841628186019,0.0037274122550855,-0.0107841443018278,0.0038273117381074,0.350734484418082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,40116,0.00310922529425548,0.0033354404208527,-0.00342823793061581,0.00964668851912678,0.351264975633943
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,40199,-0.00428903419154161,0.00462357878391542,-0.0133512486080158,0.00477318022493262,0.353612713792247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00432737168900274,0.00466918430931095,-0.0134789729352522,0.00482422955724673,0.354054014309714
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.0108932330025179,0.0118194183841526,-0.034059293035457,0.0122728270304211,0.35673398785001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00625738101492484,0.00679017252093176,-0.0195661191559511,0.00705135712610141,0.356791541739594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.00505552082113078,0.00550631369899149,-0.0158478956711541,0.00573685402889255,0.358570073816393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,40302,0.00338995708847728,0.00369572877924083,-0.00385367131883476,0.0106335854957893,0.359024497231348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0127050245978297,0.0138693613014085,-0.0398889727485904,0.014478923552931,0.3596611070433
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00465328981791982,0.00508229457529455,-0.00530800754965749,0.0146145871854971,0.359903113041103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00301968073472529,0.00329900248378048,-0.00948572560293502,0.00344636413348444,0.3600342707307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,42370,0.00533640255621316,0.00583723479346213,-0.00610457763897262,0.0167773827513989,0.360628267172529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.00634895621506419,0.00694854671027501,-0.0199681077672032,0.00727019533707482,0.360888707639566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00419372783298339,0.00460127679197146,-0.00482477467928067,0.0132122303452475,0.36209055591994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,42674,0.00536721884950954,0.00588906628746809,-0.00617535107392792,0.016909788772947,0.362107763018474
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,42370,-0.0122125478453172,0.0134075860658576,-0.0384914165343981,0.0140663208437636,0.362381326354427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42543,0.00436878357381913,0.00482121922277052,-0.00508080610281108,0.0138183732504493,0.364868892015521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,40527,-0.00787003516607268,0.00872310920504269,-0.0249673292079564,0.00922725887581099,0.366967005472583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00402677222275734,0.00446660193571349,-0.0047277675712411,0.0127813120167558,0.367326757285779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.00514264965088148,0.00571243571241975,-0.0163390236472242,0.00605372434546123,0.368000440331708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.0026683965201909,0.00296411952113218,-0.00314127774122818,0.00847807078160997,0.368016484970648
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,40116,-0.00453178235125659,0.00503954220117924,-0.0144092850655679,0.00534572036305472,0.3685420824833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00282441004603372,0.00314150217689695,-0.0033329342206843,0.00898175431275174,0.36863860486822
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00245273833727248,0.00273240676113016,-0.00290277891454263,0.0078082555890876,0.369389537269285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,40199,-0.0048443097089729,0.00541314341274611,-0.0154540707979553,0.00576545138000948,0.370851460664545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.00364964208541904,0.00407875495913262,-0.00434471763448089,0.011644001805319,0.370917444468588
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00561632258252234,0.00628603175881101,-0.00670429966474724,0.0179369448297919,0.371626806406435
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,40136,-0.00627917003796897,0.00704707447160973,-0.020091436002324,0.0075330959263861,0.372931505358593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00338256485186838,0.0038068838585322,-0.0108440572145915,0.00407892751085473,0.374267126331007
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,-0.00309266658127966,0.0034905243800027,-0.00993409436608496,0.00374876120352564,0.37562683322846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00310375160454646,0.00352226533990165,-0.0100073916707537,0.00379988846166079,0.378236194233855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00309061267216875,0.00350861430083159,-0.00996749670179867,0.00378627135746117,0.378410601290121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,40449,-0.00948860754010348,0.0108500018045173,-0.0307546110769574,0.0117773959967505,0.38185058476244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00460498603376962,0.00528282051333628,-0.0149593142399087,0.00574934217236948,0.383396126589434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,40080,0.00560051815516852,0.00642512276021217,-0.00699272245484733,0.0181937587651844,0.383413480449499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.00673558074968209,0.00773966670942591,-0.00843416600079269,0.0219053275001569,0.384173016366014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42646,-0.00467312562410883,0.00537079252253153,-0.0151998789682706,0.00585362772005297,0.384261379933685
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00374351050508572,0.00431602204411024,-0.0122029137115418,0.00471589270137036,0.385768174107177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.00720601270574078,0.00836314665162835,-0.0235977801429323,0.00918575473145079,0.38890484243296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,40116,0.0047438959986392,0.00551236313330966,-0.00606033574264774,0.0155481277399261,0.389481645734066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,40539,-0.0042281048136215,0.004918538458909,-0.0138684401930831,0.00541223056584013,0.390013259113171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,40182,-0.00631530803924058,0.00735201504573811,-0.0207252575288873,0.00809464145040612,0.39036472382743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00453578753613531,0.00528950976418936,-0.0149032266739465,0.00583165160167584,0.391184863376933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.0024064375823506,0.0028139154940795,-0.00792171195074642,0.00310883678604522,0.39246356765339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.00224678811994847,0.0026288109376485,-0.00739925755773952,0.00290568131784259,0.392747309282851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0150240797049796,0.0176339545404117,-0.0195384711942274,0.0495866306041865,0.394230905683417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00475248570624994,0.00558164209143232,-0.00618753279295741,0.0156925042054573,0.39453849955998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,40182,-0.00284891884827473,0.00335065895088118,-0.00941621039200184,0.00371837269545239,0.395201138607892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,42346,-0.00318878928608852,0.00375701167818523,-0.0105525321753316,0.00417495360315453,0.396032069247747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,-0.00400585443226042,0.00473574546343093,-0.0132879155405851,0.00527620667606421,0.39764019548189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00634276879630378,0.00752151806293995,-0.0210849441996661,0.00839940660705852,0.399088680950521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,-0.00470259598356018,0.00560446673737489,-0.015687350788815,0.00628215882169461,0.401442840022417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00394123500483486,0.00470231010566553,-0.0131577628119393,0.00527529280226958,0.401965547390125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00220948739301195,0.00263743866721778,-0.0029598923947349,0.00737886718075879,0.402191566116341
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00290167340328798,0.00346798171929315,-0.0038955707665266,0.00969891757310256,0.402773911184693
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,40182,-0.00288225428619105,0.00344521592542467,-0.0096348775000234,0.0038703689276413,0.402837818833028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.00392749542266818,0.00470029138188658,-0.00528507568582952,0.0131400665311659,0.403403568805667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,42721,-0.00358330291126546,0.00429372164183236,-0.0119989973292569,0.00483239150672597,0.403988811491878
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,40080,0.00762819747056475,0.00917234663843494,-0.0103496019407677,0.0256059968818972,0.405623825210182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,40116,-0.00533170468491791,0.00641733232386923,-0.0179096760397016,0.00724626666986577,0.406088496711839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,-0.0042793947544468,0.00516193635882049,-0.014396790017735,0.00583800050884135,0.407106134586741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00487837754624661,0.00590301029523259,-0.00669152263240926,0.0164482777249025,0.408582770263697
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,42311,0.00592223547348998,0.00717666191089491,-0.00814402187186405,0.019988492818844,0.409268784092783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,42346,-0.0110157611829056,0.0134404482219844,-0.037359039697995,0.0153275173321838,0.412460306118144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42679,-0.00248141399439638,0.0030330643950703,-0.00842622020873416,0.0034633922199414,0.413302494552123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.0030686770292934,0.00377579486478155,-0.0104692349642652,0.00433188090567844,0.416391317267312
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00591451174750585,0.00731705751540001,-0.00842692098267817,0.0202559444776899,0.418924923501142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00510991191244333,0.00632174783839326,-0.0175005376756941,0.00728071385080745,0.418928634668912
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.00831985216908001,0.0102951704609486,-0.0284983862725393,0.0118586819343793,0.419032739993566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,40269,-0.00457313286860536,0.00566660544988214,-0.0156796795503743,0.00653341381316363,0.419665282363363
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00332444097511234,0.00412021779397755,-0.0114000678513083,0.00475118590108365,0.419764487643438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.00753908093799023,0.00934884806230802,-0.025862823140114,0.0107846612641335,0.420018809879583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,0.00584235029833684,0.00724569613319199,-0.00835921412271947,0.0200439147193931,0.420075300953793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00376144780940328,0.00468055752872878,-0.00541244494690512,0.0129353405657117,0.421626778770585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.0031876284158299,0.00397242406838655,-0.00459832275820773,0.0109735795898675,0.422316354754405
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.00505722364873678,0.00631582229518307,-0.0174362353472956,0.00732178804982204,0.423309547370259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00251400868536319,0.00314052671121053,-0.00364142366860944,0.00866944103933582,0.423435430505923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,-0.00553245797339895,0.00693074818276287,-0.0191167244116142,0.00805180846481627,0.424743767655042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,42654,0.00377367027371117,0.00473127152682831,-0.00549962191887231,0.0130469624662946,0.425115726936938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.00249269193354983,0.003126456537389,-0.00862054674683226,0.00363516287973261,0.425297131243779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.00618145467491906,0.00775645517217274,-0.00902119746253951,0.0213841068123776,0.425501365451103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,40483,0.0032591630309925,0.00409199468102812,-0.00476114654382262,0.0112794726058076,0.425773946988788
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,40286,-0.0076883970368007,0.00965485658615344,-0.0266119159456614,0.01123512187206,0.425860600329144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00223266315067896,0.00280836381983642,-0.00327172993620042,0.00773705623755834,0.426627863827005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,40302,0.00215944551419338,0.00272237730187934,-0.00317641399749011,0.00749530502587688,0.427666301834394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,40182,-0.00662410877957815,0.00836357033373732,-0.0230167066337033,0.009768489074547,0.428366544391781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.00230513846345227,0.00291361170154632,-0.00340554047157853,0.00801581739848307,0.428863424361976
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,42311,-0.00270611405199294,0.00342359355576376,-0.00941635742128992,0.00400412931730404,0.42929046640576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.00397542371287091,0.00503672113116534,-0.00589654970421315,0.013847397129955,0.429960893157197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.00395984339946021,0.00502122285123911,-0.00588175338896844,0.0138014401878889,0.430347579979454
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,42357,-0.0080771638914184,0.0102671814222906,-0.0282008394791081,0.0120465116962713,0.431473248643304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42611,-0.00351567837452091,0.00447365402128193,-0.0122840402562335,0.00525268350719167,0.431961735211087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,40302,-0.00265498717827427,0.00340953421336512,-0.00933767423646991,0.00402769987992136,0.43617600092436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.0039366958293434,0.00506874117873868,-0.0138714285396712,0.00599803688098442,0.437375360861833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00395587956581711,0.00509822828975745,-0.00603664788210749,0.0139484070137417,0.437805311732754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.00314755255759722,0.00406113498644956,-0.00481227201584391,0.0111073771310384,0.438330776074113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.00452277750204803,0.00583867075665777,-0.0159665721850973,0.00692101718100119,0.438577836608451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.0037508099561212,0.00486755665218158,-0.00578960108215469,0.0132912209943971,0.440976436376633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,42370,0.00462758164070786,0.006027122262286,-0.00718557799337271,0.0164407412747884,0.442623996214968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00287483844940731,0.00375762471116293,-0.00449010598447203,0.0102397828832867,0.444247579967308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00280098954340546,0.00366428153291602,-0.00998298134792085,0.00438100226110993,0.444643351506321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.00249645452755636,0.0032694120110359,-0.00890450206918672,0.003911593014074,0.445131453204662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00624441103605943,0.00818601254687968,-0.0222889956279436,0.00980017355582474,0.44559041779042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,40483,0.0057551129422807,0.00755021820267919,-0.00904331473497052,0.0205535406195319,0.445929965633086
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,40511,-0.00269034199779892,0.00353092138800993,-0.00961094791829839,0.00423026392270055,0.446113087070951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00166333541073087,0.00218910218357848,-0.00262730486908296,0.00595397569054469,0.447372137264037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,40337,0.0024999965788048,0.00330427104068313,-0.00397637466093414,0.00897636781854374,0.449308237747943
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,40527,0.00349900642800994,0.00462695962608655,-0.0055698344391197,0.0125678472951396,0.449532112625086
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,-0.00193275537213141,0.00256335315159031,-0.00695692754924842,0.0030914168049856,0.45086536889181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,42370,0.00232244301595451,0.0030857413199857,-0.00372560997121747,0.00837049600312649,0.451681537557356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,42346,0.00388279901159896,0.00519531566912747,-0.00630001969989088,0.0140656177230888,0.454856405029053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,42311,0.00322162357114951,0.00432491756636881,-0.00525521485893336,0.0116984620012324,0.456346572632465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42495,-0.000858460093206676,0.00115428170314429,-0.00312085223136948,0.00140393204495613,0.457060227300415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.00199409145691227,0.00269283442658297,-0.00727204693301488,0.00328386401919035,0.458998855939127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,-0.00378611312789848,0.00514661119721822,-0.0138734710744462,0.00630124481864923,0.461958267603481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.0021276481911879,0.00289678421979986,-0.00780534526199564,0.00355004887961983,0.462665564218752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00257194818884748,0.00353250302973972,-0.00949565412713734,0.00435175774944238,0.466579544493548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,40080,-0.002977125929339,0.00409210320317961,-0.010997648207571,0.00504339634889304,0.466917277159238
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,40136,0.00663348509204007,0.00918342540410975,-0.011366028700015,0.0246329988840952,0.47010561586742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.00409979426649175,0.0057265498796344,-0.0153238320305752,0.00712424349759168,0.474051502487865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00237090844062024,0.00332593420991282,-0.0041479226108089,0.00888973949204937,0.475950761445397
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,40116,-0.00264038239912814,0.00371346663019041,-0.00991877699430135,0.00463801219604506,0.4770814597938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,40136,0.00448406432454508,0.00635062956625419,-0.00796316962531313,0.0169312982744033,0.480152265963354
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00226124187687684,0.00321892893616133,-0.00857034259175304,0.00404785883799937,0.482393132951745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.00446797821246413,0.00637635653842766,-0.0169656370277823,0.0080296806028541,0.483498357419254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00302085796955019,0.00431513338628483,-0.0114785194066685,0.00543680346756808,0.48390380935234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,40182,-0.00196673245823019,0.00282359509744613,-0.0075009788492246,0.00356751393276422,0.48610865848273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,42594,-0.0036636768378605,0.00529427093251973,-0.0140404478655992,0.00671309418987816,0.488944414021303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,40539,-0.001384846017529,0.00200520463268517,-0.00531504709759194,0.00254535506253393,0.489814869920366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00524950606801712,0.00761533013814976,-0.0201755531387907,0.00967654100275641,0.490627655803983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,40136,0.00628131599592586,0.0091211379661441,-0.0115961144177166,0.0241587464095683,0.491055088957431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,40136,0.00319972661222389,0.00465107597001032,-0.00591638228899634,0.0123158355134441,0.491496292654703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,0.00131508580024281,0.00191221556421001,-0.0024328567056088,0.00506302830609442,0.49163763674479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0158406948248244,0.0231417387962641,-0.0611985028655019,0.0295171132158532,0.493668778315118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,42311,-0.00312710336640855,0.00456911846919066,-0.0120825755660223,0.00582836883320515,0.493734889103631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42656,-0.00208448551564266,0.00305780636090023,-0.00807778598300711,0.00390881495172179,0.495444754821018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42711,-0.00420773359793395,0.00618326305775327,-0.0163269291911304,0.00791146199526246,0.49619721408199
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,42370,-0.00339315681968993,0.00498647801298197,-0.0131666537251346,0.00638034008575474,0.496217836229185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00744653919230568,0.0109596728008436,-0.0289274978819591,0.0140344194973478,0.49686532023824
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,40511,-0.00697499025115317,0.0102858842095666,-0.0271353233019036,0.0131853427995973,0.497714008365323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,-0.00249840535774379,0.00368771686956562,-0.00972633042209241,0.00472951970660484,0.498104612341981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,42311,0.00216973239816956,0.00321181142218888,-0.00412541798932064,0.00846488278565976,0.499339650918945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00440256427430565,0.00654110837245283,-0.0172231366843132,0.0084180081357019,0.500922703924994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00367278734389407,0.00546485682216391,-0.0143839067153353,0.0070383320275472,0.501548469638328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,40136,0.00340393876644747,0.00507069013654505,-0.00653461390118083,0.0133424914340758,0.502045555204241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.00464778498870424,0.00697448737597545,-0.00902221026820765,0.0183177802456161,0.505170309280115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.00339351635972543,0.00509780557815107,-0.00659818257345067,0.0133852152929015,0.505628617527962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00300069614225721,0.00452602976239044,-0.0118717144765425,0.00587032219202805,0.507352753240907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.0037642863524371,0.00568236019253224,-0.00737313962492608,0.0149017123298003,0.507696121401558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00374756461170562,0.00565849732837781,-0.0148382193753261,0.00734309015191488,0.50779951219114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.00422323005956834,0.00637806812043079,-0.0167242435756127,0.00827778345647602,0.507887522369995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00284862883704397,0.00430811114528826,-0.011292526681809,0.00559526900772103,0.508481854501127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00238163414351624,0.00360383250210013,-0.00468187756060001,0.00944514584763248,0.508714994899385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.00224112931978009,0.00341579011250172,-0.00445381930072328,0.00893607794028345,0.511767929046853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00311551577018333,0.00475031015565266,-0.00619509213489587,0.0124261236752625,0.511928778284153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.006286580958577,0.00966531637794143,-0.0252306010593422,0.0126574391421882,0.515430241482033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,40223,-0.00538851022988336,0.00829718226571335,-0.0216509874706815,0.0108739670109148,0.516068461476893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,42794,-0.00156739281851786,0.00243169573100259,-0.00633351645128294,0.00319873081424721,0.519218165202207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,-0.00223650657168925,0.00348371911420605,-0.0090645960355331,0.00459158289215461,0.52089387980366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00161928028068125,0.0025234423619573,-0.00656522731011756,0.00332666674875507,0.521084281795198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00175234575795816,0.00273114912388869,-0.00360070652486367,0.00710539804077999,0.521134214735941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00266077080545589,0.00414936988959046,-0.0107935357890532,0.00547199417814142,0.521375621666465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00268620364989192,0.00420680959949032,-0.010931550464893,0.00555914316510911,0.523137330556481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.0025055705993773,0.00392519190474276,-0.0101989467326731,0.00518780553391851,0.523271574112655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00439659964661765,0.00689030589199398,-0.00910839990169056,0.0179015991949259,0.523431815763661
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42636,-0.00462038384063217,0.00724424713846255,-0.0188191082320188,0.00957834055075443,0.523614472590615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42652,-0.002804211091103,0.00440802526211244,-0.0114439406048434,0.00583551842263738,0.524682702743091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.00496437702946476,0.00780981727316823,-0.0202716188848745,0.010342864825945,0.525009861524923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.00443293581716888,0.0070067705575478,-0.0181662061099626,0.0093003344756248,0.526965495183236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00471538000491942,0.00750960481942281,-0.0194342054509881,0.0100034454411493,0.530071695366505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,-0.00240399510803163,0.00383084264866561,-0.00991244669941622,0.00510445648335296,0.53032034978327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00302740913840931,0.0048353848176609,-0.0125047633810247,0.00644994510420605,0.531265788402981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42721,-0.0019572748257889,0.00313037597740892,-0.00809281174151037,0.00417826208993258,0.531816018870079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00314097144821192,0.00502608173484196,-0.00671014875207833,0.0129920916485022,0.532027159146579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,40080,-0.00248914339567393,0.00399292925228581,-0.0103152847301541,0.00533699793880627,0.533042771358389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,40182,0.00291436460240558,0.00470256154581566,-0.00630265602739312,0.0121313852322043,0.535441951601732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,-0.00418619502575993,0.00676072632881905,-0.0174372186302453,0.00906482857872541,0.535799535316195
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,40509,0.00215827323016548,0.00349435613873469,-0.00469066480175451,0.00900721126208547,0.536821496178713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00338667156197329,0.00554179936053406,-0.00747525518467348,0.0142485983086201,0.541136783637688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,40080,0.00697755691089489,0.0114341052830759,-0.015433289443934,0.0293884032657237,0.541715082181339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00382463934420198,0.00627166230004079,-0.0161170974522819,0.00846781876387797,0.541985613129977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42477,0.00408282888574602,0.00670182543303425,-0.00905274896300111,0.0172184067344931,0.542394701576216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,40302,0.00320606057679599,0.00527050545365545,-0.00712413011236868,0.0135362512659607,0.54299943507306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.00441928106277307,0.00726829348747167,-0.0098265741726714,0.0186651362982175,0.543185430469442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00235046303335135,0.0038662622475779,-0.00992833703860403,0.00522741097190133,0.543238612087203
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,42370,0.00277635175905767,0.00456684070425665,-0.00617465602128537,0.0117273595394007,0.543239690008626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.00347687921401171,0.00572241992507274,-0.0146928222671543,0.00773906383913085,0.543472342241508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.00359934721194002,0.00592728289271493,-0.0152168216816613,0.00801812725778124,0.543694780790042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00179815176985861,0.00296617911299658,-0.00401555929161469,0.0076118628313319,0.544380320967283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,40065,-0.00241718270647334,0.00398800858478678,-0.0102336795326554,0.00539931411970876,0.544452564182799
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00262324455605241,0.00434406401675593,-0.011137610028894,0.00589112091678921,0.545943067689584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,40080,-0.00184978627756962,0.00307336689323241,-0.00787358538830515,0.00417401283316591,0.547269105969561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,42552,-0.00141453120566559,0.00236202099547644,-0.00604409235679941,0.00321502994546823,0.549273208553898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,40302,-0.00236275937850232,0.0039680918629887,-0.0101402194299602,0.00541470067295554,0.551561733932868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42594,-0.00531472277461038,0.00894681782690487,-0.0228504857153439,0.0122210401661232,0.552498743235386
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00156082065270159,0.00263410012819654,-0.00360201559856362,0.0067236569039668,0.553498524632487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0026945835785406,0.00456949298473485,-0.00626162267153971,0.0116507898286209,0.555408739035519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,40080,-0.00326467052891936,0.00556733793676037,-0.0141766528849697,0.00764731182713097,0.557620886475479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,40136,-0.00351016104903313,0.00599098547224722,-0.0152524925746377,0.00823217047657141,0.557950016359989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42636,-0.00664692779768227,0.0113555317556448,-0.0289037700387461,0.0156099144433815,0.558324164185295
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,42346,0.00441730929183803,0.00757161132559229,-0.0104230489063229,0.0192576674899989,0.559631284374962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,0.00274187949925545,0.00470328297099575,-0.00647655512389622,0.0119603141224071,0.559924583462221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00270830701310919,0.00466328550161507,-0.00643173257005635,0.0118483465962747,0.561405914033198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00266249146313478,0.00458620055884132,-0.0116514445584638,0.0063264616321942,0.561559564604774
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,40419,0.00189785043804106,0.00329101415163375,-0.0045525372991611,0.00834823817524321,0.564169591152688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.0026756954601385,0.00464460859454114,-0.0117791283054391,0.00642773738516213,0.564568709602037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00230688709927814,0.00403355361376594,-0.0102126521822594,0.0055988779837031,0.567384980287114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.00345808432050158,0.00605349247645177,-0.0153229295743471,0.00840676093334389,0.56783898825522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00190577690433771,0.00333971371494424,-0.00464006197695301,0.00845161578562843,0.568252623621479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,42293,-0.0031160124776878,0.00546198082034515,-0.0138214948855643,0.0075894699301887,0.568354314210852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,-0.0016297268483878,0.00286056710304256,-0.00723643837035122,0.00397698467357561,0.568878170886763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,-0.00308255523424582,0.00543779296827166,-0.0137406294520583,0.00757551898356664,0.570809945497408
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,40136,0.00192548012302003,0.00340364534412115,-0.00474566475145743,0.00859662499749749,0.571601754156806
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00336107329976676,0.00595048438683283,-0.0150240226979591,0.00830187609842557,0.572193916064476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00269189008849816,0.00479127943780872,-0.00669901760960694,0.0120827977866033,0.574242587760276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00442366218546756,0.00788651752821422,-0.0198812365407674,0.0110339121698323,0.574866944427887
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,40136,-0.00417964431590158,0.00745168742565133,-0.0187849516701782,0.010425663038375,0.574877850478678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0028291103570388,0.00508098442331545,-0.0127878398267371,0.00712961911265948,0.577670935966428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,-0.00195108671699492,0.00351597840541176,-0.00884240439160197,0.00494023095761213,0.578960680616762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.00358792993251399,0.00646572491871664,-0.0162607507731986,0.00908489090817062,0.578963933449962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.0039733142509873,0.0071735432149989,-0.0100868304504105,0.0180334589523851,0.579669056694942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00305009627729473,0.00551177688742138,-0.0138531789766406,0.00775298642205118,0.580015880890776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00217879823631995,0.00394083003462995,-0.00554522863155475,0.00990282510419466,0.580356373161669
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-0.00242644517611914,0.00439203281158421,-0.0110348294868242,0.00618193913458591,0.580639101242348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,42636,-0.00204610694559855,0.00372546364453062,-0.00934801568887856,0.00525580179768147,0.582862166805855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00314172131022233,0.00572504804801547,-0.0143628154843326,0.00807937286388799,0.583176113423826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.00259468602507253,0.00474593068004434,-0.0118967101579594,0.00670733810781437,0.584581742954539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.00293068498674582,0.00537723308128861,-0.0134700618260715,0.00760869185257985,0.585752793306471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00335145238932881,0.00616510607254445,-0.0154350602915159,0.00873215551285831,0.586716423661712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00541149141385099,0.0099711605450213,-0.0249549660820927,0.0141319832543908,0.5873375343457
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,40136,-0.00297487130416508,0.00551759157083308,-0.0137893507829979,0.00783960817466775,0.589786598326909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.00173071601419459,0.00321760491120822,-0.00457578961177352,0.0080372216401627,0.590663889890651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00256429741167548,0.0047747524670008,-0.011922812246997,0.0067942174236461,0.591241549958336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,-0.00130049497835451,0.0024266513950633,-0.00605673171267858,0.00345574175596956,0.592021551822752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,40199,-0.00157929129905685,0.00297267907417654,-0.00740574228444287,0.00424715968632916,0.595243325369121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,42311,-0.00195782778085312,0.00369235872831881,-0.00919485088835799,0.00527919532665175,0.595956114403094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,40482,0.00245282378492092,0.0046352840847229,-0.00663233302113595,0.0115379805909778,0.596702344723665
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00224442188925351,0.00424795408620526,-0.0060815681197088,0.0105704118982158,0.597264344302396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.00522113996341483,0.00991512088549868,-0.0246547768989923,0.0142124969721626,0.59849331877698
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.00555840203352703,0.0105740566095805,-0.0262835529883048,0.0151667489212507,0.59913031466351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00323577905411378,0.0061724142314227,-0.00886215283947472,0.0153337109477023,0.600127580198621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00159947397910531,0.00307275666136001,-0.00762207703537092,0.00442312907716031,0.602702001277452
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,-0.0019786925768773,0.00381743350533101,-0.00946086224732608,0.00550347709357147,0.604237764063882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.00181416755001223,0.00350195136530828,-0.00504965712599199,0.00867799222601646,0.604435657597411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,40429,-0.00267234128196153,0.00516564395055922,-0.0127970034250576,0.00745232086113455,0.604936176061369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,40482,-0.00181059202803373,0.00351601202555293,-0.00870197559811748,0.00508079154205003,0.606593743097843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,0.00255228260923212,0.00499195642985547,-0.00723195199328461,0.0123365172117488,0.609166007438718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00295488416864024,0.00579881102649317,-0.0143205537805668,0.00841078544328637,0.610364970578519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00134700551399355,0.00264839711692402,-0.00384385283517753,0.00653786386316463,0.611032741662569
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,42353,-0.00431617641994586,0.00856792759891886,-0.0211093145138268,0.0124769616739351,0.614438701299758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.00262867099841247,0.00522755925129924,-0.012874687130959,0.00761734513413404,0.615080822146423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,40199,-0.00276869584215955,0.00556920838774099,-0.0136843442821319,0.00814695259781279,0.619097780851838
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00189259055031524,0.00381002194039149,-0.00557505245285209,0.00936023355348257,0.619380689240124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,40116,0.00195568611104144,0.00393742187684379,-0.00576166076757239,0.00967303298965528,0.619416231926023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00133286099785859,0.00270164849236402,-0.00662809204289207,0.00396237004717489,0.621774154858492
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.00431764555253708,0.00883044425179585,-0.0129900251809828,0.021625316286057,0.624886831685755
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00273217158353397,0.00560032642632269,-0.0137088113791264,0.00824446821205849,0.625657626752065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00265920082847001,0.00545837996431948,-0.00803922390159616,0.0133576255585362,0.626142206027731
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00284173881087635,0.00584485307403046,-0.00861417321422335,0.014297650835976,0.626838595671217
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,42590,0.00340666562307659,0.00701748919343164,-0.0103476131960494,0.0171609444422026,0.627362534790758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,40136,0.00342548876108879,0.00705668969493222,-0.0104056230409784,0.0172566005631559,0.627385106961746
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.00298618313904512,0.00615208989232278,-0.0150442793279978,0.00907191304990753,0.62740699529112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,40199,-0.00211806153809182,0.00436578004460418,-0.010674990425516,0.00643886734933236,0.627579059581618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00176852482503593,0.00364858313888855,-0.00538269812718562,0.00891974777725749,0.627887529075009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.00123967739109353,0.00258828522592794,-0.00383336165172524,0.00631271643391229,0.631976902187163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00171722636259282,0.00359232675713058,-0.00875818680656877,0.00532373408138312,0.632641113884315
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,40483,-0.00104113153272811,0.00218466954409187,-0.00532308383914817,0.00324082077369196,0.633682930993408
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,40302,-0.00189429116328692,0.00397858569985816,-0.00969231913500892,0.00590373680843507,0.633997010722919
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,40080,-0.00194341159428414,0.00412778747074928,-0.0100338750369527,0.00614705184838445,0.637784476365268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00268854859173712,0.00571784419761752,-0.0138955232190675,0.00851842603559322,0.638219171701572
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00306191698849284,0.00653666848504642,-0.0158737872191838,0.00974995324219815,0.639492441912294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42721,-0.00207752076354128,0.00443706137024206,-0.0107741610492157,0.00661911952213316,0.639634833128932
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42495,0.00151248731964359,0.0032616549408149,-0.00488035636435363,0.0079053310036408,0.642857560179947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00283583210339659,0.00612928362710722,-0.00917756380573356,0.0148492280125267,0.643610588258042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00193634813873499,0.0042131416327725,-0.0063214094614991,0.0101941057389691,0.645812945056672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,40302,-0.00241548190672436,0.0052723432601391,-0.012749274696597,0.00791831088314828,0.646859385354986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,40302,-0.0027276446214285,0.00596835884714818,-0.0144256279618389,0.00897033871898193,0.647667382243216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00266380306104939,0.00585977540929671,-0.0141489628632709,0.00882135674117216,0.649412295649873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.00251767764292986,0.00554320490272676,-0.0133823592522743,0.00834700396641459,0.64969821484619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.00246026149929103,0.00543799625010726,-0.0131187341495013,0.0081982111509192,0.650973502828459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.00164052476946922,0.00362754858523941,-0.00875051999653846,0.00546947045760002,0.651102956798329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00245165126952425,0.00542270055240265,-0.0130801443522334,0.00817684181318493,0.651199445257306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,40116,-0.00234393788504837,0.00521415054092908,-0.0125636729452694,0.00787579717517263,0.653055416261445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00336444777437828,0.00754059241676648,-0.011415113362484,0.0181440089112406,0.655477374568286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,40199,0.0012611496753685,0.0028346932288136,-0.00429484905310616,0.00681714840384315,0.656402134386597
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42689,-0.00131672905666785,0.00297035441635562,-0.00713862371272486,0.00450516559938915,0.657562936480249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.00482661993107509,0.0109071177647685,-0.0262045707500213,0.0165513308878711,0.658119948839494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,40302,0.00151261813932427,0.00343258972661029,-0.0052152577248319,0.00824049400348045,0.659464960139865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,40116,-0.00163595254647522,0.00371551861840584,-0.00891836903855067,0.00564646394560023,0.65972666366691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00111502760131485,0.00253313350635103,-0.00384991407113316,0.00607996927376287,0.659817514638905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,42584,0.00301057971746779,0.00685311661122097,-0.0104215288405253,0.0164426882754609,0.660450672233404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.00326060905461295,0.00743578249805698,-0.0178347427508046,0.0113135246415787,0.661029276372346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00404766109428971,0.00925003896101773,-0.014082415269305,0.0221777374578845,0.661697147723082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00234638359002752,0.0053743321801645,-0.0128800746631499,0.0081873074830949,0.662416848169192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00356610785298306,0.0082404683892773,-0.0125852101900005,0.0197174258959666,0.665199515608861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,-0.00311450665846152,0.00720356336938759,-0.0172334908624612,0.0110044775455382,0.66549094408331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,0.00232895111512457,0.0053866858291838,-0.00822895311007568,0.0128868553403248,0.66549314483316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.00190290316204854,0.00440656473042163,-0.0105397700336749,0.00673396370957784,0.665869145622313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00154259487610974,0.00361400623289964,-0.00862604709259303,0.00554085734037356,0.669505553140348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,-0.00172950665977779,0.00407130810089216,-0.00970927053752643,0.00625025721797085,0.670988113296832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.0017494107583904,0.00413397777052973,-0.00985200718862867,0.00635318567184787,0.672173072604944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,42357,0.00198589254748522,0.00470170845746565,-0.00722945602914746,0.0112012411241179,0.672756911786582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00201530395392033,0.00483055548070938,-0.00745258478827005,0.0114831926961107,0.676540899329256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,40060,-0.00178577643838193,0.00429110759871564,-0.0101963473318646,0.00662479445510073,0.677303005129053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,40539,0.000596740598659812,0.00143409917014278,-0.00221409377482003,0.00340757497213966,0.67733861193524
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,-0.00148494556219558,0.00357261817842381,-0.00848727719190624,0.00551738606751509,0.677676950887913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00148842776757293,0.00359044441652122,-0.00852569882395452,0.00554884328880867,0.67847739239665
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42771,-0.00122707268490858,0.00296784698411329,-0.00704405277377063,0.00458990740395346,0.679279442877143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00103334112948361,0.00250136540304744,-0.00386933506048937,0.00593601731945659,0.679533527329555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,40302,-0.00328952597338825,0.00804591172468305,-0.019059512953767,0.0124804610069905,0.682661733834237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,-0.00116679650184992,0.00290062953812434,-0.00685203039657362,0.00451843739287378,0.687502999346628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,42334,-0.00226831211329871,0.00566777789610916,-0.0133771567896727,0.00884053256307525,0.689006962608254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,40116,0.00178316463683377,0.00446172400540736,-0.00696181441376466,0.0105281436874322,0.689416089939778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.00112094406480352,0.00280510033044187,-0.00437705258286255,0.00661894071246958,0.689450840091834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.00156898130905412,0.00394483783141337,-0.00930086345862431,0.00616290084051608,0.690836814999017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00143771077088489,0.00362264009841921,-0.00566266382201676,0.00853808536378654,0.691471187332644
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.00237556332932209,0.00603067455456795,-0.0141956854562753,0.00944455879763109,0.693652574084795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,40080,-0.00129257790495361,0.00330434064583526,-0.00776908557079073,0.00518392976088351,0.695674993202199
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,40136,-0.00341567011890414,0.00880983303725904,-0.0206829428719319,0.0138516026341236,0.698237376957075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00203484572814887,0.00528233589282599,-0.0123882240780878,0.00831853262179007,0.700084005087335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,40116,0.00192183739423092,0.00499042101191186,-0.00785938778911632,0.0117030625775782,0.700166928198778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42699,-0.00566912477543505,0.0148472208221912,-0.0347696775869298,0.0234314280360597,0.70259295046385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,42292,0.00128621269379624,0.00337526294110776,-0.00532930267077497,0.00790172805836746,0.703157214380175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,40182,-0.00247978070405476,0.00652698932110914,-0.0152726797734287,0.0103131183653192,0.704006807146973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.00118041777751725,0.00311545496173107,-0.00728670950251015,0.00492587394747566,0.704774800337667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,-0.00172584521598981,0.00456091526052758,-0.0106652391266239,0.00721354869464425,0.705140340774031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42710,-0.00161444067617644,0.00428642720586726,-0.0100158379996763,0.00678695664732338,0.706446942683046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,42721,-0.00107894381334691,0.00287777822087979,-0.0067193891262713,0.00456150149957748,0.707723980649713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,40182,0.00218647998840019,0.00588102191817064,-0.00934032297121426,0.0137132829480146,0.71005956308028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00239264126602326,0.00643931361766121,-0.0102284134245927,0.0150136959566392,0.71022070667049
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,40199,-0.00168045574321287,0.00452981863401025,-0.010558900265873,0.00719798877944722,0.710662261218598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00205864960786452,0.00555633310008031,-0.00883176326829289,0.0129490624840219,0.711013405139228
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00172217215346266,0.00465946660337327,-0.00741038238914894,0.0108547266960743,0.711682378430748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,42370,0.00179319135852331,0.00486114449044239,-0.00773465184274377,0.0113210345597904,0.71222120027295
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00178862646943973,0.00489294461506584,-0.00780154497608931,0.0113787979149688,0.714706381551671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00246463661491032,0.00676062631861264,-0.0157154641993911,0.0107861909695704,0.715448848142631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,40136,-0.00176812296240008,0.00486998157675511,-0.0113132868528401,0.00777704092803994,0.71656286670757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.00209743899639275,0.00579299600582819,-0.0092568331750305,0.013451711167816,0.717310733628354
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.000740216900629643,0.0020511328287784,-0.00476043724503531,0.00328000344377602,0.71819335802574
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,40116,0.00210420237704859,0.00584086520252602,-0.0093438934199024,0.0135522981739996,0.718663224188202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,42794,0.00060258211959728,0.00167304075171531,-0.00267657775376473,0.00388174199295929,0.718724245716817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.00107605249653668,0.00299953579422625,-0.00695514265322013,0.00480303766014678,0.719795436834411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.0013741135713361,0.00387090035356731,-0.00896107826432802,0.00621285112165582,0.722607227576931
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00142734432864047,0.00407311700206693,-0.00655596499541072,0.00941065365269165,0.72602237558961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,40116,0.00200943174936466,0.00575142178936518,-0.00926335495779108,0.0132822184565204,0.726810781236172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0029377580398906,0.0085199911570477,-0.0196369407077041,0.0137614246279229,0.730245528664184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00208433768180046,0.00605804704878733,-0.0139581098974236,0.00978943453382272,0.730807028729348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00182492442343033,0.00531195104428392,-0.00858649962336615,0.0122363484702268,0.73119081744974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.00367409918022152,0.0108392559479014,-0.0249190408381083,0.0175708424776653,0.734644631650514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.00359258848452056,0.0106021577390987,-0.0243728176531539,0.0171876406841128,0.734725653608657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00187461741238645,0.00555019212838238,-0.0127529939840159,0.00900375915924302,0.735551548186602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,0.00105118326704308,0.0031283556616261,-0.00508039382974408,0.00718276036383023,0.736862677998189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.00182856381700703,0.00545100185430341,-0.00885539981742765,0.0125125274514417,0.737287513471211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.000948666163221339,0.00290287808351833,-0.00663830720691726,0.00474097488047458,0.743822799653248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00205099813512756,0.00627885531604438,-0.0143575545545745,0.0102555582843194,0.743937632885727
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.00161110464147719,0.00497264744870376,-0.0113574936409366,0.00813528435798219,0.745949440323592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,40080,-0.00149003220232283,0.00462725061856091,-0.0105594434147022,0.00757937901005656,0.747449463264331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.00186775788164105,0.00580138966977065,-0.00950296587110942,0.0132384816343915,0.74749557065752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,40302,-0.00183362955563511,0.00573453508948899,-0.0130733183310335,0.00940605921976331,0.749162285651776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,40223,-0.000560705466254053,0.00176149261057143,-0.00401323098297406,0.00289182005046595,0.750253779927895
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.000564932890776968,0.00180860038769672,-0.00410978965066253,0.0029799238691086,0.754773328012095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00132775938851753,0.00425180884214583,-0.00966130471912336,0.00700578594208831,0.754832791498281
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,42370,-0.00192160644956965,0.00620174907255797,-0.0140770346317833,0.010233821732644,0.756680601552533
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,40116,-0.00135595927231997,0.00438531617753463,-0.00995117898028783,0.0072392604356479,0.757171907922823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.0037705568985564,0.0122141188050107,-0.0277102297563774,0.0201691159592646,0.757550994431013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.00342322498027078,0.0111488707948466,-0.0252750117381702,0.0184285617776286,0.758813422520466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.000785658520030278,0.0025626315701774,-0.00423709935751742,0.00580841639757798,0.759166893955358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.00193700707635885,0.00634908739003871,-0.0143812183608347,0.010507204208117,0.760307525155547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,-0.000855878331633242,0.00283545594815479,-0.00641337199001663,0.00470161532675015,0.762773204659881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,40182,-0.000976599497571065,0.00324397596436713,-0.00733479238773063,0.0053815933925885,0.763381938379013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00107013018058886,0.00359639891621333,-0.00597881169518925,0.00811907205636699,0.766047664046196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00147491548672519,0.00496931283918526,-0.00826493767807792,0.0112147686515283,0.766621248579733
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,40080,-0.00191182262636768,0.00645218827803124,-0.0145581116513089,0.0107344663985736,0.767001994306158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,42370,-0.000816421863148441,0.00275544935927941,-0.00621710260733608,0.0045842588810392,0.767010583657318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,40461,0.000680047032483024,0.00231467697200838,-0.0038567198326534,0.00521681389761944,0.768917817881667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,40251,-0.000934692641990696,0.003181798997993,-0.00717101867805697,0.00530163339407558,0.768945046509425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.000667075522330228,0.00228300244572634,-0.0038076092712934,0.00514176031595386,0.770145166007314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.00190063025313342,0.00662983136815612,-0.0110938392284526,0.0148950997347194,0.774362950317146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,40116,-0.00199578252504933,0.00712035759826853,-0.0159516834176557,0.011960118367557,0.779258445960505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.000856633335798937,0.00311964437762685,-0.00697113631594757,0.0052578696443497,0.783633065559611
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.0013026431127093,0.00478114115354872,-0.0106736797736648,0.0080683935482462,0.78527760531894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,0.00127205244867921,0.00469618582809343,-0.0079324717743839,0.0104765766717423,0.786495820156872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,-0.000724613493997209,0.00269317028153258,-0.00600322724580107,0.00455400025780665,0.787891530882381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,0.00165095656975621,0.00613933680910927,-0.010382143576098,0.0136840567156104,0.788000487610137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00161290609529513,0.00606475196931086,-0.0102740077645542,0.0134998199551444,0.790284553536243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.00134611956400834,0.00507099500065589,-0.00859303063727722,0.0112852697652939,0.790664021305101
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTN,Titin,40116,-0.00168243889783669,0.00634706141322469,-0.0141226792677571,0.0107578014720837,0.790957708363212
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.000723404682632061,0.00273878407862573,-0.00464461211147436,0.00609142147673848,0.791681061379333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00160651508050198,0.00609610533666497,-0.0103418513793614,0.0135548815403653,0.792145924943036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.000736880680003437,0.00280589169741083,-0.00476266704692179,0.00623642840692866,0.792849067131608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00220590931650416,0.00846884899858828,-0.0143930347207289,0.0188048533537372,0.794502761323276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.00165316161372044,0.006374513463792,-0.0141472080027528,0.0108408847753119,0.7953782949567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00173236084931055,0.00672652504507085,-0.0149163499376494,0.0114516282390283,0.796765462843903
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.00228034565238684,0.0089428816120073,-0.0152477023071475,0.0198083936119211,0.798735616425234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.00200381812522012,0.0078586810603054,-0.0133991967529785,0.0174068330034187,0.798742124091126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000715538576404951,0.00281199414313844,-0.00622704709695629,0.00479596994414639,0.799144590665746
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,-0.00100893242279136,0.00397455549107215,-0.00879906118529277,0.00678119633971006,0.799617836187278
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.00208427221841079,0.00846203161893299,-0.0186698541915195,0.0145013097546979,0.805447748189793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00104800939597517,0.00429404105545501,-0.00946432986466698,0.00736831107271664,0.80718776452383
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,40182,-0.00112800562186823,0.00464143806072087,-0.0102252242208811,0.00796921297714467,0.807987206178269
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,40482,0.000833765415712115,0.00345686460625446,-0.00594168921254662,0.00760922004397085,0.809411290824874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,42483,0.00237637574463122,0.00986316596086497,-0.0169554295386641,0.0217081810279266,0.809609694850321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,42460,0.00131496792029107,0.0054645923952152,-0.00939563317433072,0.0120255690149129,0.809842345303595
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42673,0.000869726283931939,0.0036486970756179,-0.00628171998427915,0.00802117255214303,0.811600655657586
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.00192638762078664,0.00813448052825791,-0.0178699694561722,0.0140171942145989,0.812802781250062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00206392854034826,0.00879115084148924,-0.0151667271089706,0.0192945841896672,0.814388992686341
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,42595,0.00295764134368189,0.0126952952357889,-0.0219251373184643,0.0278404200058281,0.815787133182616
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.000996585545831573,0.00429762524933994,-0.00941993103453785,0.0074267599428747,0.816626120584682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.00159724736793272,0.00694363991643799,-0.0152067816041512,0.0120122868682857,0.818071717718558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,42370,-0.000986247340826328,0.00429996155749165,-0.00941417199350996,0.00744167731185731,0.818591208457014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,42549,-0.000813019884011099,0.00354575093889037,-0.00776269172423623,0.00613665195621403,0.818643825195122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000650618999952989,0.00286194094115962,-0.00495878524471987,0.00626002324462585,0.820166879968796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.000863219283271392,0.00388189598291503,-0.00847173540978485,0.00674529684324207,0.824029574470998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.000530701333916754,0.00244063920817191,-0.00531435418193371,0.0042529515141002,0.827866744593664
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,40302,0.000738228140921175,0.00341099970401452,-0.00594733127894728,0.00742378756078963,0.828659877000085
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,40199,-0.000627470343290244,0.00289960938779009,-0.00631070474335882,0.00505576405677833,0.828681355677723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.0018401771733023,0.00850864314311364,-0.018517117733805,0.0148367633872004,0.828780147562941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,0.00293171733708403,0.0137066762857109,-0.0239333681829094,0.0297968028570774,0.830636894312486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.000970385909100999,0.00460547694417705,-0.00999712071968801,0.00805634890148602,0.833122559153396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.00161818625952155,0.00772648393867087,-0.0167620947793164,0.0135257222602733,0.834112836738073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.00061420406987527,0.00296273463863313,-0.00519275582184567,0.00642116396159621,0.8357716831766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.000716420980653336,0.0034583704131809,-0.0074948269904879,0.00606198502918123,0.835892179945827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.0015714429770653,0.00759198221426745,-0.0164517281170295,0.0133088421628989,0.836023723384138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.000811732770687364,0.00396912930876537,-0.00696776067449276,0.00859122621586749,0.837957581050235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.000969084182479088,0.00474691825669008,-0.0102730439655916,0.00833487560063346,0.838239951291822
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,0.000571601729937839,0.00282337825692768,-0.00496221965364042,0.0061054231135161,0.839565735504513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42629,0.0035709223262168,0.0178910403354826,-0.0314955167313291,0.0386373613837627,0.841802102146911
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,40136,-0.0011884343186301,0.00603662238795201,-0.013020214199016,0.0106433455617558,0.843932347817763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00182772279208966,0.00931840748766411,-0.016436355883732,0.0200918014679113,0.844503380812906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,40527,-0.000830924770828354,0.00425280479683537,-0.00916642217262569,0.00750457263096898,0.845096808839432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,40136,0.000938129213378858,0.00481401578456489,-0.00849734172436833,0.010373600151126,0.845494767688683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00138217999085299,0.00709782532592065,-0.0125295576479515,0.0152939176296575,0.845605682859601
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00100149912003551,0.00518592072459614,-0.0111659037402439,0.00916290550017292,0.846869415751518
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.00138499874060257,0.00720313948261103,-0.0155031521265202,0.012733154645315,0.847528608452607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42711,-0.00058598184303656,0.00308157148709553,-0.00662586195774379,0.00545389827167067,0.849189099689262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,-0.000805591177755805,0.00423827137883723,-0.00911260308027677,0.00750142072476516,0.849253569725783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.00152106794275027,0.00814761364883886,-0.0144482548089739,0.0174903906944744,0.851908110769154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.000498844518794584,0.0027507567164451,-0.00589032768302698,0.00489263864543782,0.856097689051318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,40182,0.00157996872463645,0.00881577080726547,-0.0156989420576039,0.0188588795068768,0.85776770531962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42636,0.00115202501220457,0.00644617176262645,-0.0114824716425433,0.0137865216669524,0.858164497442338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.000649022852662975,0.00367271396611429,-0.00654949652092102,0.00784754222624697,0.859735685120947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.000739503007592155,0.00418821194674446,-0.00746939240802698,0.00894839842321129,0.859851230130996
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.00122996650662455,0.00698953357407207,-0.0124695192985567,0.0149294523118058,0.860318116590858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.000605813653538025,0.00346064031084869,-0.00617704135572541,0.00738866866280146,0.86103709850756
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.000524424091081955,0.00304074887318931,-0.0054354437003691,0.00648429188253301,0.863074805786543
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.00139397718586596,0.00849880503611616,-0.0180516350566536,0.0152636806849217,0.869718148589856
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42563,0.00101099646093078,0.00624580234288573,-0.0112307761311253,0.0132527690529868,0.871412131975087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.000625199322634805,0.00401838955277318,-0.00725084420080063,0.00850124284607024,0.876362848965383
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00052658279009051,0.0034141145522836,-0.00616508173238534,0.00721824731256636,0.877425696800517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,-0.000506588819996984,0.003296227982081,-0.00696719566487573,0.00595401802488177,0.877858511488183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.000681331776957095,0.00450363124912314,-0.00814578547132427,0.00950844902523846,0.879753626104364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.000754872853724509,0.00506331764552336,-0.0106789754389503,0.00916922973150128,0.881487944484437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.00162375238684907,0.0109115629825785,-0.0230104158327029,0.0197629110590047,0.881706030465681
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.000762587879766639,0.00521130427330425,-0.0094515684959097,0.010976744255443,0.883660894903477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,40116,-0.00155205371204454,0.0108215937225411,-0.022762377408225,0.0196582699841359,0.88595962082827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.000856268122350767,0.00598272679307168,-0.0125824126367713,0.0108698763920697,0.886195370303009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,42475,-0.000639448212679068,0.00447863061899747,-0.00941756422591412,0.00813866780055598,0.886467979952424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,-0.000787524465290019,0.00556867920920786,-0.0117021357153374,0.0101270867847574,0.887540496125881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,0.000544319316949083,0.00385230119716475,-0.00700619102949383,0.008094829663392,0.887637778827392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.000411392241948593,0.00295620395912923,-0.0053827675179447,0.00620555200184188,0.889324002894273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,40199,0.000519495826337652,0.00377037088222533,-0.006870431102824,0.0079094227554993,0.89041385088379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,40302,-0.000944555881330968,0.00686225618616011,-0.0143945780062048,0.0125054662435428,0.890523411546507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00064261122660894,0.00473858971663244,-0.00993024707120851,0.00864502461799063,0.8921302592857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.000498153151451352,0.0037774146932415,-0.00790188595020469,0.00690557964730198,0.895083764316032
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,40539,0.000246130072030797,0.00187461202518653,-0.00342810949733481,0.0039203696413964,0.895543057191995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,40199,-0.00133237247832422,0.0101618337032417,-0.021249566536678,0.0185848215800295,0.895686447668073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42654,-0.00137529978936035,0.0105663909176589,-0.0220854259879717,0.019334826409251,0.896443406890591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,40483,0.00127250914532805,0.00999896859001636,-0.018325469291104,0.0208704875817601,0.898733686885735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,40080,-0.000420909248216667,0.00332021763755406,-0.00692853581782263,0.00608671732138929,0.899123528479792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.000749419938623027,0.00594323047022058,-0.0123981516602554,0.0108993117830093,0.899657902974728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,39989,-0.000555086265068517,0.0045594272528461,-0.00949156368064688,0.00838139115050985,0.903103448970463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,0.000571842624611839,0.0047443669086761,-0.00872711651639332,0.00987080176561699,0.904064432892628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.000489046445968183,0.00418463034525519,-0.00869092192266836,0.00771282903073199,0.906967356966883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.000501776893527153,0.00447751904669071,-0.00927771422504095,0.00827416043798664,0.910772873536786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,40539,0.00027659782309211,0.00249683676481157,-0.00461720223593856,0.00517039788212278,0.911793321967786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.000649698446761264,0.00592723774620086,-0.012267084429315,0.0109676875357924,0.912718831122109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,40080,-0.000728562790213537,0.00668049564617299,-0.0138223342567126,0.0123652086762855,0.91315834349622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,40283,-0.000472568889702905,0.00433657551729291,-0.00897225690359701,0.00802711912419121,0.913226015325443
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00183962739627254,0.016939337653009,-0.0313614744036251,0.0350407291961702,0.913520979003596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,40199,-0.000581568536413309,0.0053622317577654,-0.0110915427816335,0.00992840570880688,0.913635614246903
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42569,-0.000297477672310711,0.00275101665369024,-0.00568947031354358,0.00509451496892216,0.913891240045585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.000528024538983738,0.00509206425254503,-0.010508470473972,0.00945242139600451,0.917412809073182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.000781604990436125,0.00811455172701451,-0.0166861263753846,0.0151229163945123,0.923266786110329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.000285008201677552,0.00299843333067439,-0.00616193752979936,0.00559192112644426,0.924274674871235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-0.000263483670855196,0.00279159311347544,-0.00573500617326706,0.00520803883155667,0.924804973984612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.000285077960457123,0.00304777848728152,-0.00625872379552889,0.00568856787461465,0.925478897118131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.000493396884548995,0.00527612394961299,-0.00984780605669246,0.0108345998257905,0.92549610029932
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.000312132433492365,0.00335855646938508,-0.00689490311348712,0.00627063824650239,0.925955401318507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,40199,-0.000499936393449892,0.00545188679609698,-0.0111856345138,0.0101857617269002,0.926938303352169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,42311,-0.000585365047134319,0.0064507409328268,-0.0132288172754748,0.0120580871812062,0.927697515181535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.00061729388746697,0.00712136480615682,-0.0133405811326004,0.0145751689075343,0.930925890129121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,0.000326151027094512,0.00377318155154513,-0.00706928481393395,0.00772158686812297,0.93111882723635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.000411450811184255,0.00518596119686968,-0.00975303313468031,0.0105759347570488,0.936764155843363
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,42618,-0.000278848948620078,0.00353863075287689,-0.00721456522425879,0.00665686732701863,0.937191789467267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,40182,0.000439771911087265,0.0057949815562517,-0.0109183919391661,0.0117979357613406,0.939509262785784
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,42357,-0.00019769317993531,0.00266567482696647,-0.00542241584078959,0.00502702948091897,0.940882190165
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,40182,-0.000343696838457788,0.00475483784206431,-0.00966317900890385,0.00897578533198827,0.942377524461499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,40080,0.000213466485740174,0.00302465241850085,-0.0057148522545215,0.00614178522600185,0.943736872401585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.000495400144563032,0.00763919245586666,-0.0154682173580617,0.0144774170689356,0.9482947655692
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00022549759359707,0.00350616606622806,-0.00709758308340406,0.00664658789620992,0.9487209223206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.000320589076623938,0.00500177332685429,-0.0101240647972583,0.00948288664401046,0.948895480154734
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42754,-0.000231220445018185,0.00381323199088042,-0.0077051551471438,0.00724271425710743,0.951649722403791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.000228536814705481,0.0038188238896526,-0.00771343163842458,0.00725635800901361,0.952280295554641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,42311,0.000306538786749207,0.00512719452716232,-0.00974276248648895,0.0103558400599874,0.952326313445642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.000217983254684553,0.00367631358511951,-0.0074235578815188,0.00698759137214969,0.952719036765455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.000357253036227999,0.0063336976867242,-0.0120567944297514,0.0127713005022074,0.955019902008445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.000249752075881988,0.00458077977438684,-0.00872857628191621,0.00922808043368019,0.9565202954861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,40451,0.000185789538377795,0.00384002330201383,-0.00734065613356932,0.00771223521032491,0.961412345001952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.000139111302404095,0.00306699118401496,-0.00587219141826523,0.00615041402307342,0.963822979894108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,42357,-0.000140481065882176,0.00320534132371667,-0.00642295006036685,0.0061419879286025,0.965042827484426
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.000314026749380909,0.00717272798129667,-0.0143725735927224,0.0137445200939606,0.965080043993124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,40080,0.000323748911363973,0.00744195567531636,-0.0142624842122561,0.014909982034984,0.965301208890348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000155419740055301,0.00365590612890347,-0.00732099575270611,0.00701015627259551,0.966091353690189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,-0.000178924471150063,0.00433145208330748,-0.00866857055443272,0.00831072161213259,0.967050929846925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.000176108001170298,0.00446085906544115,-0.00856717576709435,0.00891939176943495,0.968509614972545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.000109164840469595,0.00306306119689513,-0.00611276478638406,0.00589443510544487,0.97157075588813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.000139992578976109,0.00393159291337983,-0.00756592953124837,0.00784591468920058,0.971596305179094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,42357,0.000210637973958517,0.00595758115038594,-0.0114662210807979,0.011887497028715,0.971796173593776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,40199,0.000178214819473743,0.00535064699756844,-0.0103090532957604,0.0106654829347079,0.973430253503259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,40080,-0.000140996409591305,0.00447092920204512,-0.00890401764559973,0.00862202482641712,0.974842449106825
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.000107129660955871,0.00347475579112989,-0.00670339168965871,0.00691765101157045,0.975404908311067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.000206592578807865,0.00694993161077559,-0.0134152733783123,0.013828458535928,0.976286240822762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.000224389260045853,0.00781382525918683,-0.015539486768052,0.0150907082479603,0.977090861793194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,5.29465690357493e-05,0.0021432080649836,-0.0041477412383321,0.0042536343764036,0.980291150282457
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,-9.07710704707868e-05,0.00410920020826549,-0.00814480347867115,0.00796326133772958,0.982376793829303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.00011595635292741,0.00538370198221923,-0.0106680122380771,0.0104360995322223,0.982816549721768
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-9.80921477612886e-05,0.00473714125372221,-0.00938288900505682,0.00918670470953424,0.983479732840607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.000107704127423519,0.00649349225323142,-0.0126195406889101,0.0128349489437571,0.986766814745484
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-3.49182404354648e-05,0.00229606140614099,-0.0045351985964718,0.00446536211560087,0.987866598928078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,3.37983160908565e-05,0.00363025322808795,-0.00708149801096152,0.00714909464314324,0.992571795036493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,40182,4.36588632635847e-05,0.00691176653167745,-0.0135034035388242,0.0135907212653514,0.99496023070739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,40293,1.25237735499029e-05,0.0023739436859483,-0.00464040585090877,0.00466545339800858,0.995790863031154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,9.52715595269855e-06,0.00490071078512301,-0.0095958659828884,0.0096149202947938,0.998448920322329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,-7.52388221184378e-06,0.00410745404856082,-0.00805813381739105,0.00804308605296736,0.998538498628784
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,40511,6.25096660471156e-06,0.00372502746231823,-0.00729480285953903,0.00730730479274845,0.998661100548545
